44063|nebulizer
44064|neuropeptide
44065|neurotoxin
44066|nonblinded
44067|objective response
44068|oral
44069|osteogenic sarcoma
44070|overall survival rate
44071|oxidative metabolism
44072|oxidative stress
44073|panacea
44074|pancreatic
44075|parasitic
44076|perioperative
44077|photophobia
44078|progression
44079|prospective
44080|protozoal
44081|ptosis
44083|rectal
44084|regional
44085|response
44086|rheumatism
44087|selection bias
44088|serum
44090|symptomatic
44091|tumor model
44092|uncontrolled study
44093|urinary
44094|viscotoxin
44095|xenograft
44096|testimonial
44097|dimethyl sulfoxide
44098|catechol
44099|beta-endorphin
44100|ingestion
44101|sodium sulfite
44102|cervical
44103|anorexia
44104|anticachexia
44105|antidepressant
44106|antituberculosis
44107|barbiturate
44108|cachexia
44109|caloric intake
44110|dose-dependent
44111|gluconeogenesis
44112|herbicide
44113|hydrogen peroxide
44114|hypoglycemia
44115|lymphosarcoma
44116|motor
44117|neurologic
44118|paresthesia
44119|polyneuritis
44120|retrospective
44121|sensory
44122|serum albumin
44123|bacteria
44124|biochemical reactions
44125|bromelain
44126|cellular metabolism
44127|collagen disease
44128|cystic fibrosis
44129|diabetes mellitus
44130|emphysema
44131|glycolysis
44132|hemophilia
44133|mutate
44134|inositol
44135|multiple sclerosis
44136|nitric acid
44137|encephalopathy
44138|degenerative disease
44139|hepatitis C virus
44140|Parkinson disease
44141|potassium hydroxide
44142|scleroderma
44143|sulfuric acid
44144|adjunctive therapy
44145|angelica root
44146|autoclave-resistant factor
44147|beta-glucan
44148|biochanin A
44149|control group
44150|freeze-dried
44151|ginseng
44152|hawthorn fruit
44153|Hedyotis diffusa
44154|inferior vena cava
44155|inositol hexaphosphate
44156|Karnofsky Performance Status
44157|lentinan
44159|mung bean
44160|nonrandomized clinical trial
44161|plant sterol
44162|polysaccharide
44163|primary endpoint
44164|red date
44165|saponin
44166|senega root
44167|statistically significant
44168|clinical
44169|contralateral
44170|dose-limiting
44171|histology
44172|ipsilateral
44173|myelosuppression
44174|performance status
44175|port-a-cath
44176|salvage therapy
44177|systemic disease
44178|terminal cancer
44179|Philadelphia chromosome
44180|seminal fluid
44181|sperm retrieval
44182|hospice
44183|acne
44184|amino acid sequence
44185|anal
44186|antiangiogenic
44213|milligram
44214|milliliter
44215|millimeter
44216|molecular mass
44217|nonmalignant
44218|proteoglycan
44219|psoriasis
44220|regional enteritis
44221|skeleton
44222|vascular endothelial growth factor
44223|parageusia
44224|diameter
44225|bioavailable
44226|embolism
44227|prophylactic mastectomy
44228|preventive mastectomy
44229|selective estrogen receptor modulator
44230|SERM
44231|thrombosis
44232|aromatase inhibitor
44233|carcinoid tumor
44234|CAT scan
44235|computerized axial tomography scan
44236|computerized tomography
44237|colon cancer
44238|follicular large cell lymphoma
44239|gastrinoma
44240|Horner syndrome
44241|Hurthle cell neoplasm
44242|liver cancer
44243|metaplastic carcinoma
44244|nuclear magnetic resonance imaging
44245|predictive factor
44246|prognostic factor
44247|synthetic retinoid
44248|teratoma
44249|collagenase
44250|embryonic
44251|Bowen disease
44252|enchondroma
44253|keratoacanthoma
44254|Klebsiella
44255|Lhermitte's sign
44256|pseudomyxoma peritonei
44257|retroperitoneal
44258|septate
44259|somnolence syndrome
44260|tomography
44261|yttrium
44262|Zollinger-Ellison syndrome
44264|Cancer Information Service
44265|CIS
44266|National Cancer Institute
44267|NCI
44268|National Institutes of Health
44269|NIH
44270|Physician Data Query
44271|PDQ
44272|anticarcinogenic
44273|carcinostatic
44274|compound nevus
44275|decortication
44276|dermatofibrosarcoma protuberans
44277|de novo
44278|disseminate
44279|dysplastic nevus
44280|glucagonoma
44281|heterogenic
44282|heterogenous
44283|hydrazine sulfate
44284|irradiation
44285|junctional nevus
44286|leukopenia
44287|localization
44288|lymphoepithelioma
44289|mucinous carcinoma
44290|necrosis
44291|obtundation
44292|perineural
44293|pheresis
44294|pleurodesis
44295|radiotherapy
44296|relative survival rate
44297|signet ring cell carcinoma
44298|spindle cell sarcoma
44299|stereotactic biopsy
44300|subependymal
44301|survival rate
44302|x-ray therapy
44303|arsenic
44304|segmental cystectomy
44305|superficial
44306|surgeon
44307|urologic oncologist
44308|vaginal
44309|vas deferens
44310|parasite
44311|disease-specific survival rate
44312|regional lymph node
44313|lymphadenopathy
44314|5-hydroxyindoleacetic acid
44315|ampulla
44316|ampulla of Vater
44317|calcification
44318|colitis
44319|hydronephrosis
44320|hydroureter
44321|idiopathic
44323|mesothelioma
44324|pharmacokinetics
44325|sella turcica
44326|thermal ablation
44525|hormone treatment
44526|amelanotic melanoma
44527|aorta
44528|assay
44529|atelectasis
44530|macroglobulinemia
44531|margin
44532|medullary breast carcinoma
44533|nephrotoxic
44534|patient advocate
44535|pretracheal space
44536|superior vena cava
44537|xerostomia
44538|complete hysterectomy
44539|augmerosen
44540|transabdominal ultrasound
44541|anaplastic thyroid cancer
44542|cold nodule
44543|thyroid follicular cell
44544|follicular thyroid cancer
44545|goiter
44546|hot nodule
44547|hypothyroidism
44548|iodine
44549|isthmus
44550|medullary thyroid cancer
44551|multiple endocrine neoplasia syndrome
44552|nuclear medicine scan
44553|papillary thyroid cancer
44554|parathyroid gland
44555|radioactive fallout
44556|thyroglobulin
44557|thyroidectomy
44558|thyroid hormone
44559|thyroid-stimulating hormone
44560|mammary
44561|general anesthesia
44562|hepatectomy
44563|hepatic artery
44564|hepatic portal vein
44565|microwave therapy
44566|mold
44567|percutaneous ethanol injection
44568|resectable
44569|transplant surgeon
44570|human epidermal growth factor receptor 2
44571|fungus
44572|proliferating
44573|trace element
44574|luteinizing hormone-releasing hormone
44575|nonconsecutive case series
44576|kilogram
44577|immunization
44578|C cell
44579|athymic nude mouse
44580|attenuated
44581|bacillus Calmette-Guérin
44582|bispecific monoclonal antibody
44583|booster
44584|co-culture
44585|control animal
44586|cytoplasm
44587|delayed-type hypersensitivity response
44588|enveloped virus
44589|erythema
44590|fibroblast
44591|fusion protein
44592|ganglioside
44593|genome
44594|helper T cell
44595|hemagglutinin-neuraminidase
44596|historical control subject
44597|host cell
44598|immune system tolerance
44599|immunocompetence
44600|inhalation
44601|intracolonic
44602|intradermal
44603|intratumoral
44604|inviable
44605|laryngitis
44606|lysis
44607|mastocytoma
44608|microscopic
44609|neural
44610|neurotropism
44611|oncolysate
44612|oncolysis
44613|palpable disease
44614|paramyxovirus
44615|plasma membrane
44616|progeny
44617|rabies
44618|radical lymph node dissection
44619|recombinant
44620|regional lymph node dissection
44621|replicate
44622|resting
44623|sialic acid
44624|replication cycle
44625|syncytium
44626|synovial sarcoma
44627|tumor burden
44628|tumor-specific antigen
44629|viral
44630|virulence
44631|virus-neutralizing antibody
44632|virus replication cycle
44633|viscera
44634|synovial membrane
44648|blood cell count
44649|CBC
44650|breast carcinoma in situ
44651|calorie
44652|chemoprevention study
44653|child-life worker
44654|chronic pain
44655|clavicle
44656|cobalt 60
44657|colon polyp
44658|Data and Safety Monitoring Board
44659|dehydration
44660|diet
44661|dietitian
44662|nutritionist
44663|distraction
44664|dose
44665|dosimetrist
44666|dysphagia
44667|electron beam
44668|estrogen receptor test
44669|fluid
44670|fluoride
44671|follow-up
44672|generic
44673|high-dose-rate remote brachytherapy
44674|remote brachytherapy
44675|hypnosis
44676|breast implant
44677|informed consent
44678|injection
44679|Institutional Review Board
44680|IRB
44681|intervention group
44682|intracavitary
44683|intracavitary radiation therapy
44684|intralesional
44685|investigator
44686|lactose
44687|linear accelerator
44688|mega-voltage linear accelerator
44689|linac
44690|lumen
44691|narcotic
44692|negative test result
44693|nerve block
44694|nonopioid
44695|nonprescription
44696|over-the-counter
44697|nutrient
44698|nutrition
44699|oncology pharmacy specialist
44700|onset of action
44701|pain threshold
44702|pathology report
44703|patient-controlled analgesia
44704|PCA
44705|peripheral neuropathy
44706|phantom limb pain
44707|physical therapist
44708|physical therapy
44709|phytochemical
44710|positive test result
44711|prescription
44712|primary care doctor
44713|progesterone receptor test
44714|protocol
44715|proton
44716|psychologist
44717|radiation nurse
44718|radiation physicist
44719|radiation therapist
44720|rapid-onset opioid
44721|reconstructive surgeon
44722|reconstructive surgery
44723|relaxation technique
44724|scientist
44725|silicone
44726|simulation
44727|single blind study
44728|skin patch
44729|skin stimulation
44730|social worker
44731|sodium
44732|soft diet
44733|stomatitis
44734|study agent
44735|surgical oncologist
44736|TENS
44737|therapy
44738|tissue flap reconstruction
44739|drug tolerance
44740|transcutaneous electrical nerve stimulation
44741|treatment field
44742|unconventional cancer treatments
44743|unsealed internal radiation therapy
44744|vitamin
44745|high-dose-rate remote radiation therapy
44746|pineal body
44747|pineal organ
44748|lupus
44749|ATP
44750|RSV
44751|thyroid gland
44752|5-FU
44753|appendix
44754|Bellini duct carcinoma
44755|cystosarcoma phyllodes
44756|dyscrasia
44757|eosinophilia
44758|experimental
44759|fatty breast tissue
44760|Gerota's fascia
44765|meiosis
44766|mitosis
44767|mitotic activity
44768|nodular parenchyma
44769|proliferative index
44770|parotidectomy
44771|S-phase fraction
44772|thrush
44773|candidosis
44774|candidiasis
44775|undifferentiated
44776|vulvar cancer
44777|FAP
44778|metasynchronous
44779|nuclear grade
44780|granulosa cell tumor
44781|papillary serous carcinoma
44782|progression-free survival
44783|time to progression
44784|epitope
44786|abscess
44787|asthenia
44788|benign proliferative breast disease
44789|cellulitis
44790|clinical practice guidelines
44791|coloanal pull-through
44792|coloanal anastomosis
44793|isointense
44794|lamina propria
44795|plasmacytic
44796|pluripotent
44797|pluripotent stem cell
44798|polymerase chain reaction
44799|totipotent
44800|urea nitrogen
44801|cerebrospinal fluid diversion
44802|intestinal villi
44803|villus
44804|tumor load
44805|polymorphism
44806|hepatic veno-occlusive disease
44807|heterogeneous
44808|tubulovillous adenoma
44809|villous adenoma
44810|5Q- syndrome
44811|aerodigestive tract
44812|aminoglycoside antibiotic
44813|antiestrogen
44814|antifolate
44815|folate antagonist
44816|antineoplastic
44817|bisphosphonate
44818|diphosphonate
44819|COX-2 inhibitor
44820|cyclooxygenase-2 inhibitor
44821|endothelin receptor antagonist
44822|epipodophyllotoxin
44823|glossectomy
44824|glycinamide ribonucleotide formyltransferase inhibitor
44825|hand-foot syndrome
44826|palmar-plantar erythrodysesthesia
44827|neuroepithelial
44828|nonsteroidal aromatase inhibitor
44829|signal transduction inhibitor
44830|superior vena cava syndrome
44831|synthetic protegrin analog
44832|thymidylate synthase inhibitor
44833|tyrosine kinase inhibitor
44834|histologic examination
44835|immunocompetent
44836|irradiated
44837|lytic
44838|nonlytic
44840|placebo-controlled
44841|vaccinated
44842|virulent
44843|visceral
44844|eosinophil
44845|mast cell
44846|chronic lymphocytic leukemia
44847|stage 0 chronic lymphocytic leukemia
44848|stage III cutaneous T-cell lymphoma
44849|acridine carboxamide
44850|3-aminopyridine-2-carboxaldehyde thiosemicarbazone
44851|alemtuzumab
44852|staurosporine
44853|isolated limb perfusion
44854|Waldenström macroglobulinemia
44855|L-377,202
44856|rosiglitazone
44857|ISIS 2503
44858|VNP20009
44859|stage I multiple myeloma
44860|filgrastim-SD/01
44861|AFP
44862|AG3340
44863|stage II multiple myeloma
44864|TPA
44865|radiofrequency ablation
44866|stage III multiple myeloma
44867|PSA
44868|pedigree
44869|P-32
44896|enoxaparin
44897|Biomed 101
44898|phosphorus P 32
44899|cervical intraepithelial neoplasia
44900|psoralen
44901|chronic myelogenous leukemia
44902|ILX-295501
44903|stent
44904|neuroendocrine tumor
44905|isolated lung perfusion
44906|levofloxacin
44907|BMS-188797
44908|suberoylanilide hydroxamic acid
44909|lycopene
44910|phenethyl isothiocyanate
44911|diabetes
44912|autologous
44913|APC vaccine
44914|antigen-presenting cell
44915|antigen-presenting cell vaccine
44916|anthracycline
44917|anti-idiotype vaccine
44918|antibody
44919|analog
44920|allogeneic
44921|alternative medicine
44922|adverse effect
44923|whole cell vaccine
44924|1H-nuclear magnetic resonance spectroscopic imaging
44925|ultrasound energy
44926|tubal ligation
44927|tumor antigen vaccine
44928|T cell
44929|stromal tumor
44930|standard therapy
44932|prophylactic oophorectomy
44933|ovulation
44934|nonspecific immune cell
44935|omentum
44936|nonmalignant hematologic disorder
44937|node-positive
44938|musculoskeletal
44939|multicenter study
44940|MS 209
44941|median
44942|intraperitoneal radiation therapy
44943|irreversible toxicity
44944|hydration
44945|HER2/neu
44946|functional magnetic resonance imaging
44947|esophagitis
44948|dendritic cell
44949|dendritic cell vaccine
44950|conventional treatment
44951|complementary medicine
44952|cancer vaccine
44953|B lymphocyte
44954|obstruction
44955|p-value
44956|retrospective study
44957|St. John's wort
44958|receptor
44959|perfusion magnetic resonance imaging
44960|hematopoietic growth factor
44961|genetic counseling
44962|diverticulosis
44963|cruciferous vegetable
44964|complementary and alternative medicine
44965|computed tomographic colonography
44966|APC8015
44967|CC-1088
44968|CP-609,754
44969|indole-3-carbinol
44970|biliary
44971|radiation therapy
44972|BMS-275291
44973|virtual colonoscopy
44974|vulva
44975|urothelium
44976|nonhematologic cancer
44977|digital photography
44978|computed tomography colonography
44979|yttrium Y 90-SMT 487
44980|donepezil
44981|LY293111
44982|ERA-923
44983|spiral CT scan
44984|ovarian
44985|HIV
44986|DHEA
44987|beta alethine
44988|renal cell cancer
44989|unilateral
44990|total androgen blockade
44991|Transcendental Meditation
44992|malignant mesothelioma
44993|peritoneal
44994|mistletoe lectin
44995|dental implant
44996|chest wall
44997|clear cell sarcoma of the kidney
44998|gastrointestinal stromal tumor
44999|ceramide
45000|caspofungin acetate
45002|atamestane
45003|karenitecin
45442|zinc oxide
45443|tributyrin
45444|disulfiram
45445|exemestane
45446|glutamine
45447|UCN-01
45448|tetracycline
45449|clarithromycin
45450|omeprazole
45451|amoxicillin
45452|dolastatin 10
45453|radioimmunoguided surgery
45454|denileukin diftitox
45455|ALVAC-CEA vaccine
45456|pemetrexed disodium
45457|lurtotecan
45458|thalidomide
45459|perillyl alcohol
45460|tyrosinase peptide
45461|RMP-7
45462|Allovectin-7
45463|interleukin-11
45464|peldesine
45465|oxaliplatin
45466|hyperuricemia
45467|cetuximab
45468|motexafin gadolinium
45469|lutetium texaphyrin
45470|phenobarbital
45471|dehydroepiandrosterone
45472|MDL 101,731
45473|marimastat
45474|DX-52-1
45475|VX-710
45476|pneumonia
45477|systemic lupus erythematosus
45478|cirrhosis
45479|aplastic anemia
45481|aspergillosis
45482|stage I pancreatic cancer
45483|plasmapheresis
45484|seizure
45485|dialysis
45486|respiratory therapy
45487|chemoprevention
45488|Down syndrome
45489|T4N5 liposomal lotion
45490|stage II pancreatic cancer
45491|Cockayne syndrome
45492|prednisone
45493|ulcerative colitis
45494|arginine butyrate
45495|doxycycline
45496|deoxycytidine
45497|stage III pancreatic cancer
45498|hydrocephalus
45499|Fanconi anemia
45500|zoledronate
45501|CT-2584
45502|nitrocamptothecin
45503|CEP-2563 dihydrochloride
45504|anastrozole
45505|radiology
45506|DPPE
45507|amyloidosis
45508|enalapril
45509|cidofovir
45510|penicillamine
45511|stage IV pancreatic cancer
45512|RPR 109881A
45513|sirolimus
45514|pentetic acid calcium
45515|carzelesin
45516|ecteinascidin 743
45517|LU 79553
45518|KRN5500
45519|lamivudine
45520|indinavir
45521|FR901228
45522|CGP 48664
45523|tin ethyl etiopurpurin
45524|18F-fludeoxyglucose
45525|rituximab
45526|ethynyluracil
45527|RSR13
45528|raltitrexed
45529|R115777
45530|SCH-58500
45531|umbilical cord blood transplantation
45532|aminolevulinic acid
45533|LU-103793
45534|isotretinoin
45535|ritonavir
45536|cordycepin
45537|tocladesine
45540|glufosfamide
45541|LMB-7 immunotoxin
45542|MEN-10755
45543|bizelesin
45544|voriconazole
45545|eniluracil
45546|saquinavir mesylate
45547|nelfinavir mesylate
45548|leuvectin
45550|interleukin-4 PE38KDEL cytotoxin
45551|technetium Tc 99m-dextran
45552|anaplastic large cell lymphoma
45553|paroxetine hydrochloride
45554|mycophenolate mofetil
45555|lisofylline
45556|laparoscopy
45557|ultrasonography
45558|technetium Tc 99m-sulfur colloid
45559|anetholtrithione
45575|vorozole
45576|tamoxifen
45577|Biafine cream
45578|emitefur
45579|histamine dihydrochloride
45580|lymphography
45581|testosterone
45582|3-dimensional
45583|9-cis retinoic acid
45584|90Y-DOTA-biotin
45585|acute
45586|acute lymphoblastic leukemia
45587|adjuvant therapy
45588|aggressive lymphoma
45589|alkylating agent
45590|analgesic
45591|anaplastic
45592|androgen
45593|androgen suppression
45594|anthracenedione
45595|anthraquinone
45596|antiangiogenesis
45597|anti-CEA antibody
45598|antineoplastic antibiotic
45599|antisense c-fos
45600|antithymocyte globulin
45601|ascites
45602|astrocytoma
45603|thiotepa
45604|autoimmune disease
45605|autologous lymphocyte
45606|autologous tumor cell
45607|axillary lymph node
45608|axillary lymph node dissection
45609|B3 monoclonal antibody
45610|bacterial toxin
45611|B cell
45612|breakthrough pain
45613|oblimersen sodium
45614|benign
45615|bilateral cancer
45616|biological response modifier therapy
45617|biological therapy
45618|biomarker
45619|biopsy specimen
45620|bolus dose
45622|bone marrow
45623|bone marrow metastasis
45624|brain stem glioma
45625|brain stem tumor
45626|breast-conserving surgery
45627|Brief Pain Inventory
45628|bronchoscopy
45629|bronchus
45630|bryostatin 1
45631|c-erbB-2
45632|calcium
45633|camptothecin analog
45634|cardiac
45635|cardiopulmonary
45636|castration
45637|catheter
45638|CD34 antigen
45639|chemoprotective agent
45640|chemosensitizer
45641|chronic disease
45643|CNS
45644|CNS metastasis
45645|CNS tumor
45646|coactivated T cell
45647|colectomy
45648|colonoscopy
45649|colony-stimulating factor
45650|combination chemotherapy
45651|complete remission
45652|complete response
45653|compression bandage
45654|consolidation therapy
45655|continuous infusion
45656|NCI clinical trials cooperative group
45657|core biopsy
45658|corticosteroid
45659|Corynebacterium granulosum
45660|crisnatol mesylate
45661|Crohn disease
45663|cytotoxic chemotherapy
45664|cytotoxic T cell
45665|D-20761
45667|dermatitis
45668|digital rectal examination
45669|disease progression
45670|distant cancer
45671|DNA
45672|dose-rate
45673|double-blinded
45674|ductal carcinoma in situ
45675|dysplasia
45676|edema
45677|endometrial disorder
45678|endoscopy
45679|ependymal tumor
45680|epidermal growth factor receptor
45681|epidural
45682|epithelial
45683|epithelial ovarian cancer
45684|Epstein-Barr virus
45685|estrogen replacement therapy
45686|evaluable disease
45687|fallopian tube
43966|stage II cutaneous T-cell lymphoma
43967|6-hydroxymethylacylfulvene
43968|arterial embolization
43969|arteriogram
43970|arteriography
43971|bcl-2 antisense oligodeoxynucleotide G3139
43972|DX-8951f
43973|speech pathologist
43974|sperm banking
43975|STI571
43976|activate
43977|APC
43978|passive antibody therapy
43979|phagocyte
43980|postoperative
43981|preventive
43982|clinical resistance
43983|response rate
43984|specific immune cell
43985|therapeutic
43986|toxic
43987|immunological adjuvant
43988|vaccine adjuvant
43989|viral vector
43990|adenopathy
43991|aerobic
43992|aerobic metabolism
43993|aerobic respiration
43994|alkaloid
43995|anecdotal report
43996|animal model
43997|antioxidant
43998|aqueous
43999|ataxia
44000|benzaldehyde
44001|camphor
44002|Campath
44003|carcinosarcoma
44004|cardiotoxicity
44005|cardiovascular
44006|case series
44007|case report
44008|cell respiration
44009|chemotherapeutic agent
44010|clinical series
44011|concurrent therapy
44012|conditioned stimulus
44013|connective tissue
44014|controlled clinical trial
44015|controlled study
44016|cultured cell line
44017|cultured cell
44018|cyanogenic glucoside
44019|cyanosis
44020|cytotoxic agent
44021|dark-field microscope
44022|derivative
44023|disease-free survival
44024|effector cell
44025|electron microscope
44026|endogenous
44027|epigastric
44028|epilepsy
44029|evaluable patients
44030|free radical
44031|gamma irradiation
44032|germfree
44033|glucose
44034|glycoprotein
44035|hematopoiesis
44036|hematopoietic tissue
44037|hydrolysis
44038|hypertension
44039|hypotension
44040|hypoxic
44041|immunosuppressive
44042|inflammation
44043|insomnia
44044|interleukin-1-alpha
44045|interleukin-6
44046|intestinal
44047|intracellular
44048|intramuscular
44049|intramuscular injection
44050|intravenous injection
44051|lectin
44052|light microscope
44053|lysosome
44054|macrophage
44055|metabolic disorder
44056|metabolic
44057|metabolic therapy
44058|metastatic
44059|microorganism
44060|mitochondria
44061|nasal
44062|natural killer cell
45804|nonmelanomatous
45805|nonmetastatic
45806|NR-LU-10 antigen
45807|NSAID
45808|oligodendroglial tumor
45809|omega-3 fatty acid
45810|osteolytic
45811|ovarian ablation
45812|overexpress
45813|p53 gene
45814|Paget disease of the nipple
45815|palliative therapy
45816|palpation
45817|Pancoast tumor
45818|partial remission
45819|partial response
45820|pathologic fracture
45821|peau d'orange
44187|anti-inflammatory
44188|arthritis
44189|binding agent
44190|cartilage
44191|chondrocyte
44192|chondroitin sulfate
44193|chorioallantoic membrane
44194|circulatory system
44195|clinical study
44196|collagen
44197|conjunctiva
44198|conventional therapy
44199|cornea
44200|dyspepsia
44201|dysgeusia
44202|embryo
44203|endothelial cell
44204|enema
44205|filler
44206|glycosaminoglycan
44207|hemorrhoid
44208|hyperglycemia
44209|hypothesis
44210|keratan sulfate
44211|matrix metalloproteinase
44212|mesenteric membrane
45899|stage I ovarian epithelial and fallopian tube cancer
45900|stage II ovarian epithelial, fallopian tube, and primary peritoneal cancer
45901|stage III ovarian epithelial, fallopian tube, and primary peritoneal cancer
45902|stage IV ovarian epithelial, fallopian tube, and primary peritoneal cancer
45903|stage I gastric cancer
45904|stage III gastric cancer
45905|stage IV gastric cancer
45906|stage I adult non-Hodgkin lymphoma
45907|stage II adult non-Hodgkin lymphoma
45908|stage III adult non-Hodgkin lymphoma
45909|stage IV adult non-Hodgkin lymphoma
45910|limited-stage small cell lung cancer
45911|extensive-stage small cell lung cancer
45912|streptavidin
45913|strontium
45914|subcutaneous
45915|subcutaneous port
45916|supplementation
45917|support group
45918|supraclavicular lymph node
45919|supratentorium
45920|surgical castration
45921|systemic
45922|systemic therapy
45923|T-cell depletion
45924|T-cell lymphoma
45925|TAG-72 antigen
45926|thoracotomy
45927|topical
45928|total estrogen blockade
45929|total hysterectomy
45930|total-body irradiation
45931|tracer
45932|transurethral resection of the prostate
45933|tumor-derived
45934|ultraviolet radiation
45935|umbilical cord blood
45936|unresectable
45937|vaccination
45938|vaccine
45939|ventricle
45940|video-assisted surgery
45941|virus
45942|watchful waiting
45943|Whitmore-Jewett staging system
45944|x-ray
45945|ISIS 3521
45946|Wilms tumor
45947|myelofibrosis
45948|idoxifene
45949|GEM 231
45950|AIDS
45951|secondary tumor
45952|neuroectodermal tumor
45953|myelodysplasia
45954|leukoplakia
45955|locally advanced cancer
45956|hyperplasia
45957|melphalan
45958|erythropoietin
45959|diagnostic procedure
45960|cytomegalovirus
45961|clinical trial
45962|central venous access catheter
45963|carcinoma
45964|Montanide ISA-51
45965|ISIS 5132
45966|flt3L
45967|antibiotic
45968|LMB-9 immunotoxin
45969|celecoxib
45970|EF5
45971|transurethral resection
45972|stage I cancer of the uterus
45973|stage II cancer of the uterus
44327|beta hemolytic streptococcus group B
44328|citric acid/potassium-sodium citrate
44329|c-kit
44330|comedo carcinoma
44331|cribriform
44332|metabolic acidosis
44333|mucinous
44334|alkalinization
44335|cerebellopontine
44336|chiasma
44337|creatinine
44338|electrolyte
44339|parathyroid hormone
44340|phosphorus
44341|pilocytic
44342|pleomorphic
44343|ploidy
44344|potassium
44345|prostatic intraepithelial neoplasia
44346|psammoma body
44347|renal tubular acidosis
44348|sepsis
44349|serous
44350|skeletal
44351|stellate
44352|telangiectasia
44353|thalamus
44354|urachus
44356|phosphoric
44357|Fanconi syndrome
44358|LY231514
44359|hormone receptor
44360|laparoscope
44361|proton magnetic resonance spectroscopic imaging
44362|ALL
44363|AML
44364|CMV
44365|acquired immunodeficiency syndrome
44366|human immunodeficiency virus
44367|IL-2
44369|androgen ablation
44370|Chamberlain procedure
44371|blood thinner
44372|benign prostatic hypertrophy
44373|BPH
44374|BPU
44375|BRM therapy
44376|precancerous dermatosis
44377|precancerous dermatitis
44378|interstitial radiation therapy
44379|windpipe
44380|CAP-1
44381|CQS
44382|CML
44383|N-acetyldinaline
44384|CAM
44385|CTC
44386|HPV
44387|CHPP
44388|undescended testicles
44389|AZQ
44390|DFMO
44391|DRE
44392|D&C
44393|deoxyribonucleic acid
44394|DCIS
44395|EPT
44396|ETS
44397|EGFR
44398|ErbB1
44399|HER1
44400|EBV
44401|RBC
44402|ER
44403|ER-
44404|ER+
44405|ERT
44406|GIST
44407|grade IV astrocytoma
44408|glycoprotein 100
44409|H. pylori
44410|HNPCC
44411|endocrine therapy
44412|HRT
44413|4-demethoxydaunorubicin
44414|IP6
44415|phytic acid
44416|IL-1-alfa
44417|IL-11
44418|IL-12
44419|IL-3
44420|IL-4
44421|IL-6
44422|IM
44423|BCG solution
44424|chlorine
44425|partial cystectomy
44426|IP
44427|CPT 11
46103|stage I hypopharyngeal cancer
46104|stage II hypopharyngeal cancer
46105|Photofrin
46106|Merkel cell cancer
46107|genistein
46108|endometrium
46109|diagnostic trial
46110|dihematoporphyrin ether
46111|cytopenia
46112|cutaneous
46113|blastic phase chronic myelogenous leukemia
46114|GPX-100
46115|bevacizumab
46116|dimesna
46117|venlafaxine
46118|acitretin
46119|thoracoscopy
46120|stage I vulvar cancer
46121|stage II vulvar cancer
46122|stage III vulvar cancer
46123|stage IV vulvar cancer
46124|red blood cell
46125|peritoneal cavity
46126|nolatrexed
46127|hormone replacement therapy
44428|13-cis retinoic acid
44429|KPS
44430|WBC
44431|triiodothyronine
44432|T-3
44433|LCIS
44434|lymphatic fluid
44435|lymph node dissection
44436|LAK cell
44437|mucosa-associated lymphoid tissue lymphoma
44438|CI-980
44439|NK cell
44440|large granular lymphocyte
44441|nicotinamide
44442|AG337
44443|NMRI
44444|ENT doctor
44445|ovarian suppression
44446|pulmonary sulcus tumor
44447|PEITC
44448|apheresis
44449|PR-
44450|PR+
44451|PAP
44452|radiosurgery
44453|stereotactic external-beam radiation therapy
44454|Halsted radical mastectomy
44455|radioactive drug
44456|ICI D1694
44457|secondary cancer
44458|ultrasonogram
44459|speech therapist
44460|helical computed tomography
44461|SIL
44462|Hypericum perforatum
44463|stereotaxic radiosurgery
44464|stereotactic radiation therapy
44465|SnET2
44466|trach tube
44467|TM
44468|TUR
44469|TURP
44470|TVS
44471|TNF
44472|UV radiation
44473|womb
44474|VEGF
44475|video-assisted resection
44476|xeroradiograph
44477|SNX 111
44478|AZT
44479|solar keratosis
44480|senile keratosis
44481|nonsteroidal anti-inflammatory drug
44482|LGD1069
44483|biotherapy
44484|dacliximab
44485|phytosterol
44486|3-D
44487|3-dimensional radiation therapy
44488|antitumor antibiotic
44489|lymph gland
44490|respiratory tract
44491|oxidation
44492|ductal lavage
44493|brachial plexopathy
44494|brachial plexus
44495|desmoplastic small round cell tumor
44496|DIEP flap
44497|embryonal rhabdomyosarcoma
44498|extrahepatic
44499|focal
44500|hamartoma
44501|myalgia
44502|nodule
44503|parenchyma
44504|plexopathy
44505|spiculated mass
44506|spindle cell tumor
44507|cleaved
44508|diffuse
44509|nontoxic
44510|biological
44511|Dukes classification
44512|laboratory study
44513|micrometastasis
44514|morbidity
44515|pons
44516|pontine
44517|preclinical study
44518|bilirubin
44519|distal pancreatectomy
44520|outpatient
44521|pancreatic cancer
44522|pancreatic duct
44523|local anesthesia
44524|overactive thyroid
46202|peginterferon alfa-2b
46203|perifosine
46204|geldanamycin analog
46205|cephalexin
46206|aflatoxin
46207|agranulocyte
46208|alpha-fetoprotein
46209|alveoli
46210|amputation
46211|amylase
46212|accelerated phase chronic myelogenous leukemia
46213|achlorhydria
46214|acoustic
46215|acute nonlymphocytic leukemia
46216|adenocarcinoma
46217|adenoma
46218|positron emission tomography scan
46219|postremission therapy
46220|precancerous
46221|plastic surgeon
44635|open colectomy
44636|abnormal
44637|action study
44638|acute pain
44639|addiction
44640|agent study
44641|allogenic
44642|alopecia
44643|alteration
44644|anesthesiologist
44645|anxiolytic
44646|bias
44647|biofeedback
46318|laryngectomee
46319|laryngectomy
46320|laryngoscope
46321|laryngoscopy
46322|Li-Fraumeni syndrome
46323|ligation
46324|lesion
46325|kidney
46326|IV
46327|IVP
46328|jaundice
46329|keloid
46330|Krukenberg tumor
46331|intraperitoneal chemotherapy
46332|acute lymphocytic leukemia
46333|intravenous pyelogram
46334|intravenous pyelography
46335|intestine
46336|intraepithelial
46337|intrahepatic
46338|intraoperative radiation therapy
46339|intraperitoneal
46340|intravesical
46341|invasive cervical cancer
46342|IORT
46343|islet cell carcinoma
46344|islet of Langerhans cell
46345|internal radiation therapy
46346|inguinal orchiectomy
46347|acute myeloid leukemia
46348|infertility
46349|infiltrating cancer
46350|implant radiation therapy
46351|impotent
46352|in vivo
46353|incision
46354|incontinence
46355|indolent
46356|immune system
46357|immunodeficiency
46358|hyperfractionation
46359|hypothalamus
46360|ileostomy
46361|imaging
46362|humidifier
46363|hepatocellular carcinoma
46364|hepatocyte
46365|hereditary mutation
46366|herpesvirus
46367|hormonal therapy
46368|hormone receptor test
46369|hematogenous
46370|hematologist
46371|hepatitis
46372|grading
46373|graft
46374|granulocyte
46375|groin
46376|GVHD
46377|gynecologic oncologist
46378|gynecologist
46379|hair follicle
46380|glottis
46381|genitourinary system
46382|germ cell
46383|pineal germinoma
46384|germline mutation
46385|GI14721
46386|gland
46387|gastroenterologist
46388|gastroscope
46389|gastroscopy
46390|gene deletion
46391|genetic
46392|fractionation
46393|fulguration
46394|fundus
46395|gallbladder
46396|Gamma Knife therapy
46397|gastrectomy
46398|gastric atrophy
46399|fertility
46400|fetus
46401|fiber
46402|fibroid
46403|fibrosarcoma
46404|fluoroscope
46405|fluoroscopy
46406|follicle
46407|esophagram
46408|esophagus
46409|estrogen receptor
46410|etiology
46411|excisional biopsy
46412|familial dysplastic nevi
46413|erythroplakia
46414|esophageal
46415|esophageal speech
46416|esophagectomy
46417|esophagoscopy
46418|epidermis
46419|epidermoid carcinoma
46420|epidural block
46421|epiglottis
46422|epithelial carcinoma
46423|epithelium
46424|ERCP
46425|erythrocyte
44870|leiomyoma
44871|intrahepatic bile duct
44872|hypervascular
44873|DES
44874|stage IV cutaneous T-cell lymphoma
44875|didanosine
44877|endostatin
44878|captopril
44879|CI-994
44880|10-propargyl-10-deazaaminopterin
44881|3-AP
44882|Lynch syndrome
44883|immune adjuvant
44884|hereditary nonpolyposis colon cancer
44885|DACA
44886|alum
44887|EMD 121974
44888|SC-70935
44889|BMS-214662
44890|TG4010
44891|BMS-247550
44892|ILX23-7553
44893|imatinib mesylate
44895|XR9576
46550|radioactive
46551|radiologist
46552|radionuclide scanning
46553|radiosensitizer
46554|radon
46555|rectum
46556|recur
46557|Reed-Sternberg cell
46558|reflux
46559|regional chemotherapy
46560|remission induction therapy
46561|renal capsule
46562|renal pelvis
46563|reproductive cell
46564|reproductive system
46565|resection
46566|respiratory system
46567|retropubic prostatectomy
46568|RNA
46569|salpingo-oophorectomy
46570|scan
46571|Schiller test
46572|schwannoma
46573|scrotum
46574|sebum
46575|segmental mastectomy
46576|seminal vesicle
46577|seminoma
46578|shave biopsy
46579|shunt
46580|side effect
46581|skin graft
46582|small intestine
46584|soft tissue sarcoma
46585|somatic cell
46586|somatic mutation
46587|sonogram
46588|speculum
46590|laboratory test
46591|SPF
46592|spinal tap
46593|spleen
46594|splenectomy
46595|squamous cell carcinoma
46596|squamous intraepithelial lesion
46597|staging
46598|stem cell
46599|stereotaxis
46600|sterile
46601|steroid drug
46602|endoscopic ultrasound
46603|mechlorethamine hydrochloride
46604|stomach
46605|stool
46606|stool test
46607|subglottis
46608|sunscreen
46609|supportive care
46610|supraglottis
46611|testicle
46612|thoracentesis
46613|thoracic
46614|thrombocyte
46615|thrombophlebitis
46616|thymus
46617|megestrol acetate
46618|tonsil
46619|topical chemotherapy
46620|total mastectomy
46621|total nodal irradiation
46622|toxin
46623|trachea
46624|tracheoesophageal puncture
46625|tracheostomy
46626|tracheostomy button
46627|tracheostomy tube
46628|transformation
46629|transitional cell cancer
46630|transitional cell
46631|transplantation
46632|transrectal ultrasound
46633|transvaginal ultrasound
46634|tumor
46635|tumor debulking
46636|tumor marker
46637|upper GI series
46638|ureter
46639|mercaptopurine
46640|urethra
46641|urinalysis
46642|urine
46643|urologist
46644|urostomy
46645|uterus
46646|vagina
46647|vasectomy
46648|vinyl chloride
45023|vitamin E
45024|sentinel lymph node mapping
45025|annamycin
45026|CT-2103
45027|AG2037
45028|CP4071
45029|atrasentan
45030|pirfenidone
45031|HPPH
45032|cefepime
45033|taurolidine
45034|respiratory syncytial virus
45035|port
45036|RPI.4610
45037|TLK286
45038|phenoxodiol
45039|gabapentin
45040|CI-1033
45041|doxercalciferol
45042|methyl-5-aminolevulinate
45043|DHA-paclitaxel
45044|endometrial
45045|SU6668
45047|teicoplanin
45048|juvenile myelomonocytic leukemia
45049|VNP40101M
45050|fecal occult blood test
45051|apolizumab
45052|allopurinol
45053|omentectomy
45054|opioid
45055|iseganan hydrochloride
45056|gynecologic
45057|stage I chronic lymphocytic leukemia
45058|2-methoxyestradiol
45059|stage II chronic lymphocytic leukemia
45060|halofuginone hydrobromide
45061|stage III chronic lymphocytic leukemia
45062|stage IV chronic lymphocytic leukemia
45063|clear cell carcinoma
45064|tetanus toxoid
45065|molecule
45066|herba Scutellaria barbatae
45067|XK469R
45068|R101933
45069|fibrin sealant
45070|abdomen
45071|simple mastectomy
45072|radiation
45073|hepatic arterial infusion
45074|J-107088
45075|NB1011
45076|transdermal
45077|total parenteral nutrition
45078|sham therapy
45079|high-risk cancer
45080|imiquimod
45081|CC-5013
45082|bupropion hydrochloride
45083|rofecoxib
45084|hydroxychloroquine
45085|ductal carcinoma
45086|Pap smear
45087|pelvic
45088|septicemia
45089|magnetic-targeted carrier
45090|syndrome
45092|prophylactic surgery
45093|portal vein
45094|plexiform neurofibroma
45095|neurofibroma
45096|neurofibromatosis type 1
45097|large intestine
45098|inherited
45099|infiltrating ductal carcinoma
45100|familial adenomatous polyposis
45101|CP-358,774
45102|B7-1
45103|AE-941
45104|stoma
45105|partial mastectomy
45106|pancreatitis
45107|complete blood count
45108|hemoglobin
45109|contiguous
45110|hormone therapy
45111|steroid therapy
45112|autologous bone marrow transplantation
45113|selenium
45114|allogeneic bone marrow transplantation
45115|gestational trophoblastic tumor
45116|stage I endometrial cancer
45117|stage II endometrial cancer
45118|stage III endometrial cancer
45119|stage IV endometrial cancer
45120|localized gallbladder cancer
45121|unresectable gallbladder cancer
45122|stage I bladder cancer
45123|stage II bladder cancer
45124|stage III bladder cancer
45125|stage IV bladder cancer
45126|stage I testicular cancer
46752|cone biopsy
46753|choriocarcinoma
46754|chronic granulocytic leukemia
46755|chronic myeloid leukemia
45127|stage II testicular cancer
45128|stage III testicular cancer
45129|stage I prostate cancer
45130|stage II prostate cancer
45131|stage III prostate cancer
45132|stage IV prostate cancer
45133|actinic keratosis
45134|Kaposi sarcoma
45135|melanoma
45136|stage I melanoma
45137|stage II melanoma
45138|stage III melanoma
45139|stage IV melanoma
45140|doxorubicin
45141|octreotide
45142|stage I breast cancer
45143|congestive heart failure
45144|stage IV non-small cell lung cancer
45145|acute leukemia
45146|stage II breast cancer
45147|chronic leukemia
45148|non-Hodgkin lymphoma
45149|endocrine cancer
45150|interleukin-3
45151|brachytherapy
45152|antimetabolite
45153|radiosensitization
45154|laser therapy
45155|cytarabine
45156|stage III breast cancer
45157|levamisole
45158|progesterone
45159|hairy cell leukemia
45160|chronic phase chronic myelogenous leukemia
45161|itraconazole
45162|stage IV breast cancer
45163|buthionine sulfoximine
45164|biopsy
45165|acetaminophen
45166|acetylcysteine
45167|acyclovir
45168|AD 32
45169|bleomycin
45170|aminoglutethimide
45171|aminopterin
45172|amsacrine
45173|amphotericin B
45174|amikacin
45175|pamidronate disodium
45176|aspirin
45177|azacitidine
45178|diaziquone
45179|broxuridine
45180|buserelin
45181|camptothecin
45182|carboplatin
45183|stage IIIA breast cancer
45184|cimetidine
45185|novobiocin
45186|cortisone
45187|cyclosporine
45188|danazol
45189|etoposide
45190|pentostatin
45191|mitolactol
45192|mitoxantrone hydrochloride
45193|dipyridamole
45194|epirubicin
45195|estramustine
45196|etidronate
45197|fentanyl citrate
45198|floxuridine
45199|fludrocortisone
45200|fludarabine
45201|tegafur
45202|gallium nitrate
45203|Burkitt lymphoma
45204|beclomethasone
45205|hydrocortisone
45206|triamcinolone
45207|calcitonin
45208|decitabine
45209|interleukin-4
45210|myeloproliferative neoplasm
45211|edrecolomab
45212|pyrazine diazohydroxide
45214|chemotherapy
45215|altretamine
45216|homoharringtonine
45217|hydromorphone hydrochloride
45218|hyperbaric oxygen
45219|idoxuridine
45220|dexrazoxane
257898|tipifarnib
257971|zosuquidar trihydrochloride
258252|Gleevec
258356|gefitinib
258399|yttrium Y 90-DOTA-tyr3-octreotide
269057|nutraceutical
269133|bortezomib
269410|adult T-cell leukemia/lymphoma
269411|ATLL
269412|BAY 56-3722
269413|brostallicin hydrochloride
269414|clofarabine
269415|electroacupuncture
269416|EPO906
269417|epothilone B
269418|epothilone
269419|HTLV-1
45221|chondrosarcoma
45222|ketoconazole
45223|indomethacin
45224|methoxsalen
45225|metoclopramide
45226|metronidazole
45227|mitotane
45228|naloxone
45229|nystatin
45230|cisplatin
45231|PALA
45232|prochlorperazine
45233|fenretinide
45234|sucralfate
45235|porfiromycin
45236|folic acid
45237|dactinomycin
45238|photodynamic therapy
45239|calcium carbonate
45240|dronabinol
45241|thymidine
45242|tiazofurin
45243|treosulfan
45244|co-trimoxazole
45245|urokinase
45246|vancomycin
45247|vindesine
45248|vitamin A
45249|warfarin
45250|amifostine
45251|antiandrogen therapy
45252|leukapheresis
45253|cyclophosphamide
45254|idarubicin hydrochloride
45255|eflornithine
45256|interleukin-2
45257|mesna
45258|paclitaxel
45259|trimetrexate glucuronate
45260|dacarbazine
45261|daunorubicin
45262|dexamethasone
45263|bone marrow transplant
45264|flutamide
45265|medroxyprogesterone
45266|myelodysplastic syndrome
45267|ifosfamide
45268|premenopausal
45269|postmenopausal
45270|estrogen receptor positive
45271|suramin
45272|estrogen receptor negative
45273|progesterone receptor positive
45275|progesterone receptor negative
45276|Piritrexim
45277|stage I lip and oral cavity cancer
45278|stage II lip and oral cavity cancer
45279|stage III lip and oral cavity cancer
45280|stage IV lip and oral cavity cancer
45281|stage I laryngeal cancer
45282|stage II laryngeal cancer
45283|stage III laryngeal cancer
45284|stage IV laryngeal cancer
45285|peripheral blood lymphocyte therapy
45286|zidovudine
45287|lymphokine-activated killer cell
45288|probenecid
45289|goserelin acetate
45290|tumor necrosis factor
45291|porfimer sodium
45292|pegaspargase
45293|ribavirin
45294|pentosan polysulfate
45295|glucocorticoid
45296|penicillin
45297|chordoma
45298|diuretic
45299|vinorelbine
45300|nilutamide
45301|solid tumor
45302|fazarabine
45303|ganciclovir
45304|sargramostim
45305|ketorolac
45306|stage I anal cancer
45307|stage II anal cancer
45308|hydroxyurea
45310|stage III anal cancer
45311|ciprofloxacin
45312|immunology
45313|inflammatory breast cancer
45314|brain metastasis
45315|lung metastasis
45316|liver metastasis
45317|bone metastasis
45318|leptomeningeal metastasis
45319|malignant ascites
45320|fluconazole
45321|heparin
45322|hematoporphyrin derivative
45323|non-small cell lung cancer
45324|interferon
45325|edatrexate
45326|mifepristone
45327|small cell lung cancer
45328|beta carotene
45329|tumor infiltrating lymphocyte
45330|flucytosine
270858|FAMMM syndrome
45331|chloroquinoxaline sulfonamide
45332|filgrastim
45333|cancer
45334|stavudine
45335|ceftriaxone
45336|finasteride
45337|epoetin alfa
45338|toremifene
45339|asparaginase
45340|iododoxorubicin
45341|cladribine
45342|topotecan
45343|leukemia
45344|mixed glioma
45345|primary central nervous system lymphoma
45346|nimodipine
45347|gemcitabine
45348|methylphenidate hydrochloride
45349|stage IA non-small cell lung cancer
45350|mafosfamide
45351|tretinoin
45352|3F8
45353|gene therapy
45354|bicalutamide
45355|alendronate sodium
45357|stage IIA non-small cell lung cancer
45358|theophylline
45359|lymphedema
45360|anemia
45361|neutropenia
45362|neurotoxicity
45363|hypercalcemia
45364|infection
45365|thrombocytopenia
45366|pyrazoloacridine
45367|stage IIIA non-small cell lung cancer
45368|lymphoma
45369|pentoxifylline
45370|methylprednisolone
45371|osteoporosis
45372|sulindac
45373|antibody therapy
45374|fluoxetine
45375|QS21
45376|GM2-KLH vaccine
45377|capsaicin
45378|procarbazine
45379|carboxyamidotriazole
45380|prolymphocytic leukemia
45381|flecainide
45382|docetaxel
45383|phenylacetate
45384|carboxypeptidase-G2
45385|lobaplatin
45386|lometrexol
45387|temozolomide
45388|deferoxamine
45390|desmoid tumor
45391|irinotecan
45392|rhizoxin
45393|methotrexate
45394|TNP-470
45395|osteosarcoma
45396|PSC 833
45397|bone marrow ablation
45398|triacetyluridine
45399|aminocamptothecin
45400|morphine sulfate
45401|losoxantrone
45402|phenylbutyrate
45403|keyhole limpet hemocyanin
45404|epinephrine
45405|clodronate
45406|oltipraz
45407|cryosurgery
45408|calcitriol
45409|stem cell factor
45410|busulfan
45411|penclomedine
45412|stage IIIB breast cancer
45413|daclizumab
45414|tacrolimus
45415|carbogen
45416|niacinamide
45417|quality of life
45418|neuroblastoma
45419|flavopiridol
45420|radioimmunotherapy
45421|letrozole
45422|imipenem
45423|bexarotene
45424|incomplete Freund's adjuvant
45425|BMS-182751
45426|interleukin-12
45427|tirapazamine
45428|gossypol
45429|CI-958
45430|boron neutron capture therapy
45431|epratuzumab
45433|uracil
45434|oncology
45435|vincristine
45436|leflunomide
45437|NG-monomethyl-L-arginine
45438|oophorectomy
45439|trastuzumab
45440|MAGE-3 antigen
45441|orchiectomy
304686|gallium scan
304687|chest x-ray
304688|Klinefelter syndrome
304689|Beckwith-Wiedemann syndrome
304690|cerebellar hemangioblastoma
304691|Sturge-Weber syndrome
304692|tuberous sclerosis
304714|breast self-exam
45560|computed tomography scan
45561|streptozocin
45562|sarcoma
45563|von Hippel-Lindau syndrome
45564|temoporfin
45565|capecitabine
45567|ofloxacin
45568|ziconotide
45569|gemtuzumab ozogamicin
45570|surgery
45571|misoprostol
45572|erb-38 immunotoxin
45573|pilocarpine
45574|COL-3
321359|bugwort
321360|bugbane
321361|bone-seeking radioisotope
321362|carnitine
321363|CT-2106
321364|deficiency
321365|desmoplastic
321367|desmoplastic melanoma
321368|dextroamphetamine-amphetamine
321372|erectile dysfunction
321374|fatigue
321375|GW786034
321376|impotence
321377|L-carnitine
321378|levocarnitine
321380|Morinda citrifolia
321381|noni
321382|oligoastrocytoma
321383|penile implant
321384|perineum
321385|polyglutamate camptothecin
321386|pomegranate
321388|soblidotin
321389|transurethral needle ablation
321390|TZT-1027
322131|alanosine
322132|BBR 2778
322133|boronophenylalanine-fructose complex
322134|Ewing sarcoma family of tumors
322135|gallstone
322136|cholelith
322138|interleukin-7
322221|moxifloxacin
322231|pixantrone
322232|SDX-102
322233|sodium borocaptate
322234|ursodiol
322806|Gorlin syndrome
322852|bilateral salpingo-oophorectomy
322855|dose-dense chemotherapy
322856|endometrial biopsy
322857|intraluminal intubation and dilation
322858|laser surgery
322859|loop electrosurgical excision procedure
322860|multidisciplinary opinion
322861|nasoscopy
322862|rhinoscopy
322869|nasoscope
322870|rhinoscope
322871|neurological exam
322872|partial oophorectomy
322873|pelvic exam
322874|pelvic exenteration
322876|pelvic lymphadenectomy
322877|pheochromocytoma
322878|prostate-specific antigen test
322879|radical hysterectomy
322880|radiologic exam
322881|randomization
322882|seminal vesicle biopsy
322883|sensitivity
322884|specificity
322885|transperineal biopsy
322891|transrectal biopsy
322892|transurethral biopsy
322893|tumor board review
322894|unilateral salpingo-oophorectomy
322895|wedge resection
322896|loop excision
327738|Adderall
330108|stage I childhood non-Hodgkin lymphoma
330109|stage II childhood non-Hodgkin lymphoma
330110|stage III childhood non-Hodgkin lymphoma
330112|stage IV childhood non-Hodgkin lymphoma
330159|aloe-emodin
330160|arctigenin
330161|arctiin
330162|blessed thistle
330164|burdock
330165|cnicin
330166|duodenitis
330167|emodin
330168|flavonoid
330169|gastritis
330170|rhubarb
330171|kelp
330172|lignan
330173|lymphocytic leukemia
330174|ounce
330175|phytoestrogen
330176|potentiation
330178|red clover
45693|gene
45694|gene-modified
45695|germ cell tumor
45696|Gleason score
45697|glial tumor
45698|glioblastoma
45699|glioblastoma multiforme
45700|glioma
45701|gliosarcoma
45702|tumor grade
45703|graft-versus-host disease
45704|graft-versus-tumor
45705|growth factor
45706|Helicobacter pylori
45707|hemangiopericytoma
45708|hematologic cancer
45709|hepatic
45710|high-grade lymphoma
45711|HIV antibody
45712|homeopathic medicine
45713|hormone
45714|human papillomavirus
45715|hypersensitivity
45716|hyperthermic perfusion
45717|hyperthyroidism
45718|hysterectomy
45719|imagery
45720|imaging procedure
45721|immune function
45722|immune response
45723|immunocompromised
45724|immunodeficiency syndrome
45725|immunoglobulin
45726|immunoscintigraphy
45727|immunosuppression
45728|immunosuppressive therapy
45729|immunotherapy
45730|immunotoxin
45731|implantable pump
45733|in vitro
45734|incubated
45735|indolent lymphoma
45736|induction therapy
45737|inflammatory bowel disease
45738|infusion
45739|intermediate-grade lymphoma
45740|intrathecal
45741|invasive cancer
45742|isolated hepatic perfusion
45743|keratinocyte growth factor
45745|lactose intolerance
45746|laparoscopic-assisted colectomy
45747|laparotomy
45748|laser
45750|leucovorin
45751|LH-RH
45752|liarozole
45753|liposomal
45754|localized
45755|local therapy
45756|loperamide hydrochloride
45757|low-grade lymphoma
45758|lumpectomy
45759|LY353381 hydrochloride
45760|lymph node drainage
45761|lymph node mapping
45762|lymph node
45763|lymphadenectomy
45764|lymphatic system
45765|lymphocyte
45766|lymphomatoid granulomatosis
45767|lymphoproliferative disorder
45768|maintenance therapy
45769|triptorelin
45770|malabsorption syndrome
45771|malignancy
45772|malignant
45773|malignant meningioma
45774|MALT lymphoma
45775|mammogram
45776|marker
45777|mastectomy
45778|measurable disease
45779|medial supraclavicular lymph node
45780|medulloblastoma
45781|meningeal
45782|meningeal metastasis
45783|meningioma
45784|menstrual cycle
45785|mesenchymal
45786|metaplasia
45787|mineral
45788|MRI
45789|mucositis
45790|multidrug resistance
45791|multidrug resistance inhibition
45792|multimodality treatment
45793|multiple myeloma
45794|mycosis fungoides
45795|myeloma
45796|myelosuppressive therapy
45797|N-acetylcysteine
45798|needle biopsy
45799|negative axillary lymph node
45800|neoadjuvant therapy
45801|neoplasia
45802|neoplastic meningitis
45803|neuroendocrine
339609|carcinoid syndrome
45822|PEG-MGDF
45823|peptide
45824|perfusion
45825|pericardial effusion
45826|perimenopausal
45827|peripheral blood stem cell transplant
45828|peripheral stem cell
45829|peritoneum
45830|phase I clinical trial
45831|phase II clinical trial
45832|phase I/II clinical trial
45833|phase III clinical trial
45834|phase II/III clinical trial
45835|phase IV clinical trial
45836|photosensitizer
45837|physiologic
45838|pilot study
45839|plasma
45840|platelet
45841|platinum
45842|pleura
45843|pleural effusion
45844|polyp
45845|positive axillary lymph node
45846|premalignant
45847|primary tumor
45848|peripheral primitive neuroectodermal tumor
45849|prognosis
45850|progressive disease
45851|prostatectomy
45852|pulmonary
45853|quadrantectomy
45854|radiation surgery
45855|radioactive iodine
45856|radioisotope
45857|radiolabeled
45858|randomized clinical trial
45859|ras gene family
45860|rebeccamycin
45861|recurrence
45862|recurrent cancer
45863|refractory cancer
45864|regimen
45865|regional cancer
45866|relapse
45867|remission
45868|resected
45869|residual disease
45870|retinoid
45871|retroviral vector
45872|rhabdomyosarcoma
45873|risk factor
45874|samarium Sm 153
45875|second-look surgery
45876|sentinel lymph node
45877|sequential treatment
45878|Sezary syndrome
45879|sialyl Tn-KLH
45880|sigmoidoscopy
45881|skin test
45882|soft tissue
45883|sputum
45884|stable disease
45885|stage
45886|stage I cervical cancer
45887|stage II cervical cancer
45888|stage III cervical cancer
45889|stage IV cervical cancer
45890|stage I colorectal cancer
45891|stage II colorectal cancer
45892|stage III colorectal cancer
45893|stage IV colorectal cancer
45894|stage I adult Hodgkin lymphoma
45896|stage II adult Hodgkin lymphoma
45897|stage III adult Hodgkin lymphoma
45898|stage IV adult Hodgkin lymphoma
350239|Paget disease of bone
350240|Polyphenon E
350244|rapid hormone cycling
350245|refractory
350246|side-to-end coloanal anastomosis
350247|sodium thiosulfate
350248|subtenon
350249|TP-38 immunotoxin
350250|antagonist
350252|severe myelosuppression
350356|contiguous lymphoma
350357|noncontiguous lymphoma
350363|stage 0 bladder carcinoma in situ
350365|stage 0 cervical carcinoma in situ
352147|stage 0 colorectal carcinoma in situ
352152|stage 0 esophageal carcinoma in situ
352154|stage 0 gastric carcinoma in situ
352156|stage 0 melanoma
352160|stage 0 nasopharyngeal carcinoma in situ
354453|beta-human chorionic gonadotropin
354454|beta-hCG
354457|centimeter
354459|erythrocyte sedimentation rate
45998|ionomycin
45999|strontium Sr 89
46000|SU101
46001|transfusion
46002|thymoma
46007|stage I adrenocortical cancer
46008|stage II adrenocortical cancer
46009|stage III adrenocortical cancer
46010|stage IV adrenocortical cancer
46011|peripheral blood
46012|electroporation therapy
46013|Barrett esophagus
46014|malnutrition
46015|exisulind
46016|prinomastat
46017|lomustine
46018|arsenic trioxide
46019|promegapoietin
46020|yttrium Y 90-ibritumomab tiuxetan
46021|diethylstilbestrol
46022|adenoid cystic carcinoma
46023|radiopharmaceutical
46024|oropharynx
46025|nasopharynx
46026|larynx
46027|leiomyosarcoma
46028|liposarcoma
46029|hypopharynx
46030|gp100
46031|Ewing sarcoma
46032|echocardiography
46033|CT scan
46034|vaccinia CEA vaccine
46035|phyllodes tumor
46036|thyroid
46037|stage II gastric cancer
46038|sodium salicylate
46039|regression
46040|O(6)-benzylguanine
46041|neuropathy
46042|KW2189
46043|Castleman disease
46044|vitamin K
46045|irofulven
46046|raloxifene
46047|BRCA1
46048|chlorambucil
46049|curcumin
46050|anesthesia
46051|anesthetic
46052|antiandrogen
46053|aggressive
46054|agonist
46055|SR-29142
46056|squamous cell
46057|retinol
46058|retinyl palmitate
46059|sedoxantrone trihydrochloride
46060|peritoneal perfusion
46061|pharynx
46062|nitrosourea
46063|mutation
46064|Mycostatin
46065|mivobulin isethionate
46066|monoclonal antibody
46067|leukocyte
46068|lipid
46069|interleukin
46070|intrahepatic infusion
46071|intraperitoneal infusion
46072|indium In 111-pentetreotide
46073|GM-CSF
46075|G-CSF
46076|estrogen
46077|cyproterone acetate
46078|continuous hyperthermic peritoneal perfusion
46079|benign tumor
46080|anticancer antibiotic
46081|enzyme
46082|anticoagulant
46083|anticonvulsant
46084|antiemetic
46085|antifungal
46086|antigen
46087|antiparasitic
46088|antiviral
46089|trimethoprim-sulfamethoxazole
46090|fluorouracil
46091|xeroderma pigmentosum
46092|protein
46093|bispecific antibody
46094|L-778,123
46095|urinary tract
46096|T138067
46097|stage I oropharyngeal cancer
46098|stage II oropharyngeal cancer
46099|stage III oropharyngeal cancer
46100|stage IV oropharyngeal cancer
46101|stage III hypopharyngeal cancer
46102|stage IV hypopharyngeal cancer
372925|chemosensitivity
372926|ectocervical
372928|German Commission E
372931|meteorism
372932|micromolar
372933|multiplicity
372935|N-butyl-N-(4-hydroxybutyl) nitrosamine
372936|osmolality
372937|peritonitis
372938|postmortem
46128|genetic testing
46129|genetic marker
46130|cytokine
46131|craniopharyngioma
46132|carotenoid
46133|cervix
46134|cancer of unknown primary origin
46135|batimastat
46136|506U78
46137|visual pathway glioma
46138|taxane
46139|rhabdoid tumor
46140|PET scan
46141|LMB-1 immunotoxin
46142|intracarotid infusion
46143|intracranial tumor
46144|intraventricular infusion
46145|incidence
46146|hepatitis B virus
46147|gonad
46148|carcinoembryonic antigen peptide-1
46149|antineoplaston
46150|B43-PAP immunotoxin
46151|budesonide
46152|saline
46153|tinidazole
46154|dalteparin
46155|prednisolone
46156|vinca alkaloid
46157|ultrasound
46158|thrombopoietin
46159|promyelocytic leukemia
46160|hepatoblastoma
46162|SU5416
46163|combretastatin A4 phosphate
46164|intoplicine
46165|carbendazim
46166|dimethylxanthenone acetic acid
46167|stage I kidney cancer
46168|stage II kidney cancer
46169|stage III kidney cancer
46170|stage IV kidney cancer
46171|screening
46172|polyposis
46173|metabolism
46174|malignant fibrous histiocytoma
46175|BL22 immunotoxin
46176|BMS-184476
46177|Ro 31-7453
46178|stage I nasopharyngeal cancer
46179|stage II nasopharyngeal cancer
46180|stage III nasopharyngeal cancer
46181|stage IV nasopharyngeal cancer
46182|sarCNU
46183|dyspnea
46184|dextromethorphan acetic acid
46185|choroid plexus tumor
46187|insulin
46188|lobe
46189|gastrointestinal tract
46190|hu14.18-interleukin-2 fusion protein
46191|lepirudin
46192|stage IVA pancreatic cancer
46193|stage IVB pancreatic cancer
46194|indium In 111-ibritumomab tiuxetan
46195|CCI-779
46196|salivary gland
46197|pump
46198|LMB-2 immunotoxin
46199|gestational trophoblastic disease
46200|exatecan mesylate
46201|IM-862
386213|low grade
386214|gimatecan
386215|primary peritoneal cancer
386216|ST1481
386219|peritoneal infusion
386220|scanner
386221|semiparasitic
386222|trabecular cancer
386223|vaccine therapy
386224|Miraluma test
386225|mitotic index
386226|scintimammography
386227|sestamibi breast imaging
386229|safingol
386233|stereotactic body radiation therapy
386234|thyrotropin alfa
386235|Thyrogen
386236|zolpidem
386237|Ambien
386432|Plummer-Vinson syndrome
386500|Paterson-Kelly syndrome
386525|sideropenic dysphagia
386976|Aspergillus
387264|brain tumor
389271|green tea extract
389458|bidi
389460|dentist
389461|erythroleukoplakia
389462|hard palate
389463|kretek
389464|oral cavity
389465|oral and maxillofacial surgeon
389466|soft palate
389467|uvula
389468|palatine uvula
390238|analysis
46222|pleural cavity
46223|pneumatic larynx
46224|pneumonectomy
46225|pigment
46226|pineal gland
46227|pineoblastoma
46228|pineocytoma
46229|pituitary gland
46230|plasma cell
46231|plasmacytoma
46232|perineal prostatectomy
46233|peripheral stem cell support
46234|peristalsis
46235|pernicious anemia
46236|petechiae
46237|pancreatectomy
46238|percutaneous transhepatic cholangiography
46239|pancreatic juice
46240|papillary tumor
46241|papilledema
46242|paralysis
46243|paraneoplastic syndrome
46244|pathologist
46245|pediatric
46246|pelvis
46247|ophthalmoscope
46248|optic nerve
46249|oral surgeon
46250|organism
46251|ostomy
46252|otolaryngologist
46253|palate
46254|pancreas
46255|nonseminoma
46257|oligodendroglioma
46258|Ommaya reservoir
46259|oncogene
46260|oncologist
46261|nonmelanoma skin cancer
46262|oncology nurse
46263|hyperthermia therapy
46264|neoplasm
46265|nephrectomy
46266|nephrotomogram
46267|neurologist
46268|neuroma
46269|neurosurgeon
46270|neutrophil
46271|nevus
46272|nipple discharge
46273|mucin/peptide
46274|mucus
46275|morphology
46276|myelin
46277|myelogenous
46278|myelogram
46279|myeloid
46280|myometrium
46281|neck dissection
46282|monocyte
46283|metastasize
46284|microcalcification
46285|modified radical mastectomy
46286|mole
46287|mediastinoscopy
46288|mediastinum
46289|medical castration
46290|medical oncologist
46291|melanin
46292|melanocyte
46293|melanoma vaccine
46294|membrane
46295|meninges
46296|menopause
46297|menstruation
46298|lymphoid
46299|M protein
46300|mantle field
46301|lymphocytic
46302|lubricant
46303|lumbar puncture
46304|luteinizing hormone-releasing hormone agonist
46305|lymph
46306|lymphangiogram
46307|lymphangiography
46308|lobule
46309|local cancer
46310|lower GI series
46311|limb perfusion
46312|liver
46313|liver-spleen scan
46314|lobectomy
46315|lobular carcinoma in situ
46316|large cell carcinoma
46317|laryngeal
393531|eccrine gland
393533|LEEP
393534|lymphatic basin
393536|uric acid
393537|CC49-streptavidin
393538|interleukin-13 PE38QQR immunotoxin
393539|autologous expanded mesenchymal stem cells OTI-010
393541|proteasome inhibitor
393543|rebeccamycin analog
393546|yttrium Y 90-DOTA-biotin
393761|lenalidomide
393786|BMS-599626
393800|mature T-cell lymphoma
396786|carotid artery
396787|spinal column
396789|stage 2 neuroblastoma
396790|stage 3 neuroblastoma
396792|stage 4 neuroblastoma
396799|stage 0 laryngeal carcinoma in situ
44761|renal fascia
44762|high-grade squamous intraepithelial lesion
44763|investigational
44764|IU
46449|dilator
46450|diagnosis
46451|diaphragm
46452|diathermy
46453|dermatologist
46454|dermis
46455|cystoscope
46456|corpus
46457|craniotomy
46458|cryptorchidism
46459|curettage
46460|curette
46461|cyst
46462|colon
46463|colonoscope
46464|colostomy
46465|colposcope
46466|common bile duct
46468|conization
46469|continent reservoir
46470|chromosome
46471|chronic phase
46472|CNS prophylaxis
46473|cholangiosarcoma
46474|CEA
46475|CEA assay
46476|cell
46477|cell differentiation
46478|cell motility
46479|cell proliferation
46480|cellular adhesion
46481|central nervous system
46482|cerebral hemisphere
46483|cerebrospinal fluid
46484|cerebrum
46486|carcinogen
46487|carcinogenesis
46488|carcinoma in situ
46489|cordectomy
46490|CA-125
46491|brain stem
46492|breast reconstruction
46493|bronchi
46494|bronchiole
46495|bronchitis
46496|bronchoscope
46497|buccal mucosa
46498|bypass
46499|bone scan
46500|bowel
46501|bladder
46502|blast crisis
46503|blast
46504|blood-brain barrier
46505|bone marrow aspiration
46506|bone marrow biopsy
46507|bilateral
46508|bile
46509|benign prostatic hyperplasia
46510|axilla
46511|axillary
46512|axillary dissection
46513|barium enema
46514|barium solution
46515|basal cell carcinoma
46516|basal cell
46517|basophil
46518|aspirate
46519|aspiration
46520|asymptomatic
46521|ataxic gait
46522|atypical hyperplasia
46523|anus
46524|apoptosis
46525|areola
46526|compassionate use trial
46527|PNU-93914
46528|asbestos
46529|angiogenesis
46530|angiogram
46531|angiography
46532|angiosarcoma
46533|anterior mediastinotomy
46534|anastomosis
46535|proctoscopy
46536|proctosigmoidoscopy
46537|prophylactic cranial irradiation
46538|prophylaxis
46539|prostate
46540|prostate-specific antigen
46541|prostatic acid phosphatase
46542|prosthesis
46543|prosthodontist
46544|PTC
46545|radiation fibrosis
46546|radiation oncologist
46547|radical cystectomy
46548|radical mastectomy
46549|radical prostatectomy
413960|Zofran
415238|biologic agent
415316|Faslodex
415317|distant metastasis
415542|capillary
415543|febrile neutropenia
415544|hepatobiliary
415545|human corticotropin-releasing factor
415546|hCRF
415547|pulmonary rehabilitation education
415548|systemic inflammatory response syndrome
415549|SIRS
415551|tachycardia
415552|tachypnea
415553|AMD 3100
415575|mammary gland
46426|erythroleukemia
46427|endometriosis
46428|endoscope
46429|endoscopic retrograde cholangiopancreatography
46430|enterostomal therapist
46431|environmental tobacco smoke
46432|ependymoma
46433|ejaculation
46434|electrodesiccation
46435|electrolarynx
46436|embolization
46437|encapsulated
46438|endocervical curettage
46439|endocrinologist
46440|dry orgasm
46441|duct
46442|dumping syndrome
46443|duodenum
46444|douche
46445|differentiation
46446|digestive system
46447|digestive tract
46448|dilation and curettage
410733|OTC
410734|Alimta
410735|ancestim
410736|SCF
410737|Stemgen
410738|Avita
410739|Renova
410740|Retin-A
410742|BSH
410743|CP-547,632
410745|Herceptin
410746|Hycamtin
410747|lactoferrin
410749|Neulasta
410750|Paxil
410751|Pegasys
410755|PEG-Intron
411371|Bence Jones protein
411372|beta-2-microglobulin
411378|monoclonal protein
411379|monoclonal gammopathy of undetermined significance
411380|MGUS
411381|Kahler disease
411383|myelomatosis
411384|plasma cell myeloma
411385|pesticide
411386|plasma cell tumor
413728|PEG-rhMGDF
413729|polyethylene glycosylated recombinant human megakaryocyte growth and development factor
413730|PN401
413731|SU006668
413732|Telcyta
413733|Trifolium pratense
413734|velcade
413735|Vioxx
413793|SB-715992
413881|stage 0 anal carcinoma in situ
413882|stage IIA breast cancer
413883|stage IIB breast cancer
413884|stage I childhood liver cancer
413885|stage II childhood liver cancer
413886|stage III childhood liver cancer
413888|stage IV childhood liver cancer
413889|stage 0 distal extrahepatic bile duct carcinoma in situ
413891|stage I distal extrahepatic bile duct cancer
413892|stage II distal extrahepatic bile duct cancer
413893|stage III distal extrahepatic bile duct cancer
413894|stage IV distal extrahepatic bile duct cancer
413895|stage 0 gallbladder carcinoma in situ
413912|stage III gallbladder cancer
413913|stage IV gallbladder cancer
413916|stage I renal cell cancer
413917|stage II renal cell cancer
413918|stage III renal cell cancer
413919|stage IV renal cell cancer
413920|stage 0 transitional cell carcinoma in situ of the renal pelvis and ureter
413921|stage I transitional cell cancer of the renal pelvis and ureter
413922|stage II transitional cell cancer of the renal pelvis and ureter
413923|stage III transitional cell cancer of the renal pelvis and ureter
413924|stage IV transitional cell cancer of the renal pelvis and ureter
413927|contraindication
413928|hyperkeratosis
413929|iFOBT
413930|immunologic fecal occult blood test
413931|immunochemical fecal occult blood test
45004|benzoylphenylurea
45005|ICI 182780
45006|BBR 3464
45007|Wobe-Mugos E
45008|vapreotide
45009|adenosine triphosphate
45010|Huang Lian
45011|lymphoscintigraphy
45012|Hodgkin disease
45013|valganciclovir
45014|MS-275
45015|ZD0473
45016|placental blood transplantation
45017|placenta
45018|cutaneous breast cancer
45020|blood vessel
45021|valdecoxib
45022|symptom
46659|ribonucleic acid
46660|isoflavone
46661|hepatoma
46662|SR-45023A
46663|DTGM fusion protein
46664|anhydrovinblastine
46665|topoisomerase inhibitor
46666|sun protection factor
46667|stage IB soft tissue sarcoma
46668|stage IIA soft tissue sarcoma
46669|stage IIB soft tissue sarcoma
46670|stage IA soft tissue sarcoma
46672|stage III soft tissue sarcoma
46673|stage IV soft tissue sarcoma
46674|piperacillin-tazobactam
46675|pineal region tumor
46676|cephalosporin
46677|ansamycin
46678|adrenal gland
46679|aldesleukin
46680|sigmoidoscope
46681|intrathecal chemotherapy
46682|intravenous
46683|tissue
46684|abdominal
46685|colorectal
46686|external radiation therapy
46687|ovary
46688|placebo
46689|MG98
46690|SR49059
46691|leridistim
46692|trichothiodystrophy
46693|aplidine
46694|total pancreatectomy
46695|stem cell transplant
46696|precancerous polyps
46697|interleukin-4 PE38KDEL immunotoxin
46698|incisional biopsy
46699|SCH 66336
46700|ultraviolet radiation therapy
46701|stereotactic radiosurgery
46702|Stromagen
46703|semen
46704|pancreatic enzyme
46705|mitotic inhibitor
46707|depsipeptide
46708|chemoembolization
46709|defibrotide sodium
46710|metastasis
46711|PTK787/ZK 222584
46712|sentinel lymph node biopsy
46713|paracentesis
46714|cerebellum
46715|RevM10 gene
46716|S-1
46717|FK463
46718|E7070
46719|PS-341
46720|KRN7000
46721|2IT-BAD monoclonal antibody 170
46722|A33
46723|acupressure
46724|acupuncture
46725|acustimulation
46726|stage I malignant mesothelioma
46727|stage II malignant mesothelioma
46728|stage III malignant mesothelioma
46729|stage IV malignant mesothelioma
46730|Prost 30
46731|pM-81
46732|muromonab-CD3
46733|muJ591
46734|IDEC-Y2B8
46735|granulocytopenia
46736|di-dgA-RFB4
46737|CC-49
46738|bile duct
46739|angiogenesis inhibitor
46740|CHS 828
46741|BIBX 1382
46742|BRCA2
46743|PNU 166148
46744|liothyronine sodium
46745|17-N-allylamino-17-demethoxygeldanamycin
46746|SCH 54031
46747|molar pregnancy
46748|intraductal carcinoma
46749|granulocyte colony-stimulating factor
46751|external-beam radiation therapy
434562|bone cancer
46756|barium swallow
46757|acute myelogenous leukemia
46758|adrenaline
46759|CD40-ligand
46760|troxacitabine
46761|ZD1839
46762|LY335979
46763|12-O-tetradecanoylphorbol-13-acetate
46764|folate
46765|thioguanine
46766|teniposide
46767|stage IIIA anal cancer
46768|ovarian epithelial cancer
46769|stage IIIB anal cancer
46770|gastric
46771|cutaneous T-cell lymphoma
46772|semustine
46773|stage I cutaneous T-cell lymphoma
46774|retinoblastoma
46775|stage I Wilms tumor
46776|stage II Wilms tumor
46777|stage III Wilms tumor
46778|stage IV Wilms tumor
46779|stage V Wilms tumor
256536|ABT-751
256537|fibromatosis
256538|light-emitting diode therapy
256539|microwave thermotherapy
256540|neurofibromatosis type 2
256541|sensor
256542|acoustic neurofibromatosis
256543|stereotactic injection
256544|VEGF Trap
256545|zinc sulfate
256546|BAY 59-8862
256547|Birt-Hogg-Dube syndrome
256548|Burkitt leukemia
256549|CpG 7909
256550|darbepoetin alfa
256551|endothelin-1 protein receptor antagonist
256552|familial cancer
256553|genetic susceptibility
256554|AJCC staging system
256555|basal cell nevus syndrome
256556|comorbidity
256557|distal
256558|dysesthesia
256559|ecchymosis
256560|emesis
256561|essential thrombocytosis
256562|essential thrombocythemia
256564|Gail model
256566|hilar
256567|hot flash
256568|MAMMOTOME
256569|menorrhagia
256570|Mohs surgery
256571|NPO
256572|opportunistic infection
256573|polyphenol
256574|prophylactic
256575|proximal
256576|thrombohemorrhagic event
256578|vasomotor
256579|venipuncture
256580|phlebotomy
257205|ABCD rating
257206|Jewett staging system
257207|dilate
257209|hormone responsive
257210|invasive procedure
257211|latent
257212|mucous membrane
257213|mucosa
257214|pathological staging
257215|penis
257216|prostatitis
257218|radioactive palladium
257219|radioactive seed
257221|sperm
257222|sphincter
257223|carcinomatosis
257225|epidemiology
257517|gastroesophageal reflux
257519|head and neck cancer
257520|hemilaryngectomy
257523|organ
257525|partial laryngectomy
257526|saliva
257527|scalpel
257528|supraglottic laryngectomy
257529|total laryngectomy
441254|nursing home
441255|philosophical
441257|rehabilitation
441262|respirator
441264|social service
441265|spirituality
441266|supplemental nutrition
441267|transitional care
441269|wound
441270|nicotine inhaler
441271|nicotine lozenge
442860|albinism
442861|excisional skin surgery
442862|photosensitizing agent
442897|nevoid basal cell carcinoma syndrome
269420|human T-cell leukemia virus type 1
269421|infliximab
269422|magnetic resonance spectroscopic imaging
269423|modafinil
269424|MRSI
269425|PKC412
269426|pyroxamide
269427|R-flurbiprofen
269428|risedronate
269429|UGT1A1
269430|valacyclovir
269431|Virulizin
269432|visilizumab
269435|acrylonitrile
269436|astrocyte
269437|burr hole
269439|formaldehyde
269440|glial cell
269443|nerve cell
269444|neuron
269445|nurse
269446|occupational therapist
269448|palliative care
269449|comfort care
269452|Schwann cell
269453|symptom management
269454|asymmetry
269457|cauterize
269459|excision
269460|intraocular melanoma
269462|lymph vessel
269463|lymphatic vessel
269467|ocular melanoma
269468|plastic surgery
269469|ulceration
269471|UVA radiation
269473|UVB radiation
269877|efaproxiral
270712|paclitaxel polyglutamate
270726|proton beam radiation therapy
270728|neuro-oncologist
270729|mental health counselor
270730|gamma ray
270731|3-dimensional conformal radiation therapy
270732|allogeneic stem cell transplantation
270733|autologous stem cell transplantation
270734|benzene
270735|blood
270737|cytogenetics
270738|electromagnetic field
270739|electromagnetic radiation
270740|lung
270741|syngeneic bone marrow transplantation
270742|targeted therapy
270800|Hodgkin lymphoma
270852|gene transfer
270853|ataxia-telangiectasia
270854|endocrine pancreas cell
270855|islet cell
270856|exocrine pancreas cell
270857|familial atypical multiple mole melanoma syndrome
446104|amino acid
446105|detoxify
446106|maternal
446108|porcine
446109|antitumor
446111|coffee enema
446112|compliance
446113|dietary protocol
446114|nervous system
446115|autonomic nervous system
446118|metabolic type
446120|trophoblast
446187|stage I salivary gland cancer
446188|stage II salivary gland cancer
446189|stage III salivary gland cancer
446190|stage IV salivary gland cancer
446191|fast-neutron beam radiation
446193|photon beam radiation therapy
446194|stage I uterine sarcoma
446195|stage II uterine sarcoma
446196|stage III uterine sarcoma
446197|stage IV uterine sarcoma
446199|internal exam
446200|circumcision
446203|foreskin
446204|glans penis
446205|penectomy
446206|stage I penile cancer
446208|stage II penile cancer
446210|stage III penile cancer
446211|stage IV penile cancer
446212|anterior
446214|posterior
446215|anterior urethral cancer
446216|posterior urethral cancer
446217|cystourethrectomy
446218|cystoprostatectomy
446220|anterior pelvic exenteration
446222|urinary diversion
446224|electrofulguration
270860|glucagon
270861|multiple endocrine neoplasia type 1 syndrome
270862|MEN1 syndrome
270863|multiple endocrine adenomatosis
270864|Wermer syndrome
270865|polypectomy
270867|chemoimmunotherapy
270868|modality
270869|mediastinal pleura
270870|parietal pericardium
270871|physical examination
270872|urine cytology
277237|syngeneic stem cell transplantation
277243|lonafarnib
285621|central nervous system primitive neuroectodermal tumor
285632|E7389
285633|EGb761
285634|epoetin beta
285635|etanercept
285636|implant
285637|photopheresis
285638|RK-0202
285639|atypical teratoid/rhabdoid tumor
285673|cohort study
285736|coumestan
285738|coumestrol
285740|daidzein
285741|shiitake mushroom
285746|Scutellaria barbata
285747|consecutive case series
285915|cellular adoptive immunotherapy
285917|dexmethylphenidate
285920|flaxseed
285921|linseed
285925|LY317615
285927|marijuana
285933|microsatellite instability
285938|microsatellite
285939|mistletoe
285942|PV701
285944|ZD6474
285947|rapamycin
285952|anaphylactic shock
285953|agglutinin
285958|bronchial
285960|carbohydrate
285963|carcinosis
285965|chitin
285966|glycopeptide
285968|immunostimulant
285970|inoperable
285971|instillation
285972|intrapleural
285973|mean
285974|mean survival
285976|mercury
285977|nanogram
285978|operable
285980|pharmacopoeia
285981|subset analysis
285982|blinded study
285990|open label study
286105|observational study
286367|historic cohort study
286525|retrospective cohort study
286693|prospective cohort study
288845|sarcosinamide nitrosourea
299584|semaxanib
301626|systemic chemotherapy
301627|tariquidar
302450|ABX-EGF
302451|anagrelide
302452|buspirone
302456|family history
302458|gastroesophageal junction
302459|GW572016
302460|hypoxia
302462|OGX-011
302463|Sho-saiko-to
302467|T900607
302468|TNFerade
302469|tropisetron
302471|YM598
302474|syringe
302475|lymphoblast
304685|blood chemistry study
446981|intravaginal
446982|vaginectomy
446983|wide local excision
449722|Traditional Chinese Medicine
449723|needling
449724|moxibustion
449725|cupping
449727|acupuncture point
449728|acupuncture needle
449732|medical device
449739|Oriental medicine
449741|homeostasis
449742|Chinese meridian theory
449744|meridian
449745|trigger point acupuncture
449746|rectitis
449747|dysphonia
449748|thoracodynia
449749|hemoptysis
449752|conventional medicine
449760|nerve growth factor
449772|endorphin
449810|electrodermal response
449817|auricular
304715|clinical breast exam
304716|diagnostic mammogram
304718|digital mammography
304719|fertile
304721|infertile
304724|bilateral prophylactic mastectomy
304725|menopausal hormone therapy
304734|needle-localized biopsy
304735|nipple
304736|obese
304742|overweight
304743|progestin
304744|screening mammogram
304745|ultrasound-guided biopsy
304750|breast-sparing surgery
304766|breast
305989|CP-724,714
305990|estradiol
305991|Gonzalez regimen
305992|hereditary leiomyomatosis and renal cell cancer syndrome
305993|milk thistle
305994|neurobehavioral
305995|photoactivity
305996|poly-ICLC
305997|talaporfin sodium
305998|zileuton
306486|agnogenic myeloid metaplasia
306487|chronic idiopathic myelofibrosis
306488|primary myelofibrosis
306489|myelosclerosis with myeloid metaplasia
306490|idiopathic myelofibrosis
306491|antihormone therapy
306492|antiretroviral therapy
306493|BAY 43-9006
306494|chemoradiotherapy
306495|chemoradiation
306496|diarrhea
306497|EP-2101
306498|fulvestrant
306499|gonadotropin-releasing hormone
306500|gonadotropin-releasing hormone agonist
306501|GTI-2040
306502|hexyl 5-aminolevulinate
306503|high-energy photon therapy
306504|highly active antiretroviral therapy
306505|BCX-1777
306506|lidocaine
306507|magnetic resonance perfusion imaging
306508|MLN2704
306509|molecular risk assessment
306510|pack year
306511|polifeprosan 20 carmustine implant
306512|Gliadel Wafer
306513|rasburicase
306514|retrovirus
306515|seocalcitol
306516|SGN-00101
306517|sildenafil
306518|Viagra
306519|single-photon emission computed tomography
306520|SU011248
306521|microgram
306523|doubling time
306524|proteomics
306525|antimitotic agent
306526|antimicrotubule agent
306531|GnRH
306532|HAART
306534|SPECT
315757|cilengitide
316080|pegfilgrastim
318813|cure
318814|histone
318815|histone deacetylase
318816|DNA intercalating agent
318818|neuropathologist
318819|neuroradiologist
318820|orchidectomy
318821|pediatric nurse specialist
318822|pediatric hematologist
318823|pediatric surgeon
318824|protein kinase C
318825|rehabilitation specialist
318826|resorption
321355|black cohosh
321357|black snakeroot
321358|rattlesnake root
454512|ventilator
454513|gastric cancer
454523|International Unit
454697|adjustment disorder
454699|appetite
454700|cope
454701|distress
454702|isolation
454704|panic
454705|pastoral counselor
454706|psychiatrist
454708|recover
454714|aggravating factor
454715|barrier
454742|allopathic medicine
454743|Western medicine
45688|familial polyposis
45689|fatty acid
45690|fibrosis
45691|fine-needle aspiration biopsy
45692|gastrointestinal
330189|spotted thistle
330190|lappa
330191|happy major
330192|da-huang
330193|Chinese rhubarb
330194|Indian rhubarb
330195|Turkish rhubarb
330196|purple clover
330197|wild clover
330199|dock
330200|sorrel
330201|gray elm
330202|Indian elm
330203|red elm
330204|sweet elm
330205|Indian cress
334457|edotecarin
335061|ablation
335062|apocrine gland
335063|chloroma
335064|cholangiocarcinoma
335065|enucleation
335066|flow cytometry
335068|Gerota's capsule
335069|hemangiosarcoma
335070|lymphangiosarcoma
335071|hotspot
335072|immunoassay
335073|intensity-modulated radiation therapy
335074|Klatskin tumor
335075|lacrimal gland
335076|microstaging
335077|Mullerian tumor
335078|malignant mixed Müllerian tumor
335079|multidisciplinary
335080|sputum cytology
335081|cytology
335082|thermography
335083|trigeminal nerve
335085|fifth cranial nerve
335091|clear cell adenocarcinoma
335092|mesonephroma
335098|granulocytic sarcoma
335101|objective improvement
335479|ACE inhibitor
335481|angiotensin-converting enzyme inhibitor
335483|anidulafungin
335484|brivudine
335487|breast density
335488|infrared coagulation
335491|lamotrigine
335492|open biopsy
335494|perineal colostomy
335496|malignant peripheral nerve sheath tumor
335498|MPNST
335500|ranpirnase
335503|Onconase
335506|rifampin
335507|selective serotonin reuptake inhibitor
335509|SSRI
335511|serotonin
335512|5-hydroxytryptamine
335513|sertraline
335514|Zoloft
335515|sorivudine
339331|variable expression
339344|penetrance
339347|sporadic cancer
339366|NF1
460201|nucleotide
460214|risk assessment
460221|translation
460228|FISH
462659|agitation
462660|antibacterial
462661|antimicrobial
462662|aromatherapy
462663|aromatherapy massage
462664|aromatic
462666|bergamot
462667|biochemist
462668|blood pressure
462669|carrier oil
462670|cedarwood
462671|chamomile
462672|dementia
462674|dilute
462675|eczema
462676|electroencephalogram
462677|essential oil
462678|eucalyptus
462679|fragrance
462680|geranium
462681|German chamomile
462682|Roman chamomile
462683|herbal medicine
462684|lavender
462685|limbic system
462687|metabolite
462688|neuropsychology
462689|odor
462690|odorant
462691|olfaction
462692|olfactory
462693|olfactory system
462728|olfactory transduction
462746|patchouli
462755|phototoxicity
462925|renal failure
462950|synthetic
340925|BG00001
340926|BMS-354825
340927|cyproheptadine
340928|false-negative test result
340929|false-positive test result
340930|ginger
340931|IH636 grape seed extract
340932|MDX-060
340933|paricalcitol
340934|pertuzumab
340935|ravuconazole
340936|silymarin
340937|spinal cord
340938|talampanel
341450|immunophenotyping
341451|antiglobulin test
344348|cadmium
344349|fibrous
344350|hypernephroma
344352|nephrologist
344353|partial nephrectomy
344355|radical nephrectomy
344356|bilateral nephrectomy
344357|simple nephrectomy
344358|renal artery
346464|angioimmunoblastic T-cell lymphoma
346465|neurocognitive
346466|oxandrolone
346467|peginterferon alfa-2a
346487|anakinra
346488|coenzyme Q10
346489|complete metastasectomy
346490|metastasectomy
346491|methoxypolyethylene glycol epoetin beta
346492|Ro 50-3821
346493|PI-88
346494|first-line therapy
346512|inverted papilloma
346513|second-line therapy
346514|third-line therapy
346516|cumulative dose
346517|efficacy
346518|eligibility criteria
346519|endpoint
346520|expanded access trial
346521|FOLFOX
346522|high-dose chemotherapy
346523|off-label
346524|treatment schedule
346525|standard of care
346526|best practice
346545|CLL
347382|Kinaret
347383|Q10
347384|CoQ10
347385|vitamin Q10
347386|ubiquinone
348921|drug
348989|case-control study
348991|indication
349382|lytic lesion
349390|prevascular space
349391|anterior mediastinum
349392|multicentric breast cancer
349393|multifocal breast cancer
349442|ribonucleotide reductase inhibitor
349454|follicular mixed cell lymphoma
349455|endometrial hyperplasia
349457|erythrodysplasia
349461|malignant fibrous cytoma
349462|erythroid dysplasia
350222|aerosolize
350223|amonafide
350224|androgen-independent
350225|BB-10901
350226|breast duct endoscopy
350227|CC-8490
350228|etoposide phosphate
350229|IL-1
350230|intensification therapy
350231|interleukin-1
350232|intraocular
350233|J-pouch coloanal anastomosis
350234|myeloablation
350235|ophthalmic
350236|blood-brain barrier disruption
350237|BBBD
350238|osteitis deformans
463732|saturated fat
463733|spasm
463734|nutritional status
463736|trans fat
463737|yohimbe
467221|emetic
467223|thoracalgia
467224|type C thymoma
467345|T lymphocyte
467819|Vesanoid
467820|vitamin A acid
467821|retinoic acid
467822|Retin-A-Micro
467823|ATRA
467824|5-HT3 receptor antagonist
467825|acupuncture point injection
467826|adjunct therapy
467827|anatomic
467828|anatomy
467829|antiepileptic
45974|stage III cancer of the uterus
45975|stage IV cancer of the uterus
45976|carmustine
45977|protease inhibitor
45978|Pap test
45979|peptide 946
45980|node-negative
45981|observation
45982|gynecologic cancer
45983|hereditary
45984|difluoromethylornithine
45985|cryotherapy
45986|cystectomy
45987|BCG
45988|cystoscopy
45989|colposcopy
45990|chemosensitivity assay
45991|blood transfusion
45992|adenovirus
45993|white blood cell
45994|ONYX-015
45995|squalamine lactate
45996|mammography
45997|magnetic resonance imaging
363609|stage IIIC breast cancer
363610|occult stage non-small cell lung cancer
363611|stage 0 non-small cell lung carcinoma in situ
367406|testis
367407|adrenocortical
367408|DJ-927
367409|iodine I 131-tositumomab
367410|tositumomab
367411|Bexxar regimen
367412|siplizumab
367413|MEDI-507
367414|valerian
367415|garden valerian
367416|Indian valerian
367417|Valeriana officinalis
367418|Pacific valerian
367419|Mexican valerian
367420|garden heliotrope
367421|Valerianae radix
367423|valproic acid
367424|abarelix
367425|Plenaxis
367426|immunomodulation
367427|fungating lesion
367428|molecularly targeted therapy
367429|overgrowth syndrome
367430|ultrasound transducer
367431|Avastin
367432|CNS sanctuary therapy
367434|ABI-007
367435|AG-013736
367436|chronic myelomonocytic leukemia
367437|CMML
367438|collecting duct
367439|renal collecting tubule
367441|cytochlor
367442|embryonal tumor
367443|embryoma
367444|epothilone D
367445|KOS-862
367446|extrapleural pneumonectomy
367447|proteomic profile
367448|TAC-101
367449|tetrahydrouridine
367450|4-nitroquinoline 1-oxide
367451|4-NQO
367452|AAP
367453|alanine aminopeptidase
367454|adjunct agent
367455|Amanita phalloides
367456|death cap
367457|azoxymethane
367458|botanical
367459|Triapine
367460|nelarabine
367461|JM 216
367462|satraplatin
367463|ixabepilone
367464|KGF
367465|all-trans retinoic acid
367468|ABT-510
367469|benzydamine
367471|Traumeel S
367472|sarcoidosis
367473|sarcoid
367474|sulfonamide
367475|sulfa drug
367477|lobradimil
368445|stage 0 nonmelanoma skin carcinoma in situ
368446|stage I nonmelanoma skin cancer
368447|stage II nonmelanoma skin cancer
368448|stage III nonmelanoma skin cancer
368449|stage IV nonmelanoma skin cancer
368450|stage 0 testicular carcinoma in situ
476287|lobeline
476288|denomination
476289|disorientation
476290|cognition
476291|Alzheimer disease
476296|compulsion
476297|involuntary
476298|retch
476299|blood poisoning
476300|toxemia
372939|postprandial
372940|pro-oxidant
372941|serum glutamic-oxaloacetic transaminase
372942|aspartate transaminase
372943|serum glutamate pyruvate transaminase
372944|alanine transferase
372945|SGOT
372947|SGPT
372948|Silybum marianum
372949|varicose vein
373009|renal glomerulus
373010|glutathione
373012|glutathione S-transferase
373014|gram
373015|hemorrhage
373016|hepatomegaly
373017|splenomegaly
373019|true histiocytic lymphoma
373080|inflammatory
373083|cholestasis
373084|isomer
373085|laxative
373086|lipophilic
373087|magnesium
373088|malondialdehyde
373932|dietary supplement
373933|erection
373934|laparoscopic prostatectomy
373935|nerve
373937|nerve-sparing surgery
373938|radical perineal prostatectomy
373940|radical retropubic prostatectomy
373943|fecal incontinence
373944|urinary incontinence
373954|r-tPA
373995|NBI-3001
374965|tympanites
377704|carbon C 11-acetate
377705|contingency management
377706|creatine
377707|cryopreservation
377708|deslorelin
377709|ibandronate
377710|iloprost
377711|metronomic therapy
377712|mindfulness relaxation
377713|nerve grafting
377714|nerve-sparing radical prostatectomy
377715|OSI-7904L
377716|Peutz-Jeghers syndrome
377717|PJS
377718|tissue plasminogen activator
377721|tPA
377722|recombinant tissue plasminogen activator
377724|Activase
377725|Alteplase
377726|celiac disease
377727|CA 19-9 assay
377729|percutaneous transhepatic biliary drainage
377730|percutaneous transhepatic cholangiodrainage
377731|PTCD
377733|abdominoperineal resection
378185|angiostatin
383920|primitive neuroectodermal tumor
383924|PNET
385698|appendectomy
386192|autologous bone marrow
386193|conjunctivitis
386194|pinkeye
386195|4-hydroxytamoxifen
386196|AEE788
386197|bendamustine hydrochloride
386199|cefixime
386200|CEP-701
386201|gene expression profile
386202|genetic analysis
386203|everolimus
386204|gp209-2M
386205|high grade
386206|HIV positive
386207|fluoropyrimidine
386209|HLA
386210|human leukocyte antigen
386211|human lymphocyte antigen
386212|leptomeningeal
482131|tonga
482156|yangona
482287|tinnitus
482289|idiopathic pneumonia syndrome
482341|sodium stibogluconate
482342|CNTO 328
482344|carina of trachea
482345|pneumonitis
482346|sleeve resection
482347|sternum
482348|renal function test
482350|Wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome
482352|hemihypertrophy
482354|hypospadias
482355|stage 0 penile carcinoma in situ
482417|ephedra
482419|medicine
482428|medical nutrition therapy
415873|benign breast disease
415874|mammary dysplasia
415875|bone mineral density
415882|BMD
415884|bone mass
415910|well-differentiated lymphocytic lymphoma
415911|Glycine max
415912|soya
415913|soybean
415914|spine
415915|backbone
415916|vertebral column
416100|drug resistance
416101|resistant cancer
416102|stage I AIDS-related lymphoma
416103|stage II AIDS-related lymphoma
416105|stage III AIDS-related lymphoma
416109|stage IV AIDS-related lymphoma
422394|compound
423043|granulocyte-macrophage colony-stimulating factor
423184|HuHMFG1
423245|trephine
423248|progesterone receptor
423251|PR
423252|RAV12
423253|silicon phthalocyanine 4
423254|SJG-136
423255|volociximab
423261|LEP-ETU
423263|paclitaxel liposome
425589|LED therapy
425594|Ulmus fulva
425595|Ulmus rubra
426405|anorexia nervosa
426406|biological agent
426407|biological drug
426408|chronic eosinophilic leukemia
426409|chronic neutrophilic leukemia
426416|lobular carcinoma
426418|polycythemia vera
426421|capillary leak syndrome
427252|cholecalciferol
427253|vitamin D
427254|liposomal SN-38
427255|Hu3S193
427271|immunoassay fecal occult blood test
427310|central nervous system tumor
428246|amethopterin
428262|tumor vasculature–targeted tumor necrosis factor alpha
428286|diffuse large B-cell lymphoma
428287|follicular lymphoma
428290|systemic radiation therapy
513077|tinzaparin sodium
513078|Innohep
514187|Zolinza
514210|biometry
514212|biometrics
514357|fluphenazine
514409|VB4-845
514413|saw palmetto
514415|atorvastatin
514433|oligofructose-enriched inulin
514434|PHA-739358
514443|denosumab
514444|deferasirox
514445|RTA 744
514446|polyvinylpyrrolidone-sodium hyaluronate gel
514448|AFP464
514449|PR-104
514453|mediastinoscope
514683|sestamibi scan
514706|venous sampling
514876|familial isolated hyperparathyroidism
518299|paranasal sinus
518301|ATN-161
518302|CDDO
518303|maytansinoid DM4-conjugated humanized monoclonal antibody huC242
518304|primary care
518306|ectomesenchymoma
518307|TNF-bound colloidal gold
518308|esomeprazole
518309|fenofibrate
518310|AEG35156
518326|cryoablation
518652|17-AAG
518654|molecular medicine
520253|N-acetyl-L-cysteine
520257|Coombs test
520359|electrodiathermy
520360|Etopophos
520361|homeopathy
520362|underactive thyroid
520363|intravenous infusion
520366|voice box
520410|pPNET
520411|oprelvekin
520508|Dukes A colorectal cancer
520509|Dukes B colorectal cancer
520510|Dukes C colorectal cancer
520552|stage C prostate cancer
520556|median umbilical ligament
520557|birth canal
46649|vital
46650|vocal cord
46651|VX 853
46652|wart
46653|Whipple procedure
46654|xerogram
46655|xeroradiography
46656|stage IV anal cancer
46657|tumor suppressor gene
46658|second primary cancer
428383|stage IVA laryngeal cancer
428385|stage IVB laryngeal cancer
428386|stage IVC laryngeal cancer
428432|stage 0 hypopharyngeal carcinoma in situ
428436|stage IVB hypopharyngeal cancer
428437|stage IVC hypopharyngeal cancer
428440|stage 1 neuroblastoma
430401|activities of daily living
430402|ADL
430404|advance directive
430405|anxiety
430407|assessment
430408|assistive device
430409|assistive technology
430476|bereavement
430477|chaplain
430478|clergy
430479|depression
430480|do not resuscitate order
430481|DNR order
430482|durable power of attorney
430483|DPA
430484|healthcare proxy
430485|HCP
430486|hygiene
430497|stage IVA hypopharyngeal cancer
430652|M200
430695|human herpesvirus 8
430696|Kaposi sarcoma-associated herpesvirus
430697|KSHV
430698|ionizing radiation
430856|adnexal mass
430857|bone marrow cancer
430859|bursitis
430860|extrahepatic bile duct
430861|grade 1 follicular lymphoma
430862|grade 2 follicular lymphoma
430863|grade 3 follicular lymphoma
430864|intraductal papilloma
430865|nephrostomy
430866|parietal peritoneum
430867|synovitis
430869|NHL
430870|visceral peritoneum
430871|AMG 706
430872|AZD2171
430874|ferumoxtran-10
430875|pravastatin
430876|Pravachol
430877|XRP9881
430878|ZD4054
430880|HMG-CoA reductase inhibitor
430881|hydroxymethylglutaryl-coenzyme A reductase inhibitor
430882|vascular endothelial growth factor receptor tyrosine kinase inhibitor
430883|VEGFR tyrosine kinase inhibitor
430896|stage I childhood Hodgkin lymphoma
430897|stage II childhood Hodgkin lymphoma
430898|stage III childhood Hodgkin lymphoma
430899|stage IV childhood Hodgkin lymphoma
430908|HHV8
523284|cCLB8
523285|Melan-A protein
523286|Richter transformation
523287|azaspirane
523288|SK&F106615
523290|immune complex hemolytic anemia
523291|immunohemolytic anemia
523294|DIM
523296|ovarian borderline malignant tumor
523297|SSG
523314|talabostat mesylate
523315|PT-100
523318|IgG-RFT5-dgA
523319|Avodart
523321|GG745
523322|HLH
523326|NCX 4016
523328|NDGA
523329|masoprocol
523330|Actinex
523429|adrenal cancer
523430|bioinformatics
523432|parotid gland cancer
523437|comprehensive cancer center
523438|fibroadenoma
523452|Trisenox
523453|Targretin
523457|epirubicin hydrochloride
523458|Ellence
523459|extrahepatic bile duct cancer
523460|vaginal cancer
434597|medroxyprogesterone acetate
434624|temsirolimus
436738|central nervous system metastasis
436740|CNS PNET
436741|central nervous system prophylaxis
437045|central nervous system sanctuary therapy
438722|stage I ovarian germ cell tumor
438723|stage II ovarian germ cell tumor
438724|stage III ovarian germ cell tumor
438725|stage IV ovarian germ cell tumor
438726|TTI-237
438727|MDX-010
438728|hA20
438729|IMMU-106
438731|stage 0 breast carcinoma in situ
438733|eculizumab
438734|paroxysmal nocturnal hemoglobinuria
438735|PNH
439317|coronary heart disease
439400|coronary artery disease
439401|CAD
439402|inhaler
439403|micronutrient
439405|nicotine
439406|nicotine gum
439407|nicotine nasal spray
439408|nicotine patch
439409|nicotine replacement therapy
439410|nomogram
439411|mycosis fungoides plaque
439412|plaque
439416|portal hypertension
439417|premycotic phase
439419|prevention
439422|protective factor
439423|psoralen and ultraviolet A therapy
439424|PUVA therapy
439425|stroke
439426|sudden infant death syndrome
439427|SIDS
439428|crib death
439429|throat
439430|total skin electron beam radiation therapy
439431|TSEB radiation therapy
439432|tobacco
439435|vitamin C
439436|ascorbic acid
439437|fotemustine
439439|fluorine F 18-EF5
439440|18F-EF5
439441|opioid growth factor
439442|OGF
440100|artery
440101|asthma
440102|cataract
440104|Denys-Drash syndrome
440105|DDS
440106|high-dose radiation
440107|HDR
440108|in vitro fertilization
440109|kidney failure
440111|PTSD
440112|post-traumatic stress disorder
440113|puberty
440115|retina
440116|social support
440117|sperm count
440118|melatonin
441251|legal aid organization
441252|living will
441253|mental health
529988|aromatherapy infusion
530319|AT7519M
530320|vandetanib
530321|measles virus
530323|PI3K
530324|DT388IL3 fusion protein
530325|tegafur-uracil
530385|pancreatic endocrine cancer
531047|5Q minus syndrome
531092|BMI
531098|BPA-F
531118|CIN
531137|organic food
532132|AZD0530
532133|tetra-O-methyl nordihydroguaiaretic acid
532134|sleep apnea
532135|yoga
532303|EGFR inhibitor
532343|GI
532346|HLRCC
533240|LH-RH agonist
533413|ABT-263
533416|phototesting
533417|levetiracetam
533419|AP5346
533434|thyroxine
533812|KLH
533838|MMMT
533839|MSI
533840|NF2
533845|IL-7
534218|congenital mesoblastic nephroma
534219|diffuse hyperplastic perilobar nephroblastomatosis
534220|uvea
534221|iris
534222|ciliary body
534223|choroid
534224|glaucoma
534231|indirect ophthalmoscopy
442898|Mohs micrographic surgery
443020|iodine I 131-monoclonal antibody BC8
443024|strontium ranelate
443026|alpha-lipoic acid
443027|angiomyolipoma
443028|palifermin
443046|velafermin
443269|allergen
443292|allergic response
443306|oral contraceptive pill
443318|extracranial
443329|sacrum
443343|coccyx
443574|peritoneal fluid
443575|mature teratoma
443576|immature teratoma
443577|tendon
443579|gingiva
443580|retromolar trigone
443581|wisdom tooth
443582|superfractionated radiation therapy
443583|discharge
443585|radical local excision
443586|skinning vulvectomy
443587|simple vulvectomy
443588|partial vulvectomy
443589|radical vulvectomy
443590|myelomonocyte
443690|premature ovarian failure
443691|primary ovarian insufficiency
443694|HCD20
444957|acute promyelocytic leukemia
444960|adverse event
444964|AIDS-related cancer
444966|anal cancer
444967|B-cell lymphoma
444968|bladder cancer
444971|breast cancer
444973|cervical cancer
444982|clear cell
444983|colorectal cancer
444985|COX inhibitor
444986|cyclooxygenase inhibitor
444987|endometrial cancer
444989|esophageal cancer
444991|eye cancer
444992|extracranial germ cell tumor
444993|extragonadal germ cell tumor
444994|genetics
444995|kidney cancer
444998|laetrile
445040|laryngeal cancer
445043|lung cancer
445046|male breast cancer
445048|mantle cell lymphoma
445071|nanotechnology
445072|nasopharyngeal cancer
445073|oral cancer
445074|ovarian cancer
445075|pharyngeal cancer
445079|prostate cancer
445084|skin cancer
445087|stomach cancer
445089|survivorship
445090|testicular cancer
445091|thyroid cancer
445093|toxicity
445094|uterine cancer
445097|uterine sarcoma
535475|AMG 162
535479|FIHP
535480|fluphenazine hydrochloride
535486|Raftilose Synergy 1
535495|Gelclair
535498|topoisomerase II inhibitor RTA 744
535555|ipilimumab
535559|Mifeprex
535560|RU 486
535569|ispinesib
535774|stage 0 lip and oral cavity carcinoma in situ
535775|stage 0 oropharyngeal carcinoma in situ
535776|stage 0 pancreatic carcinoma in situ
535777|vaginal intraepithelial neoplasia
535778|stage I vaginal cancer
535779|stage II vaginal cancer
535780|stage III vaginal cancer
535781|stage IV vaginal cancer
536078|radiation necrosis
536228|anti-EpCAM-Pseudomonas-exotoxin fusion protein
536229|Proxinium
536401|ultrasound biomicroscopy
536514|FDR
537170|epothilone ZK219477
537233|pregabalin
537246|paralytic ileus
537249|maribavir
537262|ofatumumab
537263|lexatumumab
537264|skin conduction
537331|tiacumicin B
537332|HuLuc63
446420|pituitary tumor
446430|penile cancer
446523|oropharyngeal cancer
446524|Essiac
446525|small intestine cancer
446526|adrenocortical carcinoma
446527|heart cancer
446528|salivary gland cancer
446529|parathyroid cancer
446530|cancer cluster
446531|bronchial adenoma
446532|paranasal sinus and nasal cavity cancer
446533|levels of evidence
446534|pruritus
446535|radiation enteritis
446536|energy balance
446537|Gerson therapy
446539|SNP
446540|urethral cancer
446542|Cancell
446543|genomics
446544|simian virus 40
446545|radiation dermatitis
446546|hypopharyngeal cancer
446547|telemedicine
446548|toxicology
446549|inherited bone marrow failure syndrome
446550|dosimetry
446552|Sun's Soup
446553|Claus model
446555|Newcastle disease virus
446556|heterocyclic amine
446557|pleuropulmonary blastoma
446558|teratocarcinoma
446559|gastrointestinal carcinoid tumor
446560|ovarian germ cell tumor
446561|investigational drug
446562|calendula ointment
446564|early-stage breast cancer
446566|gallbladder cancer
446800|AP23573
446802|galiximab
446803|hematuria
446804|hemochromatosis
446805|iron
446806|phenylketonuria
446922|conception
446933|hydatidiform mole
446955|invasive hydatidiform mole
446970|suction evacuation
446980|bowel function
539072|stage I soft tissue sarcoma
539073|stage II soft tissue sarcoma
539103|gonadal dysgenesis
539104|extranodal
539110|Wiskott-Aldrich syndrome
539131|GBM
539453|lapatinib ditosylate
539480|GEM640
539481|esomeprazole magnesium
539482|Nexium
539483|TriCor
539484|huC242-DM4
539485|colloidal gold-bound tumor necrosis factor
539486|Aurimmune
539489|recombinant adenovirus-p53
539499|malignant ectomesenchymoma
539530|Lofibra
540447|oligodendrocyte
540457|fluorine F 18-FEQA
540759|ependyma
540760|ependymal cell
542431|Soliris
542440|biochemical relapse
542441|PSA bounce
543112|L-arginine
543113|levonorgestrel
543114|terazosin
543115|doxazosin
543116|tamsulosin
543117|batracylin
543118|CIN 1
543119|CIN 2
543120|pegylated arginine deiminase
543121|anti-CD19 immunotoxin
543123|anti-CD22 immunotoxin
543124|marginal zone lymphoma
543126|CAT-8015
543127|DEXA scan
543384|recombinant fowlpox-TRICOM vaccine
543385|vaccinia-TRICOM vaccine
543477|colon crypt
543496|ACF
543497|gland of Lieberkuhn
543498|COPD
543499|anti-TGF-beta monoclonal antibody GC1008
543500|anti-mesothelin monoclonal antibody MORAb-009
543504|B-cell acute lymphoblastic leukemia
543509|B-cell acute lymphocytic leukemia
543513|ET-743
543514|trabectedin
543627|PSA failure
454745|biomedicine
454746|orthodox medicine
454747|mainstream medicine
454748|acupoint
454752|drug abuse
454754|drug interaction
454755|electrode
454756|impairment
454757|intervention
454759|intraspinal
454761|massage therapy
454762|methadone hydrochloride
454763|muscle wasting
454764|oxycodone hydrochloride
454765|physical dependence
454766|psychological
454769|pathognomonic
454770|proctitis
454772|TCM
454774|animal study
454775|blood stasis
454776|emetogenic
454777|National Center for Complementary and Integrative Health
454778|NCCIH
454780|polycystic ovary syndrome
454781|PCOS
454782|qi
454783|tui na
454785|Food and Drug Administration
454786|FDA
454787|yin and yang
454789|Zheng
454794|World Health Organization
454795|lipoma
454798|avoidance
454799|conditioned response
454801|interfering thought
454803|monitor
454805|obsessive-compulsive disorder
454806|phobia
454807|trauma
454808|trigger
454809|caffeine
454811|parasomnia
454812|polysomnogram
454813|rapid eye movement sleep
454814|sleep disorder
454815|sleep stage
454834|stage I mycosis fungoides
454837|stage II mycosis fungoides
454840|stage III mycosis fungoides
454841|stage IV mycosis fungoides
454933|serosa
454934|serous membrane
454935|submucosa
454936|subserosa
454991|endosonography
454994|registered dietitian
455133|human papillomavirus vaccine
455134|hepatitis A vaccine
455136|body mass index
455137|esterified estrogen
455139|amrubicin
455140|nimustine
455141|systemic mastocytosis
455143|garlic
455144|primary effusion lymphoma
455145|effusion
455146|posterior pelvic exenteration
455147|17-dimethylaminoethylamino-17-demethoxygeldanamycin
455148|syngeneic
455149|talotrexin
455150|arthralgia
455152|SAHA
455153|vorinostat
455334|capsule
455335|hypogammaglobulinemia
455350|myasthenia gravis
455364|noninvasive
455382|polymyositis
455398|rheumatoid arthritis
556402|vitamin B complex
556403|biotin
556404|thiamine
556406|riboflavin
556407|niacin
556408|pantothenic acid
556409|aminobenzoic acid
556410|choline
556412|cell culture
556417|DRI
556419|Dietary Reference Intakes
556423|pelargonium
556426|Keppra
556428|tetra-O-methyl NDGA
556430|EM-1421
556432|T4
556433|L-3,5,5’-tetraiodothyronine
556436|thyroxin
557101|ethmoid sinus
557102|maxillary sinus
557104|frontal sinus
557105|sphenoid sinus
557291|interleukin-13
557292|interleukin-5
557293|interleukin-10
557354|resiquimod
557355|spinal cord compression
557356|amitriptyline
557357|ketamine
330179|sheep sorrel
330180|slippery elm
330181|watercress
330182|sesquiterpene lactone
330183|subjective improvement
330184|synergistic
330186|St. Benedict's thistle
330187|cardin
330188|holy thistle
455423|Sjögren syndrome
455462|thymic carcinoma
455472|thyroiditis
455670|abdominal x-ray
457758|intra-arterial
457951|alcohol dependence
457952|BPD
457953|Celexa
457954|ECT
457955|electroshock therapy
457956|Lexapro
457957|mercy killing
457958|Luvox
457960|Remeron
457961|Serzone
457962|talk therapy
457964|oncolytic virotherapy
457974|adrenocortical cancer
457975|cancer of the adrenal cortex
457979|Sheridan’s Formula
457980|Jim’s Juice
457982|JS–114
457983|JS–101
457986|126–F
457987|Cantron
457993|cardiac sarcoma
458022|HCA
458026|IBMFS
458034|chorioadenoma destruens
458035|experimental drug
458036|NDV
458041|PKU
458045|SV40
458046|single nucleotide polymorphism
458047|suction aspiration
458048|vacuum aspiration
458080|joint
458082|adrenal cortex
458083|adrenal medulla
458084|norepinephrine
458085|neurotransmitter
458086|suprarenal gland
458091|high blood pressure
458094|functioning tumor
458095|nonfunctioning tumor
458096|adrenalectomy
458097|hyperparathyroidism
458098|endocrine
458099|parathyroidectomy
458100|thermotherapy
458101|gastrin
458102|hepatic arterial occlusion
458104|occult primary tumor
460127|Ashkenazi Jews
460130|base pair
460137|congenital
460150|first-degree relative
460151|fluorescence in situ hybridization
460153|genetic predisposition
460162|locus
559256|lestaurtinib
559371|debulking
559442|locally recurrent cancer
559443|duloxetine
559445|tazarotene
559451|cyclooxygenase-2
559453|immune thrombocytopenic purpura
559454|Se-methyl-seleno-L-cysteine
559455|isosulfan blue
559456|biliary tract
559457|primary therapy
559458|sickle cell anemia
560136|doxorubicin hydrochloride liposome
560137|Evacet
560138|Dox-SL
560139|LipoDox
560140|doxorubicin hydrochloride
560141|Adriamycin PFS
560142|Adriamycin RDF
560236|dietary counseling
560342|stage A prostate cancer
560343|stage B prostate cancer
560344|stage D prostate cancer
560347|water-soluble vitamin
560348|fat-soluble vitamin
560639|yttrium Y 90-DOTA monoclonal antibody HuAFP31
560640|HuAFP31
560643|broccoli sprout extract
560646|herbal supplement
560647|autoimmune enteropathy
560648|methylnaltrexone
560661|CIN 3
560745|lung biopsy
560927|glycan
560928|canertinib
560963|recombinant vaccinia-CEA-MUC-1-TRICOM vaccine
560964|CIN 2/3
560966|losartan
560967|fexofenadine
354460|ESR
354461|sedimentation rate
354462|lactate dehydrogenase
354463|lactic acid dehydrogenase
354465|LDH
354466|nephroureterectomy
354468|ureteronephrectomy
354469|serum tumor marker test
354470|ureteroscopy
354472|Cipro
354473|lymphatic mapping
357558|carcinoembryonic antigen
357559|cecum
357579|double-contrast barium enema
357580|endorectal ultrasound
357582|ERUS
357583|TRUS
357584|FOBT
357588|sigmoid colon
468787|PF-00299804
468788|recombinant fowlpox-CEA-MUC-1-TRICOM vaccine
468789|Bowman-Birk inhibitor concentrate
468790|hyperthermia
468792|neuroleptic malignant syndrome
468793|meperidine hydrochloride
468794|antihistamine
468795|Reye syndrome
468796|endocrine system
468797|lassitude
468798|prostration
468799|chronic fatigue syndrome
468800|psychostimulant
468801|euphoria
468802|paranoia
468803|immunity
470244|Nexavar
470246|Clolar
470251|translocation
470252|esophageal stent
470253|upper endoscopy
470254|talc
470256|humanized monoclonal antibody
470258|trachelectomy
471770|coronary artery bypass
471772|rectal reconstruction
471773|tinzaparin
471775|gp96 heat shock protein-peptide complex vaccine
471776|daptomycin
471777|ropivacaine
471778|SL-11047
471779|fenretinide LXS
471780|meningitis
471781|endocarditis
471782|osteomyelitis
471783|imexon
471784|D-cycloserine
471785|urea
471786|vitamin B6
471787|Langerhans cell histiocytosis
471866|prostatocystectomy
472896|histone deacetylase inhibitor
472904|hepatitis A virus
473970|HDAC inhibitor
475987|thrombus
476017|blood clot
476040|thrombectomy
476063|thrombolysis
476079|tuberculosis
476099|bronchodilator
476118|pacemaker
476135|venography
476163|oxygen saturation test
476179|maximum inspiratory pressure test
574284|classical Hodgkin lymphoma
574285|NLPHL
574286|nodular lymphocyte-predominant Hodgkin lymphoma
574728|ibritumomab tiuxetan
575396|nilotinib
575433|ALCL
575435|acute myeloblastic leukemia
575436|ANLL
575486|VHL syndrome
575843|melanocortin 1 receptor
575845|melanotropin receptor
575912|lab-on-a-chip
576489|DNA methyltransferase
577033|aminolevulinic acid hydrochloride
577034|death rattle
579601|Proleukin
579605|recombinant human interleukin-2
579610|Fosamax
579625|Provenge
579628|sipuleucel-T
579630|molecular marker
579633|signature molecule
579637|cancer antigen 125
579644|canertinib dihydrochloride
579649|Zevalin
579671|111In-ibritumomab tiuxetan
579673|111In-Zevalin
579676|90Y-ibritumomab tiuxetan
579678|90Y-Zevalin
579858|liposomal cytarabine
579859|cytarabine liposome
390240|antiapoptotic
390245|phospholipid complex
390246|physician
390247|regeneration
390250|somatostatin receptor scintigraphy
390252|spine cancer
390253|SRS
390255|statin
390257|BI-RADS
390258|cell-cycle regulation
390259|cell-to-cell signaling
390263|corticotropin
390266|cytochrome P450 enzyme system
390267|DU 145
390268|dysfunction
390271|significant
390273|EKB-569
390275|enteral nutrition
390276|enzastaurin
390277|esophageal reflux
390278|ferumoxytol
390280|gastric reflux
390282|giant cell fibroblastoma
390283|throat cancer
390284|hyperalimentation
390285|tongue cancer
390287|INS316
390288|TPN
390290|transcription
390292|late effect
390293|liver function test
390295|transferrin-CRM107
390298|tubefeeding
390299|mitigate
390300|modulate
390301|motexafin lutetium
390302|nausea
390304|octreotide scan
390305|paraganglioma
390306|parenteral nutrition
390307|peripheral blood smear
390308|perturbation
390309|phase I detoxification
390310|phase II detoxification
390314|tumor initiation
390316|tumor promotion
390317|ulcer
390319|unresected
390320|valrubicin
390321|vatalanib
390323|vitamin B12
390324|vomit
390335|lapatinib
390340|iodine I 131-metaiodobenzylguanidine
390341|131I-MIBG
390943|Breast Imaging Reporting and Data System
487470|zoledronic acid
487473|Zometa
488410|CHIR-265
488411|852A
488413|dutasteride
488414|RFT5-dgA immunotoxin
488415|hemophagocytic lymphohistiocytosis
488416|Abraxane
488417|nitric oxide-releasing acetylsalicylic acid derivative
488441|antibody-drug conjugate
488442|antihypertensive agent
488672|antisense oligonucleotide
489115|Tykerb
489304|talabostat
489306|diindolylmethane
489307|yttrium Y 90-DOTA monoclonal antibody HuPAM4
489392|anti-inflammatory agent
489395|religion
489396|Richter syndrome
489403|bulk-forming agent
489512|steroid cream
491009|calcium channel blocker
491156|cell cycle inhibitor
491158|central nervous system depressant
491160|central nervous system stimulant
491285|autoimmune hemolytic anemia
491304|differentiating agent
491501|DNA cross-linking agent
491502|EGFR tyrosine kinase inhibitor
491505|enzyme inhibitor
491507|epidermal growth factor receptor inhibitor
491538|epidermal growth factor receptor tyrosine kinase inhibitor
491867|fluoroquinolone
491913|folic acid antagonist
492104|immunosuppressive agent
593103|Lanoxin
594104|Treanda
595341|leuprolide acetate
595347|Eligard
595348|Lupron
595349|Viadur
596691|optic pathway glioma
597088|ACAPHA
597092|aldosterone
597093|AZD2281
597094|bupivacaine
397115|panitumumab
398808|phospholipid
401508|cobalamin
403135|extracorporeal photopheresis
403137|parathormone
403138|parathyrin
403139|PTH
403140|PCR
403141|PIN
403142|PKC
403143|PLL
403144|ras peptide
403145|SLE
403146|SWS
403147|transurethral radiofrequency ablation
403148|transvaginal sonography
405812|SGN-30
405813|SGN-40
405873|peripheral T-cell lymphoma
405883|NSC 655649
407581|paraganglia
407582|programmed cell death
407746|dilatation and curettage
407747|exocrine cancer
407748|Sertoli-Leydig cell tumor of the ovary
407749|androblastoma
407750|arrhenoblastoma
407751|small lymphocytic lymphoma
407755|bone density
407756|cholesterol
407757|constipation
407758|disorder
407759|drain
407760|extract
407762|fibrocystic breast changes
407765|osmotic
407766|soy
409750|lymphoplasmacytic lymphoma
409764|contrast material
409765|genital wart
409768|HSIL
409827|condyloma
410212|pioglitazone
410310|liquid-based Pap test
410401|LSIL
410514|low-grade squamous intraepithelial lesion
410605|menstrual period
410631|pelvic wall
410643|punch biopsy
410676|partial hysterectomy
410729|mast cell tumor
410730|MeV linear accelerator
492233|sunitinib
492234|SU11248
492235|Sutent
496500|carbon monoxide
496501|phlegm
496502|mortality
496503|epidemiologist
496504|biostatistics
496506|surveillance
505904|HPV vaccine
505945|Rituxan
505985|Erbitux
505987|NMS
506029|exenteration
506988|Eastern red cedar
507007|red cedar
507140|EEG
507517|Aldara
507521|Revlimid
507522|Femara
507537|Arranon
507554|Taxol
507584|Vidaza
507586|Mylosar
507600|paclitaxel albumin-stabilized nanoparticle formulation
507601|nanoparticle paclitaxel
507639|sterile talc powder
507640|Temodar
507648|Thalomid
507692|topotecan hydrochloride
507751|protein-bound paclitaxel
597120|dihydrotestosterone
597127|androstanolone
597135|DHT
597136|DNA replication
597138|dornase alfa inhalation solution
597139|Pulmozyme
597152|five-year survival rate
597153|gadolinium
597155|hypoxemia
597156|Jamshidi needle
597158|lymphoblastic lymphoma
597159|precursor lymphoblastic lymphoma
597160|myoclonic jerk
597161|nucleus
597162|obatoclax mesylate
597163|ProstaScint
597164|capromab pendetide
597165|ProstaScint scan
597166|radioimaging
597167|radioimmunodiagnostics
597169|radioimmunotherapeutics
597170|signal transduction
597171|squamous cell carcinoma of the head and neck
597173|tubulin
597182|Recentin
597183|cediranib maleate
597239|3’-deoxy-3’-(18F) fluorothymidine
597240|18F-FLT
413932|smoldering myeloma
413935|ACN53
413937|rAd/p53
413938|Actos
413941|Alkeran Tablets
413942|Angiozyme
413943|CellCept
413944|Eloxatin
413945|Flagyl
413946|forodesine
413947|gadolinium texaphyrin
413948|Genasense
413950|Mustargen
413951|NGR-TNF
413953|opiate
413955|Purinethol
413956|resveratrol
413957|Rheumatrex
413959|Thymitaq
508062|English lavender
508067|true lavender
508073|carbolic acid
508532|Xeloda
508645|Sprycel
508665|Indian saffron
508666|jiang huang
508667|Dacogen
508678|Taxotere
508683|Aromasin
508685|ointment
508686|pertussis
508688|Iressa
508893|Demerol
508929|erlotinib hydrochloride
508934|OSI-774
508938|Tarceva
508951|gemcitabine hydrochloride
508952|Gemzar
509002|Mylotarg
509038|romidepsin
509041|sorafenib tosylate
509174|Oncaspar
509190|PEG-asparaginase
509341|tamoxifen citrate
509729|precursor T-lymphoblastic leukemia
509731|T-cell acute lymphoblastic leukemia
509747|T-cell acute lymphocytic leukemia
509757|precursor T-lymphoblastic lymphoma
509758|T-lymphoblastic lymphoma
512740|Vectibix
512776|BBIC
512779|vascular endothelial growth factor-antisense oligonucleotide
512780|frankincense tree
512781|Emend
512797|Doxil
512800|OvaRex
512811|PTLD
512821|PCNSL
512828|Quadramet
512884|Javlor
512885|intrusive thought
512887|Xyotax
512893|cervicectomy
512895|REM sleep
512908|stage IVA lip and oral cavity cancer
512909|stage IVB lip and oral cavity cancer
512910|stage IVC lip and oral cavity cancer
512918|stage I Merkel cell carcinoma
512921|stage II Merkel cell carcinoma
512926|stage III Merkel cell carcinoma
512981|forodesine hydrochloride
512985|PF-3512676
512986|ProMune
513008|MLN591DM1
513009|N-benzoyl-staurosporine
513012|midostaurin
513020|enzastaurin hydrochloride
513022|Avelox
513023|moxifloxacin hydrochloride
513024|L-threo-dihydrosphingosine
513029|Trelstar
513045|MIP test
513046|artificial pacemaker
513047|cardiac pacemaker
513048|TB
513053|Seromycin
513054|LCH
513055|aortocoronary bypass
513056|CAB
513057|Cubicin
513058|fenretinide Lym-X-Sorb
513059|gp96 HSP-peptide complex
513060|Oncophage
513068|Amplimexon
513075|ropivacaine hydrochloride
513076|Naropin
599993|memantine hydrochloride
599994|Namenda
600421|asbestosis
600425|orthotopic
600434|anti-VEGFR monoclonal antibody
600436|argon beam coagulator ablation
600439|brivanib alaninate
600440|glycan analysis
600441|KX2-391
600448|montelukast sodium
600449|Singulair
600462|SNX-5422 mesylate
600463|spectroscopy
600464|whey protein powder
537335|gene expression
537398|extraocular
537399|peer-reviewed scientific journal
537425|TSH
537429|VAS
537551|chromaffin cell
537553|catecholamine
537554|varenicline tartrate
537555|aromatherapist
537556|naturopathy
537557|lemon
537695|invasive breast cancer
537795|antidiarrheal
538147|carbon dioxide
538149|oxygen
538153|oxygen therapy
538154|supplemental oxygen therapy
538155|pulmonologist
538163|respiratory therapist
538164|segmentectomy
538165|sleeve lobectomy
538166|thoracic surgeon
538168|thoracic surgical oncologist
538415|infiltrating breast cancer
538627|animal-assisted therapy
538630|recreational therapy
538634|nimotuzumab
538635|axitinib
538636|Aurora kinase inhibitor AT9283
538637|osteopenia
538639|growth hormone
538640|natural history study
538642|amoxicillin-clavulanate potassium
538643|mometasone furoate
538645|alefacept
538647|secondhand smoke
633081|AdreView
633086|composite lymphoma
633089|tomotherapy
633090|helical tomotherapy
633093|stature
633222|compression
633223|human EGF receptor 2
633224|stem cell factor receptor
633287|CEA peptide-1
633288|carcinoembryonic antigen assay
633293|glucarpidase
633296|cell-cell signaling
633297|intercellular communication
633304|cevimeline hydrochloride
633702|Evoxac
633729|CA 19-9
633730|CFS
633892|T-cell large granular lymphocyte leukemia
633893|T-LGL leukemia
633899|T-regulatory cell
633901|suppressor T cell
633903|regulatory T cell
633904|T reg
633912|granular leukocyte
633913|PMN
633916|CD4-positive T lymphocyte
633917|Ig
633941|plasmacyte
633949|thymocyte
633963|polymorphonuclear leukocyte
633964|NK-LGL
634067|cytotoxic T lymphocyte
634123|surgical menopause
634125|premature menopause
634128|in-transit metastasis
634130|papillary dermis
634132|reticular dermis
634135|satellite tumor
634810|killer T cell
634971|investigational agent
634974|pulmonary specialist
635095|HDAC inhibitor SNDX-275
635288|device
635290|diagnostic technique
635292|45 Code of Federal Regulations Part 46
635293|human participant protection regulations
635294|45 CFR 46
635295|Protection of Human Subjects
635297|research base
635299|P30 Cancer Center Support Grant
635300|CCSG
635303|Contract Research Organization
635304|CRO
635306|Standard Operating Procedure
635307|SOP
635398|quality assurance
635399|QA
635403|ancillary test
635405|Good Clinical Practice
635406|GCP
635408|ECG
635410|electrocardiogram
635411|EKG
635414|flow sheet
635415|flow chart
635418|1572 form
635419|Form FDA 1572-Statement of Investigator
449883|transfer factor
449929|analgesia
449930|diphenhydramine
449931|hematoma
449953|early menopause
450090|alcoholism
450092|body image
450093|borderline personality disorder
450095|citalopram
450096|confusion
450097|coping skills
450098|counseling
450099|crisis intervention
450100|delirium
450101|denial
450103|developmental stage
450104|electroconvulsive therapy
450105|escitalopram
450106|euthanasia
450107|family therapy
450108|fever
450109|fluvoxamine
450110|hyperactivity
450112|mirtazapine
450113|nefazodone
450114|overdose
450115|psychosis
450116|psychotherapy
450117|schizophrenia
450118|sedative
450120|self-esteem
450121|CNS stimulant
450122|stress
450123|substance abuse
450124|suicide
450125|survivor
450126|JMML
450129|stage 0 maxillary sinus carcinoma in situ
450130|stage I maxillary sinus cancer
450131|stage II maxillary sinus cancer
450132|stage III maxillary sinus cancer
450133|stage IVA maxillary sinus cancer
450134|stage IVB maxillary sinus cancer
450135|stage IVC maxillary sinus cancer
450136|stage 0 nasal cavity and ethmoid sinus carcinoma in situ
450137|stage I nasal cavity and ethmoid sinus cancer
450138|stage II nasal cavity and ethmoid sinus cancer
450139|stage III nasal cavity and ethmoid sinus cancer
450140|stage IVA nasal cavity and ethmoid sinus cancer
450141|stage IVB nasal cavity and ethmoid sinus cancer
450142|stage IVC nasal cavity and ethmoid sinus cancer
450759|EUS
450964|virotherapy
454511|amygdalin
546597|maximum tolerated dose
546598|sickle cell disease
546599|sclera
546600|pupil
546729|FdCyd
546730|Alzheimer dementia
546733|CDK inhibitor AT7519M
546734|tyrosine kinase inhibitor BIBF 1120
546735|codeine phosphate
546737|Valium
546738|fondaparinux sodium
546739|Arixtra
546740|Gd-DTPA
546741|Magnevist
546742|L-glutamic acid
546758|M-EDTA
549273|naltrexone hydrochloride
549316|ReVia
549339|Vivitrol
549422|PI3 kinase
549424|phosphatidylinositol-3 kinase
549425|breastbone
549426|CT53518
549427|MLN518
549431|UFT
549432|Ftorafur
549437|ACTH
549486|microtubule
549693|strontium chloride Sr 89
549694|licorice root extract
549700|conditioning regimen
549701|XL880
549702|YKL-40
549703|lovastatin
549705|bronchogenic carcinoma
551753|calgranulin A
551754|calgranulin B
552933|Regenecare
552934|Clostridium difficile
552935|yttrium Y 90
554353|Torisel
554834|chorioblastoma
554835|chorioepithelioma
554836|chorionic carcinoma
635454|DAR
635457|HIPAA
635460|Health Insurance Portability and Accountability Act
635461|Kassebaum Kennedy Act
462961|tea tree
463050|turmeric
463059|phytol
463072|unguent
463089|whooping cough
463097|terpene
463104|ester
463111|aldehyde
463123|ketone
463134|alcohol
463152|phenol
463160|oxide
463162|solvent
463164|practitioner
463165|arousal
463167|pharmacology
463702|absorption
463703|cavity
463706|complication
463707|digestion
463708|dong quai
463709|echinacea
463712|fistula
463713|ginkgo biloba
463714|herbal
463715|kava kava
463716|ma huang
463717|medication
463718|metallic
463725|nutrition therapy
463726|nutritional supplement
463728|peripheral venous catheter
463729|plicamycin
561399|electronic medical record
561400|genetic profile
561401|genomic profiling
561402|germline DNA
561403|healthy control
561410|APC8015F
561412|isolated limb infusion
561415|MP470
561416|SB939
561417|WX-671
561430|baclofen
561431|baclofen/amitriptyline/ketamine gel
561433|monoamine oxidase inhibitor
561440|urea/lactic acid-based cream
561598|HMGA1
561600|late-stage cancer
561601|genetic marker of susceptibility
561602|MC1R
561603|microfluidic device
561604|molecular diagnosis
561605|molecular pathway
561606|mouse model
561717|personalized medicine
561718|population study
561720|signaling pathway
561722|steroid metabolism gene
561723|tailored intervention
561724|translational research
561725|tumor microenvironment
561727|peer review process
562081|hypofractionation
562548|ampulla of Vater cancer
562550|anti-CD22 immunotoxin CAT-8015
562552|doxazosin mesylate
562553|arginine
562554|marginal zone B-cell lymphoma
562555|MZL
562556|ADI-PEG 20
562559|tamsulosin hydrochloride
562561|Flomax
562654|terazosin hydrochloride
562655|Hytrin
562657|Aldrich syndrome
562659|radiation brachytherapy
562684|stereotaxic radiation therapy
562696|L-norgestrel
562697|Plan B
562725|Cardura
562728|bone mineral density scan
562755|BMD scan
562764|dual energy x-ray absorptiometric scan
562765|dual x-ray absorptiometry
562766|DXA
562767|DEXA
562774|human T-cell lymphotropic virus type 1
563950|familial medullary thyroid cancer
563951|surgical biopsy
563954|thyroidologist
563955|thyroid hormone treatment
563964|MEN syndrome
564157|cervical squamous intraepithelial neoplasia 1
564158|cervical squamous intraepithelial neoplasia 2
566387|BCG vaccine
570294|extravasation
570422|cervical squamous intraepithelial neoplasia 3
570423|stage 0 medullary thyroid carcinoma in situ
570425|vulvar intraepithelial neoplasia
641990|adenosarcoma
642015|family medical history
642019|personal medical history
467830|baseline
467831|comparative anatomy
467832|complement protein
467833|Consensus Development Program
467834|constitutional acupuncture
467835|de qi sensation
467837|droperidol
467838|ex vivo
467839|five element acupuncture
467840|Greene Menopause Index
467841|histopathology
467842|homeostatic
467843|intrapelvic
467844|laser acupuncture
467845|libido
467846|lorazepam
467848|methodology
467849|microwave acupuncture
467850|mind-body exercise
467852|NaCl
467853|outcome
467854|palliation
467855|parasympathetic nervous system
467856|percutaneous
467857|phagocytosis
467858|phenothiazine
467859|phytohemagglutinin
467860|qigong
467861|soluble
467862|somatic
467863|splenic
467864|suppository
467866|surface electrode
467867|sympathetic nervous system
467868|t test
467869|tai chi
467870|thiethylperazine
467871|tibia
467872|tricyclic antidepressant
467873|tumor volume
467874|visual analog scale
468770|Boswellia serrata
468771|mannitol
468773|BI 2536
468774|primary CNS lymphoma
468775|samarium Sm 153-lexidronam pentasodium
468776|pyridoxine
468778|aprepitant
468779|sunitinib malate
468780|vinflunine
468781|oregovomab
468782|paclitaxel poliglumex
468783|infrared thermography
468784|18F-fluorothymidine
468785|VEGF-AS
468786|post-transplant lymphoproliferative disorder
570638|vitreous humor
570758|EFTs
572035|lens
572133|Amevive
572134|Xanax
572144|Augmentin
572146|pet-facilitated therapy
572147|AT9283
572148|S100 calcium binding protein A8
572151|S100 calcium binding protein A9
572158|somatotropin
572159|Haldol
572160|MTD
572161|Versed
572162|midazolam hydrochloride
572207|mometasone
572208|Elocon
572209|Nasonex
572210|Theraloc
572212|Zyprexa
572213|Zyprexa Zydis
572215|petroleum jelly
572216|physical medicine specialist
572218|falimarev
572222|kidney function test
572226|carbamide
572227|rV-TRICOM
572228|recombinant vaccinia-TRICOM vaccine
572229|CSF
572232|neuroglia
572239|TPO
572242|blood urea nitrogen
572243|BUN
572245|Totect
572249|Zinecard
572250|raloxifene hydrochloride
572252|Evista
572255|dexrazoxane hydrochloride
572363|Protocel
572411|endoscopic ultrasound-guided fine needle aspiration
573127|rF-TRICOM
573196|islet cell tumor
574038|Ixempra
643110|antipsychotic
643111|neuroleptic agent
643113|atypical glandular cells of undetermined significance
643114|atypical glandular cells of uncertain significance
643115|AGUS
643118|autoantibody
643122|11C-choline PET-CT scan
643123|carbon C 11-choline PET-CT scan
643125|metabolic syndrome X
476303|behavior modification
476306|haloperidol
476307|palonosetron hydrochloride
476308|midazolam
476309|alprazolam
476310|olanzapine
476319|psyllium
476320|cellulose
476326|nasogastric
476330|gastrostomy tube
476338|excrete
476339|stamina
476340|feces
476341|hallucination
476342|digoxin
476343|digitalis
476346|thiazide diuretic
476347|lithium
476348|mithramycin
476349|phosphate
476351|coma
476353|lethargy
476357|culture
476408|grief
476410|grief counseling
476411|grief therapy
476412|ritual
476461|deceased
476470|compression pump
476471|vein
476473|phlebitis
476475|physiatrist
476478|podiatrist
476484|circulation
476486|coumarin
476488|chemical imbalance
476551|generalized anxiety disorder
476561|palpitation
476581|petrolatum
476584|cramp
476585|bloating
476616|lactase
476620|sexuality
476622|orgasm
476624|genital
476625|mustine
476629|extraosseous
476630|acromegaly
476632|adrenocorticotropic hormone
476634|gigantism
476644|prolactin
476651|transsphenoidal surgery
476760|pleurectomy
476764|photocoagulation
476765|plaque radiotherapy
476766|adenosquamous carcinoma
476767|sarcomatoid carcinoma
476847|segmental resection
476884|radionuclide
476929|thoracoscope
476949|fiberoptic
478733|administration
478743|advanced cancer
478744|ethical will
478748|power of attorney
478762|notary public
478785|specialist
478786|trust
478788|will
479002|dermoid cyst
479003|noradrenaline
479004|birth control pill
479005|Kepivance
481390|tailbone
481624|purple coneflower
481753|gums
481826|ginkgo
481854|maidenhair tree
482093|intoxicating pepper
482113|rauschpfeffer
581140|Tasigna
583711|FNA biopsy
583855|Dimericine
583858|Cerubidine
583859|daunorubicin hydrochloride
583866|antioncogene
584175|Mevacor
584178|Aloxi
584343|Levulan Kerastick
584344|Levulan
584378|BDC
584379|ATT/RHT
584380|AT/RT
584382|DTH
585712|CSP
586370|HDAC
588694|tositumomab and iodine I 131-tositumomab
650254|chemabrasion
650277|partial radical vulvectomy
650559|cognitive behavior therapy
650560|cognitive therapy
650561|CBT
650563|cyclic neutropenia
650564|periodic neutropenia
650566|healthcare provider
650568|myeloablative chemotherapy
650570|nonstarchy vegetable
650572|purine
650574|pyrimidine
650576|adenine
650578|cytosine
650580|guanine
650582|thymine
650886|ABO blood group system
651169|5-alpha reductase inhibitor
651171|acute bacterial prostatitis
651173|alpha-blocker
651174|alpha-adrenergic antagonist
482432|labial mucosa
482456|resectoscope
483995|calcium gluconate
484118|Mithracin
484404|third molar
484405|johimbe
484407|hyperfractionated radiation therapy
484434|magnesium sulfate
484435|dasatinib
484438|nordihydroguaiaretic acid
484441|healing touch
485110|type 3 serotonin receptor antagonist
485163|Korean acupuncture
485166|traditional acupuncture
485223|Reglan
485224|Zarnestra
485225|intracutaneous
485395|second-degree relative
485396|SDR
486388|5-hydroxytryptamine 3 receptor antagonist
486417|involuntary nervous system
486422|ANS
486423|PXD101
486427|ovarian low malignant potential tumor
486448|MART-1 antigen
486449|exploratory surgery
486450|mineral oil
486451|atiprimod
486452|lanolin
486459|thymidylate synthase
486471|SN-38 liposome
486601|antianxiety agent
486603|protein kinase inhibitor
486923|shinbone
589104|Prialt
589337|biliary system
589338|BAK gel
589393|Trilisate
589395|cervical intraepithelial neoplasia grade 2/3
589397|nutritional counseling
589398|Cymbalta
589399|duloxetine hydrochloride
589401|pomalidomide
589402|prostaglandin-endoperoxide synthase 2
589403|COX-2
589405|Allegra
589406|ITP
589407|idiopathic thrombocytopenic purpura
589408|Ketalar
589409|ketamine hydrochloride
589410|phototherapy
589411|Cozaar
589412|losartan potassium
589413|gastric mucosal hypertrophy
589414|giant hypertrophic gastritis
589415|MAO inhibitor
589416|CD134
589417|primary treatment
589418|PG
589419|PANVAC-V
589420|inalimarev
589421|Tazorac
589422|Avage
589423|amitriptyline hydrochloride
592940|EUS-FNA
593094|Lioresal
593095|Kemstro
653131|nanoparticle
653133|nanoprobe
653135|PARP-1
653136|poly (ADP-ribose) polymerase-1
653138|PTEN
653139|PTEN tyrosine phosphatase
653146|small-molecule drug
653148|synapse
654996|oxidize
654999|reduction
655002|allograft
655004|protein signature
655005|protein expression profile
655008|acetylation
655015|acetyl group
655020|acetate
655022|acetic acid
655031|methylation
655033|methyl group
655036|fluorescence microscopy
655039|electrophoresis
655045|ELISA
655046|enzyme-linked immunosorbent assay
655048|chromatography
655052|affinity
655054|affinity reagent
655056|reagent
655060|ergocalciferol
655061|vitamin D2
655066|fortified food
655074|enriched food
655088|nanomole
655092|micromole
655094|millimole
655098|liter
655099|L
655103|ml
655104|cc
655106|cubic centimeter
655116|microliter
655121|μL
655123|rickets
655125|osteomalacia
655127|calcinosis
655132|calbindin
520890|Ontak
522475|IL-1-alpha
522476|interleukin-1-alfa
522478|placebo therapy
522541|melanoma in situ
522912|APL
522913|IMRT
522956|DSMB
523283|anti-IL-6 chimeric monoclonal antibody
612883|stage I ovarian low malignant potential tumor
612887|stage II ovarian low malignant potential tumor
612891|stage III ovarian low malignant potential tumor
612892|stage IV ovarian low malignant potential tumor
613192|acupuncturist
613193|alpha hydroxyl acid
613194|AHA
613195|fruit acid
613197|prostaglandin E1
613198|alprostadil
613199|PGE1
613201|autoclave
613202|folinic acid
613203|citrovorum factor
613204|chelating agent
613205|leucovorin calcium
613206|calcium levoleucovorin
613207|Wellcovorin
613208|Fludara
613209|fludarabine phosphate
613507|chimeric
613508|element
613509|fusion gene
613510|glycolic acid
613511|ibuprofen
613512|Motrin
613513|ICD
613514|implantable cardioverter-defibrillator
613515|isotope
613724|Advil
613761|lactic acid
613763|organelle
613764|steroid
613765|systemic sclerosis
613766|systemic scleroderma
613891|[18F]-labeled substance P antagonist receptor quantifier
613892|[18F]SPA-RQ
613897|BCL2
613899|B-cell leukemia/lymphoma 2 protein
613900|tourniquet
614167|high-selenium Brassica juncea
614168|Brassica vegetable
614169|starch
662470|DBVE
662471|DBVE regimen
662472|ABVE regimen
662474|FEC
662475|FEC regimen
662477|JEB
662478|JEB regimen
662480|TAC
662481|TAC regimen
662484|VAMP
662485|VAMP regimen
662487|VeIP
662488|VeIP regimen
662490|XELOX
662491|XELOX regimen
662493|FU-LV
662494|FU-LV regimen
662496|5-FU/LV
662498|de Gramont regimen
662500|Mayo Clinic regimen
662501|Roswell Park regimen
662503|carboplatin-Taxol regimen
662504|CaT regimen
662505|Carbo-Tax regimen
662506|PC regimen
662508|FOLFIRI-bevacizumab regimen
662509|FOLFIRI-Avastin regimen
662511|gemcitabine-erlotinib regimen
662512|gemcitabine-Tarceva regimen
662514|Leukeran
662931|carvedilol phosphate
662933|Coreg
662958|dinaciclib
662959|CDK inhibitor SCH 727965
662961|image-guided radiation therapy
662962|IGRT
662964|iobenguane I 131
662967|lisinopril
662968|Prinivil
662970|Zestril
662972|Concerta
662973|Ritalin
663013|carboplatin-paclitaxel-bevacizumab regimen
663014|carboplatin-Taxol-bevacizumab regimen
663296|MLN1202
663297|anti-CCR2 monoclonal antibody MLN1202
663299|OSI-906
663300|IGF-1R inhibitor OSI-906
663303|MammoSite
663309|rifabutin
663313|Mycobutin
663321|rosuvastatin calcium
663322|Crestor
663324|tipranavir sodium
663325|Aptivus
524192|precursor B-lymphoblastic leukemia
524193|chronic obstructive pulmonary disease
524194|aberrant crypt foci
524195|diazepam
524207|malignant pleural effusion
524215|donor lymphocyte infusion
524227|glutamic acid
524232|BIBF 1120
524255|gadopentetate dimeglumine
524260|ABT-888
527198|carcinoma of unknown primary
527199|CUP
527218|viral therapy
527219|pazopanib hydrochloride
527370|bile duct cancer
527371|obesity
527374|MORAb-009
527376|mesothelin
527377|PC-SPES
527378|GC1008
528022|naltrexone
528023|minocycline-EDTA
528024|5-fluoro-2-deoxycytidine
528027|fondaparinux
528028|tandutinib
529764|rectal cancer
615324|vincristine sulfate
615325|Oncovin
615388|anti-CD45 monoclonal antibody
615389|antisense DNA
615390|antisense RNA
615391|BSI-201
615392|liposome
615393|MK0752
615394|naproxen
615395|Naprosyn
615417|reverse transcription
615418|severe combined immunodeficiency disease
615419|SCID
615426|18F-16 alpha-fluoroestradiol
615432|18F-FES
615496|GDC-0449
615503|epididymis
615541|spermatic cord
615543|testicular cord
615576|oncolytic virus therapy
615577|oncolytic virus
615583|viral oncolysate
616060|active surveillance
616061|expectant management
616062|albumin
616067|lymphoblastic
616069|myeloblastic
616113|romiplostim
616114|Nplate
616115|AMG 531
616123|dolasetron mesylate
616125|Anzemet
616127|Kytril
616128|granisetron hydrochloride
616146|ondansetron hydrochloride
616149|subtotal hysterectomy
616710|sibling
616713|half-sibling
616715|guaiac
616716|heme
617658|CerviPrep
617659|diclofenac
617660|diclofenac sodium
617661|Voltaren
617662|diclofenac sodium gel
617663|Voltaren gel
617664|heat-shock protein
617665|HSP
617666|stress protein
617667|tanespimycin
618548|pravastatin sodium
618576|COL18A1
618582|Nipent
618610|odds ratio
618611|relative odds
618612|hazard ratio
665421|Seneca Valley virus-001
665424|monoclonal antibody Ch14.18
665425|Ch14.18
665426|MOAB Ch14.18
665427|SVV-001
665428|NTX-010
665433|vitespen
666196|absolute risk
666198|ecologic study
666199|ecological study
666201|armodafinil
666202|Nuvigil
666204|bimatoprost
666205|Latisse
666207|chaste tree berry
666208|Vitex
666209|monk’s pepper
666211|F511 cream
666216|gastroenteritis
666218|iodine I 131-ethiodized oil
666219|iodine I 131-Lipiodol
666221|RO4929097
666224|upstaging
666662|Bloom syndrome
666663|Bloom-Torre-Machacek syndrome
666665|Diamond-Blackfan anemia
666666|congenital hypoplastic anemia
666667|erythrogenesis imperfecta
543628|biochemical recurrence
543929|ampullary cancer
543930|periampullary cancer
543931|clinician
630768|Clark level II skin cancer
630770|Clark level III skin cancer
630772|Clark level IV skin cancer
630774|Clark level V skin cancer
630776|papillary-reticular dermal interface
630901|diverticulitis
630904|diverticulum
630906|hernia
630908|irritable bowel syndrome
630909|IBS
630910|irritable colon
630911|spastic colon
630912|mucus colitis
630913|alvocidib
630914|HMR 1275
630915|belotecan
630919|belotecan hydrochloride
630922|ischemia
630923|MGCD0103
630925|cold ischemia
630927|cold ischemia time
630930|warm ischemia
630931|monoclonal B-cell lymphocytosis
630932|MBL
630934|warm ischemia time
630936|CRA-024781
630941|optical coherence tomography
630942|OCT
630945|acupuncture-like transcutaneous electrical nerve stimulation
630949|ALTENS
630950|pentamidine
630952|pentamidine isethionate
630954|Pentam
630955|PARP-1 inhibitor AG014699
630957|SNDX-275
630958|AG014699
630959|entinostat
630961|vaginal dilation therapy
630963|vegan
630965|bronchiolitis obliterans
630969|CBT-1
630970|MDR modulator CBT-1
630974|clonidine hydrochloride
630975|Catapres
631041|ferrous sulfate
631043|metformin
631045|metformin hydrochloride
631046|Glucophage
631048|ophthalmologist
631051|pharmacogenetics
631052|pharmacogenomics
631054|riluzole
631057|Rilutek
631059|sodium ferric gluconate
631060|Ferrlecit
631063|zafirlukast
631064|Accolate
631490|plerixafor
631492|Mozobil
631495|degarelix
631499|Papanicolaou test
632148|daunomycin
632152|daunomycin hydrochloride
632169|kit ligand
632172|recombinant human methionyl stem cell factor
632173|r-metHuSCF
632944|CD80
632962|BBB
633062|ATN-224
633063|SOD1 inhibitor ATN-224
633066|Coriolus versicolor extract
633068|MEDI-522
633069|humanized monoclonal antibody MEDI-522
633070|etaracizumab
633080|iobenguane I 123
672499|adoptive cellular therapy
672833|acquired pure red cell aplasia
672835|dysgerminoma
672837|neuromuscular electrical stimulation
672838|NMES
672839|NES
672840|therapeutic (subthreshold) electrical stimulation
672842|doxycycline hyclate
672851|TNM staging system
672858|antilymphocyte globulin
673817|EMF
673819|EMR
674055|veliparib
674058|navitoclax
674683|Merkel cell
674694|biofilm
674696|EDTA
674697|edetic acid
674698|etheylenediaminetetraacetic acid
674701|GSK1070916A
674702|Aurora B/C kinase inhibitor GSK1070916A
674704|J-pouch colorectal anastomosis
674707|phrenic nerve
674709|simvastatin
674710|Zocor
557358|OX-40
557359|protein expression
557360|choline magnesium trisalicylate
558180|protegrin
558902|hypofractionated radiation therapy
558986|GAD
558995|ileus
558996|DHPLN
559063|direct ophthalmoscopy
559064|HuMax-CD20
559066|Lyrica
559070|galvanic skin response
559074|slit-lamp eye exam
559075|OPT-80
559076|PAR-101
559079|uveal tract
559083|Chantix
559084|WAGR syndrome
559085|WHO
559086|androgen deprivation
559089|English chamomile
559129|therapeutic angiotensin-(1-7)
559131|tremelimumab
559134|stromal cell
559136|light therapy
559137|epidermolysis bullosa
559138|Ménétrier disease
559139|indium In 111-CHX-A DTPA trastuzumab
559140|microsphere
559141|CC-4047
559143|prostaglandin
559242|carcinomatous meningitis
637631|vinblastine sulfate
637632|Velban
637654|CMF
637655|CMF regimen
637656|MTX
637711|EZN-2285
637712|Oncaspar-IV
637713|SC-PEG E. coli L-asparaginase
637716|growth and development milestones
637718|LBH589
637719|panobinostat
637720|Farydak
637723|optic chiasm
637724|optic chiasma
637726|optic tract
637730|obatoclax
637766|CBE
638170|atypia
638173|intraductal breast papilloma
638174|vacuum-assisted biopsy
638175|vacuum-assisted core biopsy
638176|VACB
638178|stage 0 disease
638183|atypical lobular hyperplasia
638184|microscope
638185|atypical lobular breast hyperplasia
638186|ALH
638188|technician
638190|atypical ductal hyperplasia
638191|atypical ductal breast hyperplasia
638192|ADH
638194|mastitis
638197|mass
638198|milk duct
638199|breast duct
638201|macrocalcification
638203|breast lobe
638205|in situ
638207|breast lobule
639507|meningeal carcinomatosis
639508|leptomeningeal carcinoma
639612|pulmonary edema
639748|RAD001
639749|Afinitor
639912|chyle
639914|modified radical vulvectomy
639916|triple-negative breast cancer
639917|ER-negative PR-negative HER2/neu-negative breast cancer
639938|aerobic exercise
639941|aluminum
639945|anticancer therapy
639990|antisocial
639992|ceremony
639993|collarbone
639996|complex decongestive therapy
639998|compression garment
640038|deep vein thrombosis
640039|DVT
640041|deviant
640043|heritage
640046|lymphostatic elephantiasis
640047|stage III lymphedema
640050|Medicaid
640052|Medicare
640055|menthol
640057|moral
687277|EGCG
687389|basicity
687391|toxicant
687883|hemolysis
687888|hyperbilirubinemia
687890|hypophosphatemia
687892|hyponatremia
687894|hypomagnesemia
687899|proteinuria
687904|transaminase
688774|assent process
688783|blood test
561228|c-ABL
561236|MUC-1
561237|BCR-ABL fusion gene
561317|antiprogestin
561319|autophagy
561320|beclin 1
561321|bench-to-bedside
561322|biological profile
561323|biorepository
561324|biospecimen
561325|BRAF gene
561326|clinical researcher
561393|cohort
561395|continuum of care
561396|DNA gene-expression microarray
561397|DNA methylase
561398|early-stage cancer
640058|ethical
640061|music therapy
640063|optimism
640066|referral
640075|scapula
640076|shoulder blade
640078|scar tissue
640080|tradition
640082|tranquilizer
640084|twelve-step program
641107|BCR-ABL fusion protein
641111|folliculitis
641114|kinase
641121|HGS-ETR2
641130|mapatumumab
641131|HGS-ETR1
641134|proto-oncogene
641137|phosphorylation
641139|urticaria
641140|hives
641143|death receptor 4
641145|TRAIL receptor 1
641146|TRAIL-R1
641147|tumor necrosis factor receptor superfamily member 10A
641148|DR4
641151|death receptor 5
641152|TRAIL receptor 2
641153|TRAIL-R2
641154|tumor necrosis factor receptor superfamily member 10B
641155|DR5
641157|vesicle
641161|TNF-related apoptosis-inducing ligand
641162|tumor necrosis factor-related apoptosis-inducing ligand
641163|Apo-2L
641164|TRAIL
641290|chronic lymphocytic leukemia/small lymphocytic lymphoma
641291|CLL/SLL
641299|SLL
641672|oral cavity cancer
641719|Abegrin
641798|heroin
641799|core needle biopsy
641862|hydrocodone bitartrate
641915|tramadol hydrochloride
641916|Ultram
641927|alveolar rhabdomyosarcoma
641928|ARMS
641930|ERMS
641933|alveolar soft part sarcoma
641934|ASPS
641939|clear cell sarcoma of soft tissue
641941|Cowden syndrome
641942|multiple hamartoma syndrome
641943|Cowden disease
641946|EndoPat
641947|Endo-Pat 2000
641949|laparoscopic-assisted resection
641952|open resection
641960|sinus
641967|9cUAB30
641969|abiraterone acetate
641976|ABT-869
641978|multitargeted receptor tyrosine kinase inhibitor ABT-869
641985|acetyl-L-carnitine
641986|ALCAR
641987|acetyl-L-carnitine hydrochloride
641988|Carnitor
689705|transurethral microwave thermotherapy
689706|TUMT
689718|TUEVAP
689719|TUVP
689720|transurethral electrovaporization of the prostate
689749|post-marketing surveillance trial
689770|physical touch methods
689781|boron phenylalanine
689782|BPA
689841|BNCT
689975|base
689977|pepsin
689979|quinone oxidoreductase 1
690074|oxygen radical
690361|Xgeva
690362|Prolia
690369|Halaven
690373|eribulin mesylate
690737|child-life specialist
691005|Firmagon
691009|RECIST
691011|Response Evaluation Criteria In Solid Tumors
597095|Sensorcaine
597096|Marcaine
597097|bupivacaine hydrochloride
597110|Carney complex
597111|cell cycle
597112|mitotic cycle
597113|cortisol
597114|CYC116
597117|definitive treatment
656312|human herpesvirus
656313|HHV
656314|HSV
657510|pralatrexate
657511|FOLOTYN
657798|art therapy
657823|atropine sulfate
657825|atropine suppression test
657827|BRCAPro
657829|calcium infusion test
657831|capsule endoscope
657832|wireless capsule endoscope
657834|C-peptide
657835|connecting peptide
657837|C-peptide suppression test
657842|gastric acid
657844|gastric acid secretion test
657845|stomach acid test
657846|stomach acid stimulation test
657848|histamine
657853|insulinoma
657854|beta cell neoplasm
657855|beta cell tumor of the pancreas
657856|pancreatic insulin-producing tumor
657859|intraoperative ultrasound
657860|IOUS
657861|endocrine-inactive tumor
657862|olaparib
657864|pancreatic polypeptide
657865|PP
657867|transoral robotic surgery
657868|TORS
658003|calcium Ca 41-chloride aqueous solution
658008|calcium Ca 46-chloride aqueous solution
658010|Hashimoto thyroiditis
658011|Hashimoto disease
658012|autoimmune thyroiditis
658017|lung function test
658018|pulmonary function test
658019|PFT
658021|mitoguazone dihydrochloride
658027|pelvic inflammatory disease
658028|PID
658034|tadalafil
658035|Cialis
658039|vinorelbine tartrate
658040|Navelbine
658043|parietal cell vagotomy
658045|polypeptide
658047|poly (ADP-ribose) polymerase
658048|PARP
658053|poly (ADP-ribose) polymerase inhibitor
658055|secretin
658058|secretin stimulation test
658059|pancreatic function test
658065|vasoactive
658067|vasoactive intestinal peptide
719141|amuvatinib
720215|stage I esophageal squamous cell carcinoma
720244|stage II esophageal squamous cell carcinoma
720246|stage III esophageal squamous cell carcinoma
720248|stage IV esophageal squamous cell carcinoma
720250|stage I esophageal adenocarcinoma
720252|stage II esophageal adenocarcinoma
720254|stage III esophageal adenocarcinoma
720258|stage IV esophageal adenocarcinoma
721252|ALK gene
721259|anaplastic lymphoma kinase gene
721263|BRAF (V600E) mutation
721283|CD20
721294|CD20 antigen
721302|chromogranin A
721308|CgA
721316|cytokeratin
721317|keratin
721324|CA 27.29
721699|stage I gallbladder cancer
721701|stage II gallbladder cancer
723335|electrosurgery
723337|geneticist
723339|anaplastic lymphoma receptor tyrosine kinase
723438|tapentadol hydrochloride
723439|Nucynta
723443|epigenomics
723816|Voraxaze
723831|scoliosis
723841|kyphosis
597245|high blood sugar
597249|ziv-aflibercept
597250|vascular endothelial growth factor trap
599959|18F-fluoromisonidazole
599960|1-methyl-d-tryptophan
599961|ammonium tetrathiomolybdate
599962|angioplasty
599963|fentanyl sublingual spray
599964|glycemic index
599980|hepatitis E virus
599981|hepatitis G virus
599983|high-intensity focused ultrasound therapy
599984|intrauterine
599986|intrauterine device
599987|FMISO
599988|18F-MISO
599989|D-1MT
599990|HIFU
599992|IUD
658069|VIP hormone
658361|Elitek
658362|recombinant urate oxidase
658364|Cervarix
658368|Votrient
658447|nitrosamine
658511|Merkel cell carcinoma
658756|3 Tesla MRI
658757|3 Tesla magnetic resonance imaging
658758|3T MRI
658764|urokinase plasminogen activator (uPA)-derived peptide A6
658765|A6
658770|blood sugar
658771|glycemia
658776|Ensure
658777|polymeric enteral nutrition formula
658781|fluorine F 18-sodium fluoride PET
658784|18F-sodium fluoride positron emission tomography
658785|mocetinostat
658786|18F-NaF PET
658817|insulin glargine
658818|insulin glargine recombinant
658820|Lantus
658827|insulin glulisine
658828|Apidra
658830|lactobacillus
658836|Lactobacillus rhamnosus GG
658837|Culturelle
658844|meningeal syndrome
658849|MET tyrosine kinase inhibitor PF-02341066
658850|PF-02341066
658855|PediaSure
658856|pediatric polymeric enteral nutrition formula
658858|phenytoin sodium
658859|Dilantin
658861|probiotic
658868|onabotulinumtoxinA
658871|urokinase-plasminogen activator
658872|u-plasminogen activator
658873|uPA
659154|board certified oncology pharmacy specialist
659155|BCOP
659607|atypical glandular cells
659608|AGC
659612|NK-LGL leukemia
659614|psilocybine
659788|nM
659790|μM
659791|mM
659792|adult rickets
659809|CT colonography
659993|malnourished
659994|Istodax
660188|Arzerra
660388|infantile rickets
660389|juvenile rickets
660392|rachitis
725034|vismodegib
725035|Erivedge
725040|Inlyta
725230|kidney function
725231|renal function
725233|irreversible enzyme inhibitor
725235|pelitinib
727110|Exalgo
727111|Cesamet
728320|CCNU
728326|childhood cancer
728860|CAPOX regimen
728861|CAPOX
729587|mycosis fungoides patch
729589|papule
729732|mind-body modality
729737|photosynthesis
729751|mevalonate pathway
729755|peroxisome proliferator-activated receptor gamma pathway
729757|PPAR gamma pathway
729764|liver X receptor alpha pathway
729765|LXR alpha pathway
729767|ABCA1 pathway
729771|gavage
729820|cyclin-D1
729822|Nrf2
729823|nuclear factor (erythroid-derived 2)-like 2
600465|Relistor
600466|methylnaltrexone bromide
600470|CT-322
600471|VEGFR-2 inhibitor CT-322
600472|Angiocept
600473|MEK inhibitor AZD6244
600474|AZD6244
600475|hepatitis D virus
600477|hepatitis delta virus
600479|ON 01910.Na
600480|R1507
600484|belinostat
601029|balloon angioplasty
601030|L-asparaginase
601031|Elspar
601170|mutagen
601171|monomer
601172|polymer
601173|copolymer
601196|brivanib
601199|montelukast
601200|SNX-5422
601318|bendamustine
601483|rosiglitazone maleate
601484|Avandia
601517|bisphosphonate-associated osteonecrosis
601522|BON
609744|nonmelanoma carcinoma in situ
660869|PARP inhibitor
660871|PARP inhibitor AZD2281
660981|PARP-1 inhibitor ABT-888
661157|anal Pap test
661158|anal Pap smear
661162|bombesin
661164|bronchial brushing
661165|bronchial brush biopsy
661172|bronchial washing
661174|dapsone
661177|efavirenz
661178|Sustiva
661181|foscarnet sodium
661182|Foscavir
661183|phosphonoformate trisodium
661190|gel electrode
661192|hydrocarbon
661194|methemoglobin
661196|methemoglobinemia
661201|MC5-A scrambler therapy
661203|mutation carrier
661205|respite care
661207|technetium Tc 99m-demobesin-4
661209|yellow fever
661220|sexual drive
661340|infantile genetic agranulocytosis
661341|genetic infantile agranulocytosis
661352|renal cell carcinoma
661353|renal cell adenocarcinoma
661948|energy healing
661950|extragonadal
661952|intestinal flora
661954|Gardasil
661957|GM-CSF-secreting breast tumor vaccine
661960|therapeutic touch
661987|Hras gene
661988|H-ras gene
661991|lintuzumab
661993|MoAb HuM195
661996|monoclonal antibody HuM195
662000|messenger RNA
662001|mRNA
662004|microflora
662006|microRNA
662007|miRNA
662010|milatuzumab
662011|hLL1
662012|IMMU-110
662021|restless legs syndrome
662022|RLS
662024|Rothmund-Thomson syndrome
662025|RTS
662026|Depakene
662027|Stavzor
662028|veltuzumab
662444|AC
662445|AC regimen
662448|ADE
662449|ADE regimen
662453|BEP
662454|BEP regimen
662457|COPP regimen
662458|COPP
662463|CP
662464|CP regimen
662466|CVP
662467|CVP regimen
662469|ABVE
730418|moderate sedation
730419|conscious sedation
730421|deep sedation
730423|short-term side effect
730425|pulmonology
730427|cardiology
730429|endocrinology
730431|psychology
732550|computed tomography angiography
732551|CT angiography
732552|CTA
732554|magnetic resonance angiography
732555|MRA
732562|tumor marker test
732564|fertility preservation
732566|egg freezing
732567|egg cryopreservation
534232|gonioscopy
534233|slit-lamp biomicroscopy
534234|charged-particle radiation therapy
535468|Lipitor
535469|atorvastatin calcium
535471|Exjade
618613|relative risk
618614|risk ratio
624949|interleukin-1-beta
624952|IL-1B
624953|IL-1-beta
626287|digital image analysis
626289|indium In 111-anti-CEA monoclonal antibody M5A
626292|lymphopenia
626293|lymphocytopenia
626294|lymphocytic leukopenia
626298|myristyl nicotinate cream
626334|nitroglycerin
626340|optical spectroscopy
626342|tumor lysis syndrome
626357|vibro-acoustography imaging
626360|yttrium Y 90-DOTA anti-CEA monoclonal antibody M5A
626363|Cushing disease
626381|iron overload
626384|IFA
626385|Melanoma Antigen Recognized by T cells 1
626500|Cushing syndrome
628802|eltrombopag olamine
628803|Promacta
629145|para-aminobenzoic acid
629146|PABA
629152|vitamin H
629154|nicotinic acid
629155|vitamin B3
629158|vitamin B5
629161|vitamin B2
629163|vitamin B1
629166|myoinositol
630445|Clark levels
630766|Clark level I skin cancer
667109|basal cell cancer
667145|synthetic human secretin
667147|ChiRhoStim
667149|secretin human
667618|deferred therapy
668174|stage 0 Merkel cell carcinoma in situ
668176|stage IV Merkel cell carcinoma
669655|bone marrow aspiration and biopsy
670002|BRAF (V600E) kinase inhibitor RO5185426
670003|RG7204
670004|PLX4032
670006|common hepatic duct
670008|cystic duct
670137|energy therapy
670138|gut flora
670139|gut microflora
670140|intestinal microflora
670768|meningeal leukemia
670770|lymphomatous leptomeningitis
670772|leukemic leptomeningitis
671805|FOLFOX-4
671807|FOLFOX-6
671816|modified FOLFOX-6
671817|modified FOLFOX-6 regimen
671820|mFOLFOX-6
671821|mFOLFOX-6 regimen
671823|FOLFOX-4 regimen
671825|FOLFOX-7 regimen
671826|FOLFOX-7
671827|FOLFOX-6 regimen
737156|chromosome 17
737158|9p21
737159|21-gene signature
737706|carfilzomib
737708|Kyprolis
737998|HER2 positive
737999|human epidermal growth factor receptor 2 positive
738000|c-erbB-2 positive
738008|microbiome
738015|HPV RNA test
738017|human papillomavirus RNA test
738430|Zaltrap
738596|embryo freezing
738629|vincristine sulfate liposome
738630|Marqibo
738849|liposomal vincristine sulfate
739353|stage 0 perihilar extrahepatic bile duct carcinoma in situ
739355|stage I perihilar extrahepatic bile duct cancer
739357|stage II perihilar extrahepatic bile duct cancer
739359|stage III perihilar extrahepatic bile duct cancer
739361|stage IV perihilar extrahepatic bile duct cancer
739782|barium sulfate
739785|individualized education plan
739786|IEP
635464|concomitant
635466|cultural competency
635469|Community Advisory Board
635470|CAB
635473|OHRP
635474|Office for Human Research Protections
635678|ABVD
635679|ABVD regimen
635680|DTIC-Dome
635682|AC-T
635683|AC-T regimen
635684|AC-Taxol regimen
635689|AC-T-T
635690|AC-T-T regimen
635691|sequential AC/Taxol-Trastuzumab regimen
635692|AC-TH regimen
635728|CTX
635729|Cytoxan
635736|BEACOPP
635737|BEACOPP regimen
635746|procarbazine hydrochloride
635747|Matulane
635753|CAF
635754|CAF regimen
635764|5-fluorouracil
635770|CHOP
635771|CHOP regimen
635776|CHOPE
635778|CHOPE regimen
635785|EPOCH
635788|EPOCH regimen
635807|FOLFIRI
635808|FOLFIRI regimen
635811|irinotecan hydrochloride
635812|Camptosar
635814|needle localization
635815|wire localization
635816|FOLFOX regimen
635817|needle/wire localization
635819|Eklund views
635820|Eklund displacement views
635821|implant displacement views
635823|gemcitabine-cisplatin
635824|gemcitabine-cisplatin regimen
635881|ICE
635882|ICE regimen
635888|Ifex
635889|Paraplatin
635891|MOPP
635892|MOPP regimen
635896|R-CHOP
635897|R-CHOP regimen
635899|Stanford V
635900|Stanford V regimen
636400|hydroxydaunorubicin
636779|genome-wide association study
636780|GWAS
637273|diffuse intrinsic pontine glioma
637277|juvenile pilocytic astrocytoma
637280|laparoscopic surgery
637572|adenosis
637585|sclerosing adenosis
637593|fat necrosis
637625|bleomycin sulfate
637626|Blenoxane
683642|DBVE-PC regimen
683643|DBVE-PC
683782|wound, ostomy, and continence nurse
683783|WOC nurse
684435|stage IA breast cancer
684439|stage IB breast cancer
686042|adulterant
686077|hormone-refractory
686083|hormone-resistant
686176|benzo(a)pyrene
686178|3,4-benzpyrene
686192|hydrogen cyanide
686194|ethylene oxide
686196|partial-breast irradiation
686197|accelerated partial-breast irradiation
686199|polycyclic aromatic hydrocarbon
686200|PAH
686202|schistosome
686204|stem cell mobilization
686207|toluene
686209|virus-like particle
686244|clinical stage
686253|pathological stage
686469|catechin
686896|jejunostomy
686898|zibotentan
687145|cancer treatment vaccine
687210|diuresis
687212|epigallocatechin-3-gallate
687214|ferritin
687216|free radical scavenger
687218|neurodegenerative disorder
687223|pepsinogen
687225|quinone reductase
687227|reactive oxygen species
687229|theaflavin
687231|thearubigin
687233|theobromine
748155|chronic bronchitis
748157|chronic cough
748159|chronic lung disease
748160|CLD
642020|personal health record
642021|personal history
642090|Gail risk model
642119|androgen receptor positive
642120|AR+
642125|chemical peel
642126|chemexfoliation
642130|ridaforolimus
642132|dermabrasion
642134|FAU
642135|1-(2’-deoxy-2’-fluoro-β-D-arabinofuranosyl) uracil
642138|gadobenate dimeglumine
642139|MultiHance
642141|gold therapy
642143|aurotherapy
642145|chrysotherapy
642150|macular degeneration
642152|age-related macular degeneration
642153|ARMD
642154|AMD
642156|nurse practitioner
642157|NP
642158|advanced practice nurse
642159|APN
642163|sex cord tumor
642164|sex cord-stromal tumor
642165|sex cord-gonadal stromal tumor
642490|anatomist
642492|cumulative exposure
642495|disinfectant
642497|embalmer
642499|fungicide
642501|germ
642503|germicide
642504|microbicide
642506|peak exposure
642508|resin
642511|regional anesthesia
642962|amiodarone hydrochloride
642964|Corderone
642967|copper Cu 64-ATSM
642972|lopinavir
642974|Norvir
642978|lopinavir/ritonavir
642979|Kaletra
642982|talactoferrin
642983|talactoferrin alfa
642985|TLF
642987|acid
642989|acidification
642991|acidity
642999|acid-base balance
643000|acid-base equilibrium
643003|alkali
643006|alkalinity
643008|chemical
643010|donor
643012|follicle-stimulating hormone
643013|FSH
643014|follitropin
643017|ion
643019|luteinizing hormone
643020|LH
643021|lutropin
643022|interstitial cell-stimulating hormone
643063|recipient
643065|pedunculated
643067|p-glycoprotein
643069|platelet-derived growth factor
643070|PDGF
643072|polyethylene glycol
643074|PEG
643082|secrete
643089|telomerase
643091|telomere
643103|accelerated-fraction radiation therapy
643105|anxiolytic agent
643109|antipsychotic agent
693593|long-term side effect
694456|convulsion
694849|benzodiazepine
694851|SNRI
694852|serotonin-norepinephrine reuptake inhibitor
695185|testicular germ cell tumor
695631|stage IV maxillary sinus cancer
695637|stage IV nasal cavity and ethmoid sinus cancer
695987|hemorrhagic cystitis
695994|cancer cell line
696810|vesicant extravasation
697122|transperineal template-guided prostate mapping biopsy
697125|TTMB
697415|fluorescence-guided surgery
752738|giant cell tumor
752739|GCT
752829|cervical squamous cell carcinoma
752832|adenocarcinoma in situ
752833|AIS
752837|glandular cell of the cervix
752839|ASC-H
752840|atypical squamous cells, cannot exclude a high-grade lesion
752842|cervical adenocarcinoma
752844|cold knife conization
752845|cold knife cone biopsy
752847|human papillomavirus test
579860|Depo-Cyt
579873|Fragmin
579874|dalteparin sodium
579876|Maxamine
579879|IL
579907|lymphopoietin-1
579910|Triostat
579911|Cytomel
579912|Imodium
579913|arzoxifene hydrochloride
579914|neuroendocrine carcinoma of the skin
580234|Neumega
580268|recombinant human interleukin-11
580275|rhIL-11
580343|scintigraphy
580375|Rapamune
580772|cyanocobalamin
580776|yttrium Y 90-edotreotide
648572|Carney syndrome
648576|Carney triad
648578|Carney dyad
648579|Carney-Stratakis syndrome
648580|Carney-Stratakis dyad
648584|anti-PDGFR alpha monoclonal antibody IMC-3G3
648585|anti-platelet-derived growth factor receptor alpha monoclonal antibody IMC-3G3
648586|IMC-3G3
648588|estrogen blocker
648590|fosaprepitant dimeglumine
648591|Emend for Injection
648594|fostamatinib disodium
648595|Syk kinase inhibitor R-935788
648596|R788 sodium
648598|glucuronic acid
648676|lymphomatous meningitis
648677|leukemic meningitis
648682|upper gastrointestinal series
648683|contrast esophagram
648685|psychosocial
648687|ramucirumab
648688|anti-VEGFR-2 fully human monoclonal antibody IMC-1121B
648689|IMC-1121B
648691|tethered capsule endoscope
648692|TCE
648941|anabolic steroid
648943|AVN944
648945|azathioprine sodium
648947|caregiver
648949|colchicine
648985|DT2219ARL immunotoxin
648987|elesclomol sodium
648989|gout
648991|idiopathic pulmonary fibrosis
648993|methoxyamine hydrochloride
648995|micelle
649003|paclitaxel-loaded polymeric micelle
649005|pharmacist
649010|skin vesicle
649011|blister
649024|antisense agent
649030|antisense therapy
649031|antisense oligonucleotide therapy
649032|c-fos antisense oligonucleotide
649042|custirsen sodium
649619|abdominal ultrasound
649775|radioimmunoconjugate
649780|yttrium Y 90-epratuzumab tetraxetan
650040|peptic ulcer
650175|gene amplification
698420|olfactory bulb
698421|Yervoy
698423|nitroarginine
698424|NG-nitro-L-arginine
698772|foreign
698774|3D-CRT
698777|Isaac syndrome
698780|neuromyotonia
698783|panhypopituitarism
698784|PHP
698789|Addison disease
698872|adrenal insufficiency
700145|peritoneal washing
700147|radical trachelectomy
700148|radical cervicectomy
700509|Zytiga
700510|HCV
700542|HBV
700838|radiation sickness
700843|acute radiation syndrome
700844|acute radiation sickness
700845|radiation poisoning
700846|radiation sickness syndrome
701525|carcinomatous lymphangitis
701526|lymphangitic carcinomatosis
701530|Behcet syndrome
701536|Behcet disease
701635|Hirschsprung disease
701642|aganglionic megacolon
753609|combined androgen blockade
643126|metabolic syndrome
643128|radiosensitizing agent
643135|Platinol
643596|anti-TRAIL R1-mAb
643597|anti-TRAIL R2 mAb HGS-ETR2
643629|accelerated radiation therapy
643793|film mammography
644298|acolbifene hydrochloride
644300|botulinum toxin A
644301|Botox
644302|botulinum toxin type A
644304|cixutumumab
644305|IMC-A12
644309|compression fracture
644311|gossypol acetic acid
644312|cottonseed meal toxin
644314|herpes simplex virus
644318|laromustine
644319|Cloretazine
644320|Onrigin
644322|natural killer-cell large granular lymphocyte leukemia
644323|NK-LGLL
644325|physician assistant
644326|PA
644328|psilocybin
644330|recombinant interferon alfa-2b
644332|IFN alpha-2B
644333|interferon alfa-2b
644342|Intron A
644373|vertebroplasty
644375|ZD6126
644726|amantadine hydrochloride
644735|demeclocycline hydrochloride
644736|Declomycin
644738|gastric feeding tube
644739|nasogastric tube
644740|NG tube
644742|percutaneous endoscopic tube
644743|PEG tube
644745|influenza A virus
644747|Kostmann syndrome
644748|Kostmann disease
644749|congenital neutropenia
644750|Kostmann neutropenia
644752|anti-IGF1R recombinant monoclonal antibody MK-0646
644753|MK-0646
644755|mifamurtide
644756|muramyl tripeptide phosphatidylethanolamine
644757|L-MTP-PE
644758|MEPACT
644760|neurofeedback
644761|EEG biofeedback
644763|oseltamivir phosphate
644765|Tamiflu
644767|alcohol ablation
644768|ethanol ablation
644769|PEI
644772|radioembolization
644773|intra-arterial brachytherapy
644775|Shwachman syndrome
644776|Shwachman-Diamond syndrome
644777|SDS
644779|tumescent mastectomy
644781|zanamivir
644783|Relenza
702051|vemurafenib
702060|atom
702062|electron
702085|MEN2 syndrome
702086|multiple endocrine adenomatosis type 2
702087|multiple endocrine neoplasia type 2 syndrome
702088|MEN2
702090|MEN2A syndrome
702091|MEN2A
702095|multiple endocrine neoplasia type 2A syndrome
702096|multiple endocrine adenomatosis type 2A
702097|Sipple syndrome
702100|multiple endocrine neoplasia type 2B syndrome
702101|MEN2B
702102|multiple endocrine adenomatosis type 2B
702104|gastric scirrhous carcinoma
702330|MEN2B syndrome
703278|bioactive compound
703281|seroma
703283|interstitial fluid
703577|recombinant human papillomavirus bivalent vaccine
703578|recombinant human papillomavirus quadrivalent vaccine
706354|tissue fluid
755132|extraskeletal
755134|immunocytochemistry
755493|appendage
755773|fallopian tube cancer
756068|Zenapax
756173|cytostatic agent
756443|Casodex
756462|siltuximab
756463|amatuximab
651177|asymptomatic inflammatory prostatitis
651179|bowel movement
651180|defecation
651182|chronic bacterial prostatitis
651184|chronic prostatitis/chronic pelvic pain syndrome
651185|CP/CPPS
651193|condition
651195|drug therapy
651197|free PSA
651199|internist
651201|open prostatectomy
651204|PSA test
651206|PSA velocity
651209|radio wave
651211|research study
651212|sex drive
651215|spinal block
651216|subarachnoid block
651217|SAB
651218|spinal anesthesia
651220|total PSA
652256|KRAS gene
652257|K-RAS gene
653099|acetylcholine
653101|ADCC
653102|antibody-dependent cell-mediated cytotoxicity
653103|antibody-dependent cellular cytotoxicity
653105|Akt
653106|protein kinase B
653109|chlorotoxin
653110|CTX
653112|cross-talk
653114|epidermal growth factor
653115|EGF
653117|immunohistochemistry
653119|insulin-like growth factor
653120|IGF
653121|somatomedin
653123|insulin-like growth factor receptor
653124|IGFR
653126|mTOR
653127|mammalian target of rapamycin
653129|nanometer
709263|liposome-encapsulated irinotecan hydrochloride PEP02
709264|PEP02
709486|tannin
709487|tannic acid
709489|indole
710387|FOLFIRI-bevacizumab
710543|brentuximab vedotin
710544|SGN-35
710547|Adcetris
710558|Zelboraf
710948|crizotinib
710949|Xalkori
711109|risk group
711864|irrigation
711865|lavage
711867|R-CVP regimen
711868|R-CVP
711870|FOLFIRINOX regimen
711871|FOLFIRINOX
712855|parametrium
712876|prenatal
712877|antenatal
712879|fetal
712881|optic neuritis
712883|cumulative risk
712884|lifetime risk
713797|Caprelsa
713798|mitomycin C
713958|Fluoroplex
713959|Efudex
714001|nuclear medicine
714353|oxymorphone hydrochloride
714355|Opana
757143|androgen receptor
757144|AR
757224|immunoconjugate
757278|pediatrician
757525|hyper-CVAD
757527|hyper-CVAD regimen
758197|Busulfex
758198|Myleran
758358|HIV negative
758612|OFF regimen
758613|OFF
773132|orphan drug
773135|orphan drug designation
773856|yeast infection
773858|beta-sitosterol
773860|NF-kappa B
773861|nuclear factor-kappa B
773862|NF-kB
773927|PCV
773928|PCV regimen
774370|investigational group
774371|experimental group
774376|testicular sperm extraction
774377|TESE
774381|ovarian tissue cryopreservation
774382|ovarian tissue freezing
774384|follow-up care
774386|radioactive glucose
774388|live virus vaccine
774405|oocyte cryopreservation
774488|clinical research
774491|testicular tissue cryopreservation
774492|testicular tissue freezing
774531|HER2 negative
774532|human epidermal growth factor receptor 2 negative
666668|congenital pure red cell aplasia
666669|DBA
666670|Blackfan–Diamond anemia
666671|inherited erythroblastopenia
666673|ectopic pregnancy
666674|extrauterine pregnancy
666675|MET/VEGFR-2 inhibitor GSK1363089
666677|pregnancy
666679|ribosome
666684|Werner syndrome
666685|adult progeria
666686|WS
666689|human papillomavirus DNA test
666690|HPV DNA test
666693|paternal
666694|ultraviolet A radiation
666695|ultraviolet B radiation
666697|UVC radiation
666698|ultraviolet C radiation
666706|AMG 102
666707|anti-HGF monoclonal antibody AMG 102
666709|ethiodized oil
666710|iodized oil
666711|Lipiodol
666712|Ethiodol
666714|LMP400
666716|LMP776
666718|stem cell rescue
740563|molecular weight
740690|trazodone
740691|Effexor
740854|hereditary paraganglioma-pheochromocytoma syndrome
740896|regorafenib
740897|Stivarga
741649|VAIN
741650|VIN
741734|vulvar carcinoma in situ
741769|precision medicine
742474|proctoscope
742478|fluid replacement therapy
742483|myeloblast
742485|PET-CT scan
742486|positron emission tomography-computed tomography scan
742487|omacetaxine mepesuccinate
742488|Synribo
742565|yttrium Y 90-clivatuzumab tetraxetan
743063|tobacco tar
743133|Oleptro
743134|Zyban
743135|Wellbutrin
743301|dura mater
764583|cervical dysplasia
765003|VIP regimen
765056|VIP
765476|malignant pericardial effusion
765478|malignant peritoneal effusion
765479|calcium antagonist
765617|stage IA esophageal squamous cell carcinoma
765619|stage IB esophageal squamous cell carcinoma
765622|stage IIA esophageal squamous cell carcinoma
765624|stage IIB esophageal squamous cell carcinoma
765626|stage IIIA esophageal squamous cell carcinoma
765628|stage IIIB esophageal squamous cell carcinoma
765630|stage IIIC esophageal squamous cell carcinoma
765862|modified radical hysterectomy
765906|blood stem cell
766166|molecular test
766286|Pap/HPV cotest
766288|stage IA esophageal adenocarcinoma
766292|stage IB esophageal adenocarcinoma
766295|stage IIA esophageal adenocarcinoma
766298|stage IIB esophageal adenocarcinoma
766308|stage IIIA esophageal adenocarcinoma
766310|stage IIIB esophageal adenocarcinoma
778478|diamorphine hydrochloride
778479|diacetylmorphine hydrochloride
778495|ketoprofen
778643|pain flare
778736|CEM
778737|CEM regimen
779095|liquid biopsy
779197|melphalan hydrochloride
779253|Alkeran for Injection
779580|bowel obstruction
779581|intestinal obstruction
779582|mechanistic target of rapamycin
779585|fecal impaction
779588|embryo banking
779589|egg banking
779590|ovarian tissue banking
779598|cryobanking
674712|straight colorectal anastomosis
674713|99m-Tc-Dx
674715|Tc-99m Dextran
674716|Tc-99m SC
674717|Tc 99m sulfur colloid
674942|balloon catheter radiation
675317|foretinib
675515|Lumigan
680417|tracheal carina
680686|18F-fluoromethylcholine
680687|fluorine F 18-fluoromethylcholine
680688|18F-FMCH
743888|ductal intraepithelial neoplasia
743889|DIN
743892|lobular intraepithelial neoplasia
743893|LIN
743915|cabozantinib-s-malate
743916|Cometriq
743926|MDS
744185|ponatinib hydrochloride
744186|Iclusig
744564|stage I intraocular melanoma of the iris
744566|stage II intraocular melanoma of the iris
744606|stage III intraocular melanoma of the iris
744608|stage IV intraocular melanoma of the iris
744611|stage I intraocular melanoma of the ciliary body and choroid
744613|stage IIA intraocular melanoma of the ciliary body and choroid
744618|stage IIIA intraocular melanoma of the ciliary body and choroid
744621|stage IV intraocular melanoma of the ciliary body and choroid
744625|palliative sedation
744627|cardiopulmonary resuscitation
744629|CPR
744631|pinealoma
744632|antiangiogenesis agent
744885|stage IIB intraocular melanoma of the ciliary body and choroid
744887|stage IIIB intraocular melanoma of the ciliary body and choroid
744889|stage IIIC intraocular melanoma of the ciliary body and choroid
745112|FOLFIRI-cetuximab
745113|FOLFIRI-cetuximab regimen
745784|TRAM flap
745785|transverse rectus abdominis myocutaneous flap
745787|latissimus dorsi flap
745789|free flap
745791|pedicle flap
745805|cerebrovascular accident
745806|CVA
766314|stage IIIC esophageal adenocarcinoma
766465|ophthalmic artery infusion
766467|intravitreal chemotherapy
766469|Rubinstein-Taybi syndrome
766471|ketogenic diet
766473|leptin
766802|heritable
766804|nonheritable
766991|XELIRI
766992|XELIRI regimen
767115|CAPIRI
767116|CAPIRI regimen
767205|blinatumomab
767206|Blincyto
767370|lanreotide acetate
767371|Somatuline Depot
767469|Lynparza
767620|recombinant human papillomavirus nonavalent vaccine
767621|Gardasil 9
779660|ROS1 gene
779694|sperm cryopreservation
779696|testicular sperm aspiration
779697|TESA
779699|percutaneous epididymal sperm aspiration
779702|scatter radiation
779748|azoospermia
779750|contraception
779751|birth control
779792|Evomela
779798|Arimidex
779936|Defitelio
780125|Hydrea
780127|Droxia
780216|treatment summary
780218|survivorship care plan
780219|follow-up care plan
780268|venetoclax
780269|Venclexta
780302|gonadal shielding
780358|testicular shielding
780360|reproductive endocrinologist
780384|oophoropexy
780385|ovarian transposition
635448|normal range
635449|reference range
635450|reference interval
635451|reference values
635453|Drug Accountability Record
680689|18F-choline
680693|11C-choline
680697|gold seeds
680698|gold fiducial marker seeds
680699|gold-seed fiducial markers
680700|gold fiducial markers
680704|plexiform fibrohistiocytic tumor
680706|fiducial marker
681118|Breslow depth
681119|Breslow thickness
681121|MR
681122|mitotic rate
681124|immunosignature
681127|microarray
681501|iniparib
682069|IL-10
682070|IL-13
682071|IL-5
682153|cabazitaxel
682154|Jevtana
682155|taxoid XRP6258
682415|stage IB non-small cell lung cancer
682419|stage IIB non-small cell lung cancer
682421|stage IIIB non-small cell lung cancer
683196|aniridia
683203|auditory
683206|bavituximab
683207|Tarvacin
683250|brain stem auditory evoked response test
683251|BAER test
683252|auditory brain stem response test
683253|ABR test
683337|choroid plexus
683339|chronic heart failure
683340|CHF
683342|concentration
683344|Costello syndrome
683346|diabetes insipidus
683348|elacytarabine
683350|CP-4055
683354|Elacyt
683420|clinical staging
683422|medicated urethral system for erection
683423|MUSE
683522|episodic breathlessness
683526|motor neuron disease
683528|Noonan syndrome
683532|reactivate
683536|water deprivation test
683640|ABVE-PC
683641|ABVE-PC regimen
746370|lobular neoplasia
746427|Pomalyst
746942|risperidone
746943|bacillus Calmette-Guérin vaccine
746944|bacillus Calmette-Guérin solution
746945|Risperdal
747093|ado-trastuzumab emtansine
747094|Kadcyla
747095|T-DM1
747355|erythropoiesis
747357|erythropoiesis-stimulating agent
747358|ESA
747577|leptomeningeal carcinomatosis
747897|pH
747977|distal urethral cancer
747979|proximal urethral cancer
748114|glucose-6-phosphate dehydrogenase deficiency
748115|G6PD deficiency
748129|acetone
748134|betel quid with tobacco
748135|gutka
748137|cardiovascular disease
748138|heart disease
748140|Centers for Disease Control and Prevention
748141|CDC
748143|chewing tobacco
748144|spit tobacco
748146|cigar
748148|cigarette
748151|clove cigarette
748153|snuff tobacco
767625|ADC
767627|nonavalent vaccine
767746|Opdivo
767747|nivolumab
768142|testicular intraepithelial neoplasia
768143|testicular intratubular germ cell neoplasia
768575|constitutional DNA
768581|R-EPOCH
768582|R-EPOCH regimen
768594|infratentorium
768872|palbociclib
768873|Ibrance
780685|double-hit lymphoma
780686|DHL
780700|Cabometyx
780780|BuMel
780781|BuMel regimen
780789|MYCN amplification study
688801|Ayurvedic medicine
688803|nurse case manager
688805|clinical trial sponsor
688810|combination therapy
688832|comprehensive pediatric cancer center
688834|consent form
688836|counselor
688838|curative surgery
688840|treatment cycle
689011|definitive diagnosis
689016|external right atrial catheter
689026|extremity
689041|lower extremity
689048|upper extremity
689062|limb-sparing surgery
689066|manipulative and body-based practice
689078|medical history
689082|clinical trial phase
689084|peripherally inserted central catheter
689086|principal investigator
689091|prosthetist
689093|reflexology
689095|staging system
689097|integrative medicine
689101|vascularized autologous bone graft
689103|oral chemotherapy
689105|venous catheter
689122|COG
689224|Ayurveda
689225|case management nurse
689226|trial sponsor
689357|subependymal giant cell astrocytoma
689414|Children's Oncology Group
689502|SEGA
689545|multimodality therapy
689546|consent process
689569|diagnostic test
689577|guided imagery
689578|imaging test
689605|intravasation
689612|extravasation injury
689621|manual healing
689626|PICC
689627|PI
689628|relaxation therapy
689630|standard medical care
689698|transurethral incision of the prostate
689699|TUIP
750857|lymphocyte-predominant Hodgkin lymphoma
750858|LPHL
751149|electrocoagulation
751150|fundoscopy
751152|OPPA regimen
751153|OPPA
751176|afatinib dimaleate
751177|Gilotrif
751196|preterm birth
751275|Aredia
751401|gemcitabine-oxaliplatin regimen
751402|gemcitabine-oxaliplatin
751862|hereditary breast and ovarian cancer syndrome
751863|HBOC syndrome
751871|Turcot syndrome
751987|jejunum
751989|ileum
751991|Platinol-AQ
752241|chronic myeloproliferative neoplasm
752243|OEPA regimen
752244|OEPA
752262|stage IV Sezary syndrome
769612|lenvatinib mesylate
769613|Lenvima
769763|liver and bile duct cancer
769815|pancreatic tumor
769886|Zarxio
770167|dinutuximab
770168|Unituxin
770184|intrahepatic bile duct cancer
770481|oligometastasis
770483|metabolomics
770485|cancer-related post-traumatic stress
770487|fight-or-flight syndrome
770605|yeast
770608|transcriptomics
770929|redox
770930|oxidation-reduction
771102|Tabloid
781864|beta-adrenergic antagonist
781867|PHACE syndrome
781869|antifibrinolytic agent
781880|propranolol hydrochloride
781881|Inderal
781882|Hemangeol
781893|emollient
781895|internal medicine
781930|Maffucci syndrome
781932|LUMBAR/PELVIS/SACRAL syndrome
781934|Klippel-Trenaunay syndrome
782021|Stewart-Treves syndrome
782178|PEB
691033|TUNA
691331|chemoreduction
691342|cerebellar mutism syndrome
691343|CMS
691409|ammonia
691411|bismuth
691415|proton pump inhibitor
691416|PPI
691418|lansoprazole
691419|Prevacid
691423|alpha-tocopherol
691466|transgenic mice
691480|cytotoxin
691484|meta-analysis
692083|chlorambucil-prednisone
692084|chlorambucil-prednisone regimen
692485|Bexxar
692594|fluid deprivation test
693054|transurethral electroevaporation of the prostate
693531|general surgery
693536|hematopathology laboratory
693540|hematopoietic stem cell
693544|latency period
693548|limb-salvage surgery
693550|nonspecific immunomodulating agent
693555|pediatric oncologist
693559|childhood acute lymphoblastic leukemia risk group system
693564|rotationplasty
693568|spinal canal
693575|metallic endoprosthesis
749669|radium Ra 223-dichloride
749670|Xofigo
749897|ophthalmoscopy
749898|funduscopy
749900|capsule endoscopy
749902|double balloon enteroscopy
749903|double balloon endoscopy
749904|DBE
749906|GTD
749907|GTT
749909|CT-guided biopsy
749912|neuropsychologist
750028|COPP-ABV
750029|COPP-ABV regimen
750069|dabrafenib
750070|Tafinlar
750072|trametinib
750073|Mekinist
750103|blood culture
750105|urine culture
750107|minimally invasive surgery
750109|sign
750209|invasive ductal carcinoma
750211|invasive lobular carcinoma
750212|infiltrating lobular carcinoma
750798|kinase inhibitor
750801|BRAF kinase inhibitor
750803|agoraphobia
771110|netupitant and palonosetron hydrochloride
771112|Akynzeo
771301|chimeric antigen receptor T-cell therapy
771302|CAR T-cell therapy
771724|radioprotective agent
772565|genomic characterization
772584|research advocate
772586|collective patient perspective
772606|immune checkpoint inhibitor
772812|bone scintigraphy
783040|undifferentiated sarcoma
783041|unclassified sarcoma
783043|malignant triton tumor
783045|sclerosing epithelioid fibrosarcoma
783047|pleomorphic liposarcoma
783049|myxoid liposarcoma
783149|MHT
783162|radiation cystitis
783164|cystitis
783187|HER2/neu test
783188|urothelial cancer
783521|copay
783522|copayment
783524|deductible
783590|explanation of benefits
783591|EOB
783668|reverse transcription-polymerase chain reaction
783669|RT-PCR
783961|epigenetic variant
784089|radiofrequency radiation
784091|electromagnetic spectrum
784093|extremely low frequency electromagnetic field
784094|ELF-EMF
784118|patient-derived xenograft
784119|PDX
787959|fluorine F 18-fludeoxyglucose
787960|fluorine F 18-16 alpha-fluoroestradiol
787963|carbon C 11-choline
787969|chimeric antigen receptor
655134|TRPV6
655135|transient receptor potential cation channel, subfamily V, member 6
655139|phosphoric acid
655175|atypical squamous cells of undetermined significance
655176|ASC-US
655177|ASCUS
655245|overall survival
655246|OS
655248|median overall survival
655249|median survival
655254|relapse-free survival
655255|RFS
655258|PFS
655259|TTP
655260|DFS
655264|cause-specific survival
655265|CSS
655269|event-free survival
655270|EFS
656227|nutrigenomics
714357|Numorphan
715242|Dilaudid
715244|Hydrostat IR
715249|Velsar
715346|linitis plastica
715624|atypical mole
716077|cannabinoid
716092|carboplatin-Taxol
716285|Cannabis
716287|controlled substance
716290|nabilone
716423|Mitozytrex
716424|Mutamycin
717157|pancreatoduodenectomy
717443|epigenetics
717445|epimutation
717446|epigenetic alteration
718931|asparaginase Erwinia chrysanthemi
718932|Erwinaze
718939|orantinib
718942|ruxolitinib phosphate
718943|Jakafi
718980|colostomy irrigation
759131|BCNU
759132|BiCNU
759140|fecal immunochemical test
759141|FIT
759143|guaiac fecal occult blood test
759144|gFOBT
759145|guaiac smear test
759146|stool guaiac test
759626|HIV test
759628|HIV window period
759894|overdiagnosis
759896|overtreatment
759898|alpha emitter radiation therapy
760312|Cyramza
760426|Sylvant
760577|Purixan
775144|Edwards syndrome
775436|PHR
775463|rolapitant hydrochloride
775464|Varubi
775580|multiple-gene test
775581|multigene test
775607|end-stage cancer
775750|Neupogen
775863|trifluridine and tipiracil hydrochloride
775864|Lonsurf
784253|infantile myofibromatosis
784255|histone methyltransferase inhibitor
784256|HMT inhibitor
784258|LOXO-101
784260|entrectinib
784261|lorvotuzumab mertansine
784304|extraskeletal Ewing sarcoma
784322|coinsurance
784324|health insurance premium
784326|non-inferiority trial
784486|Leustatin
784567|olaratumab
784568|Lartruvo
784578|PBSCT
784580|GnRHa
784756|CEV
784757|CEV regimen
784772|scattered fibroglandular breast tissue
784774|heterogeneously dense breast tissue
784776|extremely dense breast tissue
784778|2-D mammography
784779|2-dimensional mammography
784781|3-D mammography
784782|3-dimensional mammography
784783|breast tomosynthesis
784814|ovarian reserve
784816|ovarian follicle
784818|anti-Mullerian hormone
784819|AMH
784947|race
784950|ethnic group
785051|surrogate pregnancy
785054|pelvic lymph node
785060|BMT
785061|TBI
785255|hemihyperplasia
785262|ovarian insufficiency
785263|ovarian failure
789225|histiocytosis
663329|transarterial chemoembolization
663330|TACE
663332|whole-brain radiation therapy
663333|WBRT
663334|tetradecanoylphorbol acetate
663350|whole-brain radiotherapy
663502|liposomal doxorubicin hydrochloride
663505|liposomal paclitaxel
663507|LipoTaxen
735324|endocervix
735326|distal colon
735328|proximal colon
735330|gynecomastia
735450|NFE2L2
735456|Perjeta
736216|stage 0 nonmelanoma skin carcinoma in situ on the eyelid
736217|nonmelanoma skin carcinoma in situ on the eyelid
736219|stage I nonmelanoma skin cancer on the eyelid
736221|stage II nonmelanoma skin cancer on the eyelid
736223|stage III nonmelanoma skin cancer on the eyelid
736225|stage IV nonmelanoma skin cancer on the eyelid
736791|123I-MIBG
736792|iodine I 123-metaiodobenzylguanidine
736798|MIBG scan
736799|iobenguane scan
736800|metaiodobenzylguanidine scan
737122|Oncotype DX breast cancer assay
737131|MammaPrint
737132|70-gene signature
737134|fibrin
737136|fibrinogen
737139|nuclear matrix protein 22
737140|NMP22
737142|HE4
737143|human epididymis protein 4
737144|CD117
737149|chromosome 3
737154|chromosome 7
763151|TPF
763152|TPF regimen
763267|idelalisib
763268|Zydelig
763770|endoplasmic reticulum
763772|Golgi complex
763773|Golgi apparatus
763774|Golgi body
763776|nucleolus
763950|docetaxel-cisplatin-fluorouracil
763951|DCF
763954|Taxotere-Platinol-fluorouracil
764117|CNS depressant
764137|Aicardi syndrome
764538|pembrolizumab
764540|Keytruda
776992|daratumumab
776993|Darzalex
777025|primary mediastinal large B-cell lymphoma
777027|PD-1
777030|CTLA-4
777065|ixazomib citrate
777066|Ninlaro
777073|Waldeyer’s ring
777077|Chlamydophila psittaci
777080|necitumumab
777081|Portrazza
777246|Empliciti
777247|elotuzumab
777448|alectinib
777449|Alecensa
777717|uridine triacetate
777718|Vistogard
777776|Carac
778189|Tolak
778269|non-ionizing radiation
778326|restaging
778475|buprenorphine hydrochloride
787353|Ethyol
787369|Trk inhibitor LOXO-101
787460|CRISPR-Cas9
787678|ribociclib
787679|Kisqali
787895|fluorine F 18-fluoromisonidazole
787903|avelumab
787904|Bavencio
787955|fluorine F 18-fluorothymidine
790161|financial stress
790162|financial hardship
790163|financial burden
790164|economic burden
790165|economic hardship
790212|bankruptcy
790244|enasidenib mesylate
790245|Idhifa
790285|daunorubicin hydrochloride and cytarabine liposome
790286|Vyxeos
790566|inotuzumab ozogamicin
790567|Besponsa
790568|pediatric cancer
790620|IDH2 gene
790621|isocitrate dehydrogenase-2 gene
790623|therapy-related acute myeloid leukemia
723852|osteonecrosis
723854|avascular necrosis
723855|aseptic necrosis
723856|ischemic necrosis
723860|osteochondroma
723866|contracture
723872|sinusoidal obstruction syndrome
723879|topoisomerase II inhibitor
724818|CA 15-3
760747|ceritinib
760748|Zykadia
760830|giant lymph node hyperplasia
760831|angiofollicular lymph node hyperplasia
761363|proteome
761601|selumetinib
761966|PAD
761967|PAD regimen
762205|Idamycin
762307|carmustine implant
762531|HIV antibody test
762533|HIV RNA test
762605|HIV DNA test
762782|Beleodaq
762975|investigational new drug
762976|IND
763008|skull
763009|cranium
763019|multiple-gene panel test
775967|biliary bypass
775969|JAK2 gene
775971|hospitalist
776051|NCI-supported clinical trial
776353|intravenous chemotherapy
776355|National Clinical Trials Network
776356|NCTN
776368|plasmablastic lymphoma
776371|endemic
776570|irinotecan hydrochloride liposome
776571|Onivyde
776574|Yondelis
776579|VAC
776580|VAC regimen
776628|talimogene laherparepvec
776629|Imlygic
776630|T-VEC
776821|MPL gene
776823|CALR gene
776825|adolescent
776875|cobimetinib
776876|Cotellic
776961|osimertinib
776962|Tagrisso
785265|secondary ovarian insufficiency
785267|endocrine gland
785269|reproductive hormone
785476|primary renal myoepithelial carcinoma
785626|ductography
785627|galactography
785629|diffuse optical tomography
785630|DOT
785632|diffuse optical imaging
785633|DOI
785635|vaginal atrophy
785636|atrophic vaginitis
785638|vaginal stenosis
785682|Oncotype DX ductal carcinoma in situ (DCIS) assay
785684|sperm aspiration
785687|granular cell tumor
785688|Abrikossoff tumor
785690|oculodermal melanocytosis
785691|nevus of Ota
785881|rucaparib camsylate
785882|Rubraca
785884|wild-type KRAS gene
791149|abemaciclib
791150|Verzenio
791266|axicabtagene ciloleucel
791268|Yescarta
791292|Valstar
791334|acalabrutinib
791335|Calquence
791353|cytokine release syndrome
791361|patient navigator
791463|Ogivri
739789|504 plan
739791|immunomodulating agent
739821|embryo cryopreservation
739944|Afinitor Disperz
739953|bosutinib
739954|Bosulif
740024|enzalutamide
740025|Xtandi
740216|stage I thymoma
740219|stage II thymoma
740223|stage III thymoma
740225|stage IV thymoma
779599|testicular tissue banking
753854|intermediate grade
753856|National Lung Screening Trial
753857|NLST
753859|United States Preventive Services Task Force
753860|USPSTF
753862|Cancer Intervention and Surveillance Modeling Network
753863|CISNET
753865|genomic sequencing
753867|DNA sequencing
753869|mTOR inhibitor
753871|The Cancer Genome Atlas
753872|TCGA
753874|conjugate
753876|immunoconjugate therapy
753981|GEMOX
754011|monotherapy
754024|immune system disorder
754026|lead compound
754028|dihydrofolate reductase inhibitor
754029|DHFR inhibitor
754220|hereditary cancer syndrome
754221|inherited cancer syndrome
754339|obinutuzumab
754340|Gazyva
754715|humor therapy
754716|laughter therapy
754851|ibrutinib
754852|Imbruvica
729824|mind-body practice
729831|surrogate endpoint
729833|verum acupuncture
729976|absolute neutrophil count
729977|ANC
729979|CBC with differential
729980|blood cell count with differential
729982|stem cell engraftment
729984|hematocrit
729985|HCT
729988|full blood count
729990|chiropractic therapy
730162|actinomycin D
730163|Cosmegen
730354|meditation
730358|orthopedic surgeon
730363|sedation
730365|minimal sedation
730366|anxiolysis
756464|fresolimumab
756804|Nilandron
756936|LHRH
757012|transarterial embolization
757013|TAE
752848|HPV test
752850|HPV/Pap cotest
752980|bivalent vaccine
752982|quadrivalent vaccine
752984|spermicide
753083|high-risk HPV
753084|high-risk human papillomavirus
753086|low-risk HPV
753087|low-risk human papillomavirus
753198|Zoladex
753199|ZDX
753369|obstetrics and gynecology
753370|ob/gyn
753372|obstetrician
753376|estrogen cream
753517|LH-RH antagonist
753518|luteinizing hormone-releasing hormone antagonist
753519|gonadotropin-releasing hormone antagonist
753521|GnRH antagonist
753525|castrate-resistant prostate cancer
753527|CRPC
753529|pancreatic endocrine tumor
753530|testosterone flare
753531|pancreatic neuroendocrine tumor
753533|vitality
753541|GnRH agonist
753608|complete androgen blockade
780537|echocardiogram
732569|ovarian shielding
732576|HLA matching
732578|human leukocyte antigen matching
732589|histologic grade
732591|cell type
733638|scientific review panel
733639|scientific review committee
733642|cancer subtype
733684|reproductive medicine
733789|childhood cancer risk group
733794|rescue transplant
733834|blood cancer
780791|T-cell receptor gene rearrangement test
781154|atezolizumab
781155|Tecentriq
781234|cART
781235|combination antiretroviral therapy
781299|HER2 test
781300|human epidermal growth factor receptor 2 test
781531|vascular tumor
781533|benign vascular tumor
781537|angiofibroma
781539|juvenile nasopharyngeal angiofibroma
781541|tufted angioma
781543|kaposiform hemangioendothelioma
781545|retiform hemangioendothelioma
781547|papillary intralymphatic angioendothelioma
781548|Dabska tumor
781614|infantile hemangioma
781616|congenital hemangioma
781618|epithelioid hemangioma
781619|angiolymphoid hyperplasia with eosinophilia
781620|histiocytoid hemangioma
781622|composite hemangioendothelioma
781624|epithelioid hemangioendothelioma
781626|Kasabach-Merritt syndrome
781628|pyogenic granuloma
781629|lobular capillary hemangioma
781637|spindle cell hemangioma
781858|sclerotherapy
781861|beta-blocker
781862|beta-adrenergic blocking agent
787970|CAR
787980|T-cell receptor
787982|TCR
787987|squamous cell skin cancer
787988|squamous cell carcinoma of the skin
788029|hormone receptor positive
788033|hormone receptor negative
788165|niraparib tosylate monohydrate
788167|Zejula
788430|EPOCH-O regimen
788431|EPOCH-O
788711|11C-acetate
788754|Rydapt
788756|brigatinib
788757|Alunbrig
788775|durvalumab
788776|Imfinzi
789006|hypotrichosis
789008|hypohidrosis
789010|FLT3 gene
789073|aggressive systemic mastocytosis
789074|ASM
789076|systemic mastocytosis with associated hematologic neoplasm
789077|SM-AHN
789079|mast cell leukemia
790624|t-AML
790626|acute myeloid leukemia with myelodysplasia-related changes
790627|AML-MRC
790629|circadian rhythm
790631|TIL
790747|tisagenlecleucel
790748|Kymriah
790750|proteogenomics
790853|anhidrosis
790952|secondary ovarian failure
791011|IEN
791023|copanlisib hydrochloride
791024|Aliqopa
782179|PEB regimen
782188|Gleostine
782329|DICER1 syndrome
782331|pleuropulmonary blastoma familial cancer syndrome
782333|R-ICE
782334|R-ICE regimen
782356|cystic nephroma
782418|ganetespib
782467|adult-type fibrosarcoma
782469|infantile fibrosarcoma
782470|congenital fibrosarcoma
782471|desmoid-type fibromatosis
782472|aggressive fibromatosis
782474|infantile hemangiopericytoma
782476|myopericytoma
782478|pericytic tumor
782479|perivascular tumor
782481|epithelioid sarcoma
782531|perivascular epithelioid cell tumor
782532|PEComa
782534|myxofibrosarcoma
782536|extrarenal (extracranial) rhabdoid tumor
782538|extraskeletal Ewing tumor
782539|extraosseous Ewing tumor
782541|extraskeletal mesenchymal chondrosarcoma
782635|extraskeletal myxoid chondrosarcoma
782637|extraskeletal osteosarcoma
782638|extraosseous osteosarcoma
782640|low-grade fibromyxoid sarcoma
782642|inflammatory myofibroblastic tumor
782643|undifferentiated pleomorphic sarcoma
748183|THU
748220|smokeless tobacco
748224|mainstream smoke
748226|sidestream smoke
748230|tobacco-specific nitrosamine
748231|TSNA
748233|butane
748239|iq’mik
748241|electronic cigarette
748242|e-cigarette
748244|light cigarette
748245|low tar cigarette
748247|ultra light cigarette
748249|herbal cigarette
748251|smoking cessation
748333|withdrawal
748336|nicotine vaccine
748338|nortriptyline
748339|Pamelor
748340|Aventyl
748342|premature birth
748344|low birth weight
748348|pulmonary function
748349|lung function
748352|pulse
748353|heart rate
748354|primary cancer
748385|premature death
748780|stage I gestational trophoblastic neoplasia
748782|stage II gestational trophoblastic neoplasia
748785|stage III gestational trophoblastic neoplasia
748790|stage IV gestational trophoblastic neoplasia
748810|hookah
748811|water pipe
748813|Department of Health and Human Services
748814|DHHS
748816|methanol
748817|methyl alcohol
748818|wood alcohol
748820|respiratory disease
748821|pulmonary disease
748822|lung disorder
748824|pipe
748826|craving
748828|filter
748830|Surgeon General
748973|electrocautery
748975|biliary cirrhosis
748977|tyrosinemia
748979|progressive familial intrahepatic cholestasis
748980|PFIC
748982|Alagille syndrome
748984|glycogen storage disease
748985|GSD
749332|Sylatron
749437|distal urethra
749439|proximal urethra
774545|sonidegib
774546|erismodegib
774547|LDE225
774549|Odomzo
774686|treatment plan
774687|blood draw
774688|blood chemistry test
774690|well-differentiated
774692|second opinion
774694|grade
774803|COPDAC regimen
774804|COPDAC
774821|attending physician
774823|end-of-life care
774825|cardiologist
774826|electronic health record
774827|EHR
775080|nutrient-dense food
775082|school liaison
775084|rehabilitation services
775115|therapeutic medical play
775143|trisomy 18
789667|rituximab and hyaluronidase
789668|Rituxan Hycela
789683|microsatellite instability-high cancer
789684|MSI-H cancer
789686|pathologic complete response
789689|AIDS-defining cancer
789691|non-AIDS-defining cancer
789692|NADC
789725|pathologic complete remission
789734|mammary duct ectasia
789735|breast duct ectasia
789737|prevalence
789739|biosimilar drug
789741|mismatch repair deficiency
789743|intraepithelial neoplasia
789795|supplemental health insurance
789797|Medicare Part D
789798|Medicare Prescription Drug Coverage
789800|out-of-pocket cost
789802|cost sharing
789804|financial navigator
789981|neratinib maleate
789982|Nerlynx
790072|stage A esthesioneuroblastoma
790074|stage B esthesioneuroblastoma
790076|stage C esthesioneuroblastoma
790078|stage D esthesioneuroblastoma
790106|nasal cavity
790108|esthesioneuroblastoma
790109|olfactory neuroblastoma
790111|NUT midline carcinoma
790112|NMC
790142|wild-type gene
790150|asset
790152|public health insurance
790154|value-based pricing
790156|disability insurance
790159|financial toxicity
790160|financial distress